Anda di halaman 1dari 112

Q3FY13 Results Preview:

Emkay

Earnings to slump again as margins face renewed hurdles

Your success is our success

Emkay Global Financial Services Ltd.


Dhananjay Sinha
Co Head, Institutional Research
Economist and Strategist
+91 22 6624 2435
dhananjay.sinha@emkayglobal.com
Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January,


20132013
|1
8th January,

Earnings to slump again as margins face renewed hurdles


n Q2FY13 marked first sign of earnings revival (Emkay universe APAT growth of 13%) as margins expansion counterbalanced

the decelerating sales growth. However, hopes of earnings revival could possibly hit a road block as our Q3FY13 earnings
estimate highlights renewed margin pressures even as sales growth continues to be in slow lane. Muted earnings performance
will likely weigh on the strong market performance over the past two months
n Emkay Universe (ex financials & oil) is expected to deliver sales growth of 10.3%YoY in Q3FY13E vs 15.1%YoY in Q2FY13.

Decline in margins is expected to dent APAT growth at 2.1%YoY vs 13.5%YoY in Q2FY13. Excluding Top 5 companies, sales
growth in Q3FY13E is expected at 10.6% and APAT growth at -4.2%. Of the 135 companies in Emkay Universe (ex financials
& oil) 53 (39% of total) are expected to show sales growth <10% while 22 (16% of total) are expected to grow over 25%
n Strong sales growth is expected from Pharma, Consumers, Real Estate, Power and Auto Ancillary. Stronger Auto Ancillary

numbers are attributed to Exide (24%) and Motherson Sumi (67%, because of consol numbers not comparable on account of
SMP consolidation). Sectors expected to see deceleration are IT (14.9%), Auto (10.9%), Cement (8.2%) and Metals (-1.4%)
n Emkay Universe (ex financials & oil) is expected to see EBIDTA margin declining to 18.9% vs 19.4% in Q2FY13 and 19.2% in

Q3FY12. Hence our universe is likely to deliver EBIDTA growth of 8.7%YoY


n Outside of Financial and Oil sectors, robust PAT expansion is expected from Real Estate (122%YoY), Auto Ancillary (22%),

Media & Entertainment (18.5%) and Consumers (18.1%). Stress is likely to be seen for Telecom (-24%), Construction (20.2%YoY), Pharma (-17%), Autos (-5%), Metals & Mining (-3.3%) and Engineering & Capital goods (-2.4%)
%YoY growth

Sales

EBIDTA

APAT

Q2FY13

Q3FY13E

Q2FY13

Q3FY13E

Q2FY13

Q3FY13E

Emkay Universe

15.1%

10.3%

16.0%

8.7%

13.5%

2.1%

Emkay Large Cap

15.2%

10.5%

17.1%

8.7%

16.0%

2.6%

Emkay Mid Cap

13.7%

8.8%

8.7%

7.2%

-7.9%

-5.5%

Emkay Small Cap

20.7%

10.9%

19.0%

20.6%

7.2%

24.6%

Source: Company, Emkay Research

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 2

Key sectors-Expectations
n Consumer Goods:

Expect healthy performance with revenue and APAT growth of 15%YoY 18%YoY respectively. The

lopsided revenue growth arising from price led boost in earlier quarters is likely to be balanced out with 8% volume and 7%
price-led growth. Volume growth expectations- Asian Paints (+7%), Berger (+7%), HUL (+7%), Colgate (+9%), Nestle (+3%),
GSK Consumer (+4%), Marico (+9%) and Jubilant FoodWorks (SSG 20%). Titan is expected to report 5% growth in Jewellery
against volume decline in previous quarters. EBIDTA margins are likely to be supported by decline in prices of select inputs
(Palm Oil, Brent Crude and Titanium Dioxide). Robust earnings expected for GSK Consumer (27%YoY), Godrej Consumer
(28%YoY), Jubilant FoodWorks (32%YoY), Marico (37%YoY) and Page Industries (36%YoY). Hindustan Unilever & Nestle
expected to see restricted earnings growth at 12%YoY and 10%YoY respectively. Preferred- Berger, Colgate, GSK
Consumer, Marico and Titan; Avoids- Asian Paints, Hindustan Unilever, GCPL, Jubilant FoodWorks and Page Industries
n IT Services: Expect 2.6-4.2%QoQ US$ revenue growth for Tier I companies with Wipro at lower end and Infosys at the upper

end. Mid-tier companies expected to see 1-10%QoQ US$ revenue growth with TechM at the higher end. We expect margins
to decline sequentially. A reset in INR assumption to Rs 55/$ (vs Rs 53/$ earlier) will lead a reset in FY13 EPS outlook to ~Rs
159.5 vs ~Rs 160.5 earlier. Preferred- HCL Tech, MindTree, TechM/Mah Satyam
n Automobile: We expect the automobile OEM universe to report modest results in Q3 owing a late festive season even as

overall volume growth trajectory remains lackluster. Adjusted EBIDTA margins are likely to decline 80bpsYoY but increase 30
bpsQoQ to 12.7%. Adjusted net profits are likely to decline 5%YoY but improve 12%QoQ to Rs 58 bn. Companies which we
expect to report significantQoQ improvement in margins are MSIL (+170 bps), BJAUT (+100 bps) and HMCL (+60 bps). Poor
CV volumes are likely to lead to a significantQoQ margin drop for AL (-410 bps). We remain cautious on OEM (AL, EIM,
MSIL). Maintain Buy on HMCL, EXID, AMRJ, MSS and Accumulate on MM, TTMT

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 3

Key sectors-Expectations
n Cement: Subdued volumes growth (+2.1%YoY and 7.4%QoQ) for coverage companies and 3.6%QoQ decline in average

price are likely to result in decline in revenue growth at 8%YoY vs 20%YoY in Q2FY13. EBITDA/t at Rs814/t is expected to
decline 1.9%YoY and 19.2%QoQ. Overall EBIDTA is expected to grow 1.2%YoY but decline 11%QoQ led by lower
realizations. We estimate APAT to grow by 4.1%YoY but decline 15%QoQ. Preferred- Shree Cements and Madras Cements
(strong volume growth and improving cost structure led by better energy efficiencies)
n Engineering & Capital goods: Expect muted operational performance in Q3FY13, lower revenue growth (6.2%YoY), lower

other income and higher interest costs. Expect 2% drop in net profits. Muted revenue growth on back of lower order backlogs
and muted demand. Notable exceptions are L&T (+13%), Elecon Engg (+12%) and Punj Lloyd (+12%). Expect stable EBITDA
margins at 12.4% (-20 bpsYoY) with EBITDA growth at 4.9%YoY. High financial leverage to impact earnings performance.
Expect order inflows to decline 7%QoQ. Expect positive earnings surprise for Greaves Cotton and Blue Star. PreferredL&T, Cummins India, Greaves Cotton and Blue Star.
n Agri Input and Chemicals: We expect our universe to report topline growth of 7%YoY on the back of 18%YoY for chemicals

and flat growth for fertilizers. Aggregate APAT is expected to increase by 6%YoY. Fertiliser revenues to be impacted by 31%
decline in Complex fertiliser consumption during Oct/Nov12. Aggregate fertiliser margins for our universe are expected to
decline by 170bpsYoY to 8.7%. Aggregate chemicals EBIT margin is expected to decline by 130bpsYoY to 17.3%. Rabi
season has panned out well for agrochemicals consumption & we are likely to witness volume growth during this quarter.
Preferred-Dhanuka Agritech, Coromandel Intl and Tata Chemicals

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 4

Key

sectors-Expectations

n Banking: Expect modest NII growth for our banking universe at 8%YoY (10% in Q2FY13) due to sluggish 3.3%YoY growth in

NII for PSU banks. NII growth for private banks is expected to remain healthy at 22%YoY. Operating profit growth for our
universe is expected to remain modest at 11%YoY / 5%QoQ. NPA pressure will persist with PSU space (18%YoY growth in
gross slippages to 2.5% of loans). We suspect PSU banks to resort to more of write-off/OTS towards problematic loans. We
factor in 68bps of credit cost for our PSU universe and lower 58bp for our private sector universe. Overall, our universe is
expected to report 12%YoY growth in net profit- 6%YoY for PSU space and 23%YoY for private space. Preferred HDFC
Bank, ICICI Bank & United bank and Mahindra Finance and CRISIL in NBFC space
n Pharmaceuticals: Our Pharma universe expected to report 21%YoY (1%QoQ) revenue growth. OPM expected to increase by

181bps to 24.3%YoY. PAT of Pharma universe is likely to grow by 21%YoY (-4%QoQ). Growth in APAT on account of
Dr.Reddy (78%), Wockhardt (38%), Aurobindo (24%) and Lupin (32%). Preferred- Dr Reddy, Lupin, Wockhardt, Glenmark,
Aurobindo.
n Key things to watch for: Management commentaries on (a) Demand growth & outlook (b) Implications of global slowdown

(c) volatility in commodity prices and (e) Currency volatility. Recent policy measures and their implications on corporate
sentiment, future price actions and financial conditions can reflect on management guidance
n Potential result suprises:

Positive - Allahabad Bank, Blue Star, Colgate, Dr. Reddy, Federal Bank, GIPCL, Glenmark, GPIL, Greaves Cotton, Hero Motocorp,
Lupin, Mahindra & Mahindra, Maruti Suzuki, MindTree, Nava Bharat Ventures, PGCIL & Titan Industries

Negative - ACC, Ambuja Cement, Ashok Leyland, Bhushan Steel, Cadila, Eicher Motors, Godrej Consumer, HEG, Hindustan
Unilever, IPCA, JPVL, Jubilant FoodWorks, Lakshmi Machine Works, Tata Steel, Ultratech Cement & Union Bank

Note: ex Banks & FS, FS - Others and Oil & Gas # Nos in bracket are %YoY change in PAT

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 5

Q3FY13 Preview

Parameters ---->

Net Sales
Growth

Ebitda
Growth

EBITDA
Margin
growth

EBIT
margin
growth

Adjusted
PBT
Growth

Adjusted
PAT
Growth

Interest
Cost
Growth

Tax
Growth

Emkay Universe

10.3%

8.7%

-28 bps

-1 bps

8.3%

2.1%

16.6%

30.3%

Emkay Large Cap

10.5%

8.7%

-32 bps

2 bps

9.5%

2.6%

11.9%

32.3%

8.8%

7.2%

-23 bps

-42 bps

-6.0%

-5.5%

35.5%

6.7%

Emkay Small Cap

10.9%

20.6%

144 bps

148 bps

25.7%

24.6%

16.4%

36.4%

Emkay Universe ex Top 3 Cos

11.1%

7.5%

-65 bps

-29 bps

5.9%

-1.8%

16.5%

34.7%

Emkay Universe ex Top 5 Cos

10.6%

5.0%

-100 bps

-64 bps

3.0%

-4.2%

18.1%

31.9%

Emkay Universe ex Top 3 and Bottom 3 Cos

13.0%

12.1%

-15 bps

-26 bps

7.0%

6.2%

30.7%

14.3%

Emkay Universe ex Top 5 and Bottom 5 Cos

13.0%

12.1%

-16 bps

-33 bps

7.1%

7.3%

32.8%

15.5%

Emkay Mid Cap

# Top 5 companies based on Contribution to PAT Growth are TCS, Sterlite Industires, Tata Steel, DLF and NTPC
Bottom 5 companies based on Contribution to PAT Growth are Ranbaxy, SAIL, Tata Motors, NMDC and Bharti Airtel

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 6

Q3FY13 Strong Results


Company Name

Sector

APAT (Rs mn)


Dec-12

APAT Gr
Dec-11

(%)

Large Caps
DLF

Real Estate

6694

2475

170.5

HCL Tech

IT Services

8635

5529

56.2

JSW Energy

Power

1989

274

626.2

Maruti Suzuki India

Automobiles

5016

2056

143.9

Shree Cements

Cement

Sterlite Industries

Metals & Mining

Tata Power
Union Bank of India

1979

712

178.0

14328

9199

55.7

Power

2261

1172

92.9

Banks & Financial Services

6269

1969

218.4

Mid Caps
Ballarpur Inds

Paper

394

136

190.0

CESC

Power

1749

740

136.4

Gujarat Gas

Oil & Gas

760

248

206.7

Nava Bharat Ventures

Power

Prestige Estates

Real Estate

Sterlite Tech

Others

United Phosphorus

666

378

76.3

1023

282

262.9

237

95

149.8

Agri Input & Chemicals

1744

1154

51.1

Dhanuka Agritech

Agri Input & Chemicals

129

78

65.1

Dishman Pharma

Pharmaceuticals

181

86

110.5

Godawari Power

Metals & Mining

173

106

63.3

Gujarat Industries Power

Power

506

168

201.5

Piramal Glass

Others

331

188

76.0

Small Caps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 7

Q3FY13 Weak Results


Company Name

Sector

APAT (Rs mn)


Dec-12

APAT Gr
Dec-11

(%)

Large Caps
Allahabad Bank

Banks & Financial Services

3021

5604

-46.1

Bharti Airtel

Telecommunications

6923

10113

-31.5

Jaiprakash Associates

Construction

1210

3097

-60.9

JSW Steel

Metals & Mining

2643

4561

-42.1

Ranbaxy Labs

Pharmaceuticals

2899

15146

-80.9

SAIL

Metals & Mining

4218

10984

-61.6

Mid Caps
Hexaware Technologies

IT Services

585

986

-40.7

India Cements

Cement

149

563

-73.6

KSK Energy

Power

502

755

-33.5

Madras Cements

Cement

492

768

-36.0

Manappuram General Finance

Banks & Financial Services

1123

1614

-30.4

Orient Paper

Cement

135

478

-71.8

United Bank Of India

Banks & Financial Services

1470

2260

-34.9

Voltas

Engineering & Capital Goods

396

610

-35.1

HEG

Metals & Mining

393

595

-33.9

JK Paper

Paper

34

74

-54.1

Mcnally Bharat Engineering

Engineering & Capital Goods

64

125

-48.6

Small Cap

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 8

Possible Surprises Positives


Name of the
company
Allahabad Bank
Blue Star
Colgate
Dr. Reddy
Federal Bank

EPS
(Rs)

YoY Reason
gr (%)

-48.7 Assumed tax rate of 30% in Q3FY13 vs 8% in Q3FY12. Management has guided at significant thrust on recoveries
which may bring provision costs lower than we have expected

1.4

Loss to Expect positive earnings surprise led by improvement in operational performance in EMP&PAC division. We have
Profit factored segment EBIT margins at 5.5% (vs 7% in Q2FY13)

10.2
27
12.7

20 Continuation of strong volume and value growth


89 Gain in the market share in key products in US can boost the revenue growth and margins
7.6 Assumed Rs2.6bn of slippages vs Rs1.5bn in last quarter. If no large accounts turn NPAs, slippage number may
come lower than we expected

GIPCL

3.3

Glenmark

5.3

23 India business and EBITDA margins can surprise positively

GPIL

5.5

63 Better than expected iron ore mining and higher sales of pellets due to lower utilizations of sponge iron might boost
the operating performance of the company

Greaves Cotton

1.6

Hero Motocorp

30.1

Lupin

201 Excellent PLF/PAF for Surat

12.6 Expect positive earnings surprise led by pick-up in 3-W volume growth after 7-8 months of decline in volumes
-2 Benefit of operating leverage (vols up 18% QoQ), price hikes and favorable JPY/INR to help margin expansion
33 Tricor sales in US can surprise positively in the numbers

Mahindra & Mahindra

13.7

27 Better product mix with higher share of tractors (31% vs 27% in Q2) and operating leverage benefits (vols up 11%
QoQ) can lead to margin surprise

Maruti Suzuki

17.4

144 Improved operating leverage (vols up 26%YoY/31% QoQ) and announcement on hedges taken for FY14 can lead to
positive surprise

MindTree

22

45.3 We expect upside risks to Dec'12 qtr earnings driven by a possible margin surprise( Emkay es 20.4%, -170 bps
QoQ, +310 bpsYoY)

Nava Bharat Ventures

7.5

76 Commissioning guidance for 150MW in 4Q13 to trigger upsides and stock likely to be re-rated

PGCIL

2.1

22 Expect positive surprise in 4Q13 and FY14 capitalization guidance

Titan Industries

2.2

21.9 Jewelery segment to rebound with volume growth

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 9

Possible Surprises Negatives


Name of the
company

EPS
(Rs)

ACC

11.8

-8.8 Cement volumes growth for the current quarter remains subdued leading to avg cement prices declining by 3.6%
sequentially to Rs289/bag with sharp declines of ~4.5% witnessed in western, eastern and northern regions which
accounts for ~60% of ACC's Dispatches. Consensus estimates for CY13 EPS at ~Rs90 appears optimistic
creating room for disappointment even as stock valuation at PER of 15.5X CY13E remain rich

Ambuja Cement

2.03

15.1 Cement volumes growth for the current quarter remains subdued leading to avg cement prices declining by 3.6%
sequentially to Rs289/bag with sharp declines of ~4.5% witnessed in western, eastern and northern regions which
accounts for ~80-85% of Ambuja's Dispatches. Consensus estimates for CY13 EPS at ~Rs13 appears optimistic
creating room for disappointment even as stock valuation at PER of 16.1X CY13E remain rich

Ashok Leyland

-0.2

NA Poor volumes, low production from Pantnagar, higher discounts and working capital debt to impact earnings

Bhushan Steel

11.6

-11 The EBITDA/ tonne against our estimate fo Rs 14213 might come lower due to rise in input costs and problems of
iron ore sourcing

Cadila
Eicher Motors

11
37.7

Godrej Consumer

6.3

HEG

9.2

YoY Reason
gr (%)

33 Margins can surprise negatively on back of dollor hedges @Rs.50


19 VECV to be impacted due to weak volumes and higher discounts
21.2 Negative surprise in margins in international business
-34 Despite stable utilizations, we believe the input costs can be higher than expected thereby impacting the margins
during this quarter

Hindustan Unilever

IPCA

-14 Margins can surprise negatively due to high base last year and increase in R&D and SG&A spend

JPVL

NA Bina PLF/PAF was very low. FY13 EPS could be downgraded. But expect FY14 to remain intact

Jubilant FoodWorks

6.2

12.1 Expected rise in media intensity

31.4 Earnings cut driven by high pre-operating expenses on Dunkin Donuts

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 10

Possible Surprises Negatives


Name of the
company

EPS
(Rs)

YoY Reason
gr (%)

Lakshmi Machine Works

24.9

-29.3 Order offtake and execution has been significantly lower than managements earlier guidance of better H2FY13.
Overall business environment continues to remain challenging. Power issues in Tamil Nadu continue to prevail,
impacting the business environment. High fuel cost to dent EBITDA during Q3FY13E, leading to lower
profitability.

Tata Steel

-1.4

NA The company might show lower volume than our estimate for both domestic (1.85 mt) and European (3.3)
markets. Also, EBITDA/ tonne in Europe can be lower than our estimate of -$5/ tonne

Ultratech Cement

19

1.4 Cement volumes growth for the current quarter remains subdued leading to avg cement prices declining by 3.6%
sequentially to Rs289/bag with sharp declines of ~4.5% witnessed in western, eastern and northern regions which
accounts for ~65% of Ultratech's Dispatches. Consensus estimates for FY14 EPS at ~Rs118 appears optimistic
creating room for disappointment even as stock valuation at PER of 17.8X FY14E remain rich

Union Bank of India

9.5

205.8 Have assumed significantly higher recoveries/upgrades at Rs5.6bn and consequently lower provisions. Lower
recoveries/upgrades could mean higher provisions and miss on estimates

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 11

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)

Growth (%)

Ebitda (Rs mn)

Growth (%)

APAT (Rs mn)

Growth (%)

EPS (Rs)

Growth (%)

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Agri Input & Chemicals

144290

148833

134649

7%

-3%

19670

19307

19397

1%

2%

9896

9466

9376

6%

5%

4.3

4.1

4.1

6%

5%

Auto Ancillaries

123352

116592

90652

36%

6%

11978

11143

8910

34%

7%

5197

4392

4262

22%

18%

2.5

2.1

2.1

22%

18%

Automobiles

873507

781509

787654

11%

12%

110955

96696

105947

5%

15%

58067

51735

61041

-5%

12%

7.4

6.6

7.7

-5%

12%

Banks & Financial Services

421994

403727

389732

8%

5%

332393

307478

305832

9%

8%

174957

156480

155890

12%

12%

12.9

11.5

11.9

8%

12%

Cement

139716

133568

129089

8%

5%

26435

29609

26171

1%

-11%

13247

15550

12748

4%

-15%

4.8

5.6

4.6

4%

-15%

Construction

80134

72005

71648

12%

11%

22634

22667

21101

7%

0%

6856

7256

8588

-20%

-6%

1.4

1.5

1.7

-20%

-6%

Consumers

204663

190998

178264

15%

7%

32222

29609

27460

17%

9%

22976

21272

19453

18%

8%

4.8

4.4

4.1

17%

8%

Engineering & Capital Goods

356120

325857

335386

6%

9%

44244

42230

42174

5%

5%

27167

25482

27839

-2%

7%

5.9

5.5

6.1

-2%

7%

Financial Services - Others

3539

3331

2718

30%

6%

1208

1140

941

28%

6%

846

755

674

25%

12%

10.6

9.4

8.2

29%

12%

509351

495482

443348

15%

3%

121094

120637

111191

9%

0%

92094

94364

83904

10%

-2%

12.0

12.2

10.9

10%

-2%

28003

26980

24914

12%

4%

6400

5940

6006

7%

8%

3080

3172

2599

19%

-3%

1.1

1.2

0.9

19%

-3%

799117

810961

810533

-1%

-1%

124764

124572

130843

-5%

0%

62828

62411

64995

-3%

1%

3.1

3.1

3.3

-3%

1%

3129636

3500145

3498925

-11%

-11%

91748

442745

424030

-78%

-79%

-37071

331540

244093

-1.8

16.1

11.8

20253

20521

18493

10%

-1%

3795

3592

2799

36%

6%

681

608

12%

0.8

0.7

0.0 1915%

12%

Pharmaceuticals

234279

231307

213454

10%

1%

57705

59757

61251

-6%

-3%

36843

38689

44255

-5%

8.1

8.5

9.7

-5%

Power

409351

396764

342138

20%

3%

119765

125020

87101

38%

-4%

44763

43802

38818

15%

2%

1.2

1.0

1.0

22%

15%

59636

30199

27419

117%

97%

20450

11407

11181

83%

79%

9877

3711

4447

122%

166%

3.8

1.4

1.7

122%

166%

256961

255970

235386

9%

0%

77108

77732

73030

6%

-1%

9267

9612

12123

-24%

-4%

1.3

1.4

1.7

-24%

-4%

Others

56605

57543

50556

12%

-2%

12915

12869

12476

4%

0%

5276

6346

5239

1%

-17%

5.2

6.2

5.1

1%

-17%

Emkay

7850506

8002290

7784959

1%

-2%

1237483

1544150

1477841

-16%

-20%

546847

886642

800378

-32%

-38%

3.7

5.8

5.3

-31%

-36%

Emkay*

4295337

4095087

3893584

10%

5%

812134

792788

747038

9%

2%

408115

397868

399721

2%

3%

3.6

3.3

3.4

4%

7%

Large Cap*

3700413

3503117

3347755

11%

6%

717242

697728

659714

9%

3%

373740

363408

364367

3%

3%

3.8

3.7

3.7

3%

3%

529394

525894

486740

9%

1%

83165

83983

77602

7%

-1%

30380

30791

32148

-5%

-1%

2.0

1.5

1.8

8%

30%

65530

66076

59088

11%

-1%

11727

11076

9722

21%

6%

3994

3669

3207

25%

9%

3.2

3.0

2.6

25%

9%

IT Services
Media & Entertainment
Metals & Mining
Oil & Gas
Paper

Real Estate
Telecommunications

Mid Cap*
Small Cap*

34 1915%
-17%

-17%

* Note: ex Banks & FS, FS - Others and Oil & Gas

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 12

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Company Name

Growth (%)

Q3FY13

Q2FY13

Q3FY12

Chambal Fertilisers

21266

23407

17966

Coromandel International

20213

25678

25497

YoY

Ebitda (Rs mn)

Growth (%)
YoY

QoQ

APAT (Rs mn)


Q3FY13

Q2FY13

Growth (%)

QoQ

Q3FY13

Q2FY13

Q3FY12

Q3FY12

18%

-9%

2056

1951

2039

1%

5%

932

896

862

-21%

-21%

1920

2374

2335

-18%

-19%

1044

1532

1472

YoY

EPS (Rs)

Growth (%)

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

8%

4%

2.2

2.2

2.1

8%

4%

-29%

-32%

3.7

5.5

5.2

-29%

-32%

Agri Input & Chemicals

Deepak Fertilisers

6207

6934

6015

3%

-10%

977

803

1149

-15%

22%

509

406

637

-20%

25%

5.8

4.6

7.2

-20%

25%

Dhanuka Agritech

1314

2063

1104

19%

-36%

184

306

127

45%

-40%

129

237

78

65%

-45%

2.6

4.7

1.6

65%

-45%

GNFC

10578

11658

10429

1%

-9%

1457

1453

1573

-7%

0%

744

724

862

-14%

3%

4.8

4.7

5.5

-14%

3%

GSFC

14452

14160

13000

11%

2%

2022

2028

2580

-22%

0%

1471

1505

1724

-15%

-2%

3.7

3.8

4.3

-15%

-2%

3792

4855

3251

17%

-22%

611

967

553

10%

-37%

353

591

310

14%

-40%

1.8

3.0

1.6

14%

-40%

Tata Chemicals

45109

41518

38099

18%

9%

6704

6165

5558

21%

9%

2968

2327

2277

30%

28%

11.6

9.1

8.9

30%

28%

United Phosphorus

21361

18560

19288

11%

15%

3738

3261

3484

7%

15%

1744

1248

1154

51%

40%

3.8

2.7

2.5

51%

40%

Rallis India

Auto Ancillaries
Amara Raja Batteries
Apollo Tyres
CEBBCO

7358

7187

6131

20%

2%

1103

1180

1063

4%

-7%

707

795

659

7%

-11%

8.3

9.3

7.7

7%

-11%

34689

33748

32282

7%

3%

3981

3669

3243

23%

9%

1628

1533

1278

27%

6%

3.2

3.0

2.5

27%

6%

1550

1538

1328

17%

1%

287

312

188

52%

-8%

145

163

113

29%

-11%

2.6

3.0

2.0

29%

-11%

Exide Industries

15475

15214

12502

24%

2%

2130

1882

1762

21%

13%

1411

1202

1182

19%

17%

1.7

1.4

1.4

19%

17%

Motherson Sumi

64280

58905

38408

67%

9%

4477

4100

2654

69%

9%

1306

700

1030

27%

87%

2.2

1.2

1.8

25%

87%

23337

32960

28798

-19%

-29%

1400

3341

2104

-33%

-58%

-400

1426

669

-0.2

0.5

0.3

Automobiles
Ashok Leyland
Bajaj Auto

54981

49724

49859

10%

11%

10674

9152

9841

8%

17%

8233

7407

8364

-2%

11%

28.5

25.6

28.9

-2%

11%

Eicher Motors

16042

14831

15766

2%

8%

1329

1114

1538

-14%

19%

1018

660

854

19%

54%

37.7

24.4

31.6

19%

54%
36%

61963

51875

60315

3%

19%

8985

7192

9430

-5%

25%

6007

4406

6130

-2%

36%

30.1

22.1

30.7

-2%

Mah & Mah

Hero Motocorp

114089

98130

83868

36%

16%

13070

11189

10208

28%

17%

8411

9018

6622

27%

-7%

13.7

14.6

10.8

27%

-7%

Maruti Suzuki India

108923

83054

78824

38%

31%

8492

5085

4172

104%

67%

5016

2274

2056

144%

121%

17.4

7.9

7.1

144%

121%

Tata Motors

475800

434029

452602

5%

10%

65793

58611

67431

-2%

12%

29180

26092

35780

-18%

12%

8.8

7.9

10.8

-18%

12%

TVS Motor

18372

16906

17622

4%

9%

1212

1012

1223

-1%

20%

603

452

565

7%

33%

1.3

1.0

1.2

7%

33%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 13

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Company Name

Growth (%)

Q3FY13

Q2FY13

Q3FY12

13649

11743

9365

8937

Axis Bank

24456

Bank of Baroda

29217

Bank of India
Canara Bank

Ebitda (Rs mn)

YoY

QoQ

Q3FY13

13805

-1%

16%

9839

-5%

5%

23269

21403

14%

5%

28623

26555

10%

2%

22079

21960

20674

7%

20363

19568

19186

6%

Corporation Bank

8254

8032

8616

-4%

Dewan Housing

1574

1546

1237

27%

2%

1367

Federal Bank

5283

5059

5280

0%

4%

4567

HDFC

13559

12941

11557

17%

5%

14549

HDFC Bank

39048

37317

31160

25%

5%

30206

ICICI Bank

34318

33712

27120

27%

2%

32798

Growth (%)

Q2FY13

Q3FY12

9339

8023

6911

6381

23945
23914

1%
4%
3%

APAT (Rs mn)

Growth (%)

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

10300

-9%

16%

3021

2342

5604

7676

-10%

8%

2843

3256

3032

21783

20592

16%

10%

12726

11235

23826

26082

-8%

0%

12183

13108

17522

18541

17318

1%

-5%

7223

15758

12821

15767

0%

23%

8105

6685

6858

8257

-19%

-3%

3376

1331

1138

20%

3%

913

3496

4187

9%

31%

2173

14940

12603

15%

-3%

10618

25713

23780

27%

17%

18683

31933

26870

22%

3%

21047

EPS (Rs)

Growth (%)

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

-46%

29%

6.0

4.7

11.8

-49%

29%

-6%

-13%

5.1

5.8

5.4

-6%

-13%

11023

15%

13%

30.7

27.1

26.7

15%

13%

12993

-6%

-7%

29.5

31.8

33.1

-11%

-7%

3019

8194

-12%

139%

12.6

5.3

15.0

-16%

139%

6610

9976

-19%

23%

18.3

14.9

22.5

-19%

23%

4057

4020

-16%

-17%

22.8

27.4

27.1

-16%

-17%

859

750

22%

6%

7.8

7.3

7.2

9%

6%

2151

2019

8%

1%

12.7

12.6

11.8

8%

1%

10811

9162

16%

-2%

6.9

7.0

6.2

11%

-2%

15600

14297

31%

20%

7.9

6.6

6.1

30%

20%

19561

17280

22%

8%

18.3

17.0

15.0

22%

8%

Banks & Financial Services


Allahabad Bank
Andhra Bank

LIC Housing Finance

3755

3535

3258

15%

6%

3672

3394

3263

13%

8%

2681

2431

2463

9%

10%

0.0

4.8

5.2

Mah & Mah Financial Services

5602

5259

4228

33%

7%

3929

3626

2797

40%

8%

2080

1876

1547

34%

11%

20.2

18.3

15.1

34%

11%

Manappuram General Finance

-100% -100%

3218

3206

4300

-25%

0%

1665

1597

2395

-30%

4%

1123

1077

1614

-30%

4%

1.3

1.3

1.9

-30%

4%

38091

36501

35360

8%

4%

27592

25336

26756

3%

9%

10782

10663

11492

-6%

1%

31.8

31.4

36.3

-12%

1%

3253

2977

2734

19%

9%

2037

1996

1790

14%

2%

1245

1189

1023

22%

5%

0.9

0.9

0.9

6%

5%

State Bank of India

115795

109738

114659

1%

6%

82980

73536

72600

14%

13%

42925

36581

32631

32%

17%

64.0

54.5

51.4

24%

17%

Union Bank of India

19007

18502

17809

7%

3%

12716

12727

12840

-1%

0%

6269

5546

1969

218%

13%

9.5

8.4

3.1

206%

13%

Punjab National Bank


South Indian bank

United Bank Of India

6317

6058

6676

-5%

4%

4787

4773

4833

-1%

0%

1470

1446

2260

-35%

2%

4.1

4.0

6.6

-38%

2%

Yes Bank

5789

5242

4276

35%

10%

5454

4847

3988

37%

13%

3472

3061

2541

37%

13%

9.8

8.6

7.2

35%

13%

ACC

26344

24445

25027

5%

8%

3859

4350

3893

-1%

-11%

2212

2487

2425

-9%

-11%

11.8

13.2

12.9

-9%

-11%

Ambuja Cements

25122

21684

23291

8%

16%

5082

5650

4300

18%

-10%

3089

3371

2683

15%

-8%

2.0

2.2

1.8

15%

-8%

India Cements

Cement

10102

11227

9415

7%

-10%

1642

2051

1946

-16%

-20%

149

391

563

-74%

-62%

0.5

1.3

1.8

-74%

-62%

Madras Cements

8536

9995

7410

15%

-15%

1964

3139

2075

-5%

-37%

492

1329

768

-36%

-63%

2.1

5.6

3.2

-36%

-63%

Orient Paper

5815

5984

5678

2%

-3%

420

417

871

-52%

1%

135

192

478

-72%

-30%

0.7

1.0

2.5

-72%

-30%

Ultratech Cement

50136

46996

45681

10%

7%

9784

10073

9647

1%

-3%

5191

5499

5118

1%

-6%

19.0

20.1

18.7

1%

-6%

Shree Cements

13662

13238

12586

9%

3%

3684

3930

3440

7%

-6%

1979

2281

712

178%

-13%

56.8

65.5

20.4

178%

-13%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 14

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Company Name

Growth (%)

Ebitda (Rs mn)

Growth (%)

APAT (Rs mn)

Growth (%)

EPS (Rs)

Growth (%)

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

7856

6976

6554

20%

13%

5415

4850

4462

21%

12%

3524

3717

3106

13%

-5%

1.7

1.8

1.5

13%

-5%

Construction
Adani Ports
Ashoka Buildcon
IL&FS Transportation
IRB Infrastructure

4115

3099

3529

17%

33%

931

841

692

35%

11%

231

286

195

18%

-19%

4.4

5.4

3.7

18%

-19%

14461

13704

12684

14%

6%

4145

4527

3207

29%

-8%

1002

1159

878

14%

-14%

5.2

6.0

4.5

14%

-14%

8278

8453

7455

11%

-2%

3680

3807

3417

8%

-3%

960

1210

1244

-23%

-21%

2.9

3.6

3.7

-23%

-21%

-0.3

-1.5

0.3

-61%

-5%

0.6

0.6

1.5

-61%

-5%

IVRCL

12310

9947

11955

3%

24%

980

699

878

12%

40%

-71

-396

68

Jaiprakash Associates

33113

29825

29470

12%

11%

7483

7944

8446

-11%

-6%

1210

1280

3097

Asian Paints

29362

26364

25605

15%

11%

4697

3816

3974

18%

23%

3166

2391

2594

22%

32%

33.0

24.9

27.0

22%

32%

Berger Paints

8945

8111

7813

14%

10%

957

900

840

14%

6%

591

534

491

20%

11%

1.7

1.5

1.4

20%

11%

Colgate-Palmolive

7834

7738

6696

17%

1%

1650

1571

1353

22%

5%

1387

1451

1156

20%

-4%

10.2

10.7

8.5

20%

-4%

Glaxosmithkline Consumer

7195

8577

6248

15%

-16%

1042

1706

844

23%

-39%

749

1286

591

27%

-42%

17.8

30.6

14.1

27%

-42%

Godrej Consumer Products

17456

16003

13509

29%

9%

3272

2489

2721

20%

31%

2131

1593

1671

28%

34%

6.3

4.7

5.2

21%

34%

Hindustan Unilever

64916

63108

59376

9%

3%

10621

9767

9705

9%

9%

8589

8053

7662

12%

7%

4.0

3.7

3.5

12%

7%

Jubilant FoodWorks

3903

3421

2770

41%

14%

686

587

524

31%

17%

402

323

303

32%

24%

6.2

5.0

4.7

31%

24%

Marico

12684

11559

10578

20%

10%

1730

1477

1218

42%

17%

1151

859

841

37%

34%

1.8

1.3

1.4

30%

34%

Nestle

21502

21156

19547

10%

2%

4390

4360

3858

14%

1%

2545

2673

2308

10%

-5%

26.4

27.7

23.9

10%

-5%

Page Industries

2119

2201

1721

23%

-4%

421

440

295

43%

-4%

271

308

199

36%

-12%

24.3

27.6

17.9

36%

-12%

Titan Industries

28748

22760

24401

18%

26%

2756

2494

2129

29%

10%

1995

1801

1636

22%

11%

2.2

2.0

1.8

22%

11%

1%

-3%

-3%

Consumers

Eng. & Capital Goods


BHEL

107887

105616

106586

1%

2%

20239

18995

19960

Blue Star

5996

5786

5840

3%

4%

309

202

-88

Cummins India

9892

10869

9624

3%

-9%

1739

1999

1612

Elecon Engineering

3359

3297

3000

12%

2%

485

605

Greaves Cotton

5079

4501

4651

9%

13%

656

577

Lakshmi Machine Works

7%

13501

12744

13936

53%

124

73

-328

6%

5.5

5.2

5.7

71%

1.4

0.8

-3.6

8%

-13%

1361

1609

1410

-3%

-15%

4.9

5.8

5.1

480

1%

-20%

152

230

577

14%

14%

385

370

152

0%

-34%

1.6

2.5

342

13%

4%

1.6

1.5

6%
71%

-3%

-15%

1.6

0%

-34%

1.4

13%

4%

4381

4696

5383

-19%

-7%

516

608

687

-25%

-15%

280

306

397

-29%

-9%

24.9

27.2

35.2

-29%

-9%

157258

131952

139836

12%

19%

15306

14054

13641

12%

9%

10571

9146

10015

6%

16%

17.3

15.0

16.4

6%

16%

4927

5142

4904

0%

-4%

336

390

318

6%

-14%

64

85

125

-49%

-25%

2.1

2.8

4.0

-49%

-25%

Punj Lloyd

30289

27778

27012

12%

9%

2810

3139

2677

5%

-10%

-484

-179

233

-1.5

-0.5

0.7

Thermax

11775

11924

12693

-7%

-1%

1166

1218

1354

-14%

-4%

808

911

955

-15%

-11%

6.8

7.6

8.0

-15%

-11%

-146

-8

0.7

-13.2

-0.8

396

333

610

-35%

19%

1.2

1.0

1.8

-35%

19%

Larsen & Toubro


Mcnally Bharat Engineering

TRF
Voltas

3107

2652

4276

-27%

17%

161

149

12170

11645

11580

5%

5%

522

440

807

8% 2552%
-35%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

19%

| Emkay Strategy | 8th January, 2013 | 15

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Company Name

Growth (%)

Q3FY13

Q2FY13

Q3FY12

2863

2707

2176

676

624

542

1693

1617

1320

YoY

Ebitda (Rs mn)

QoQ

Q3FY13

32%

6%

1004

25%

8%

204

28%

5%

655

Q2FY13

Growth (%)
QoQ

APAT (Rs mn)


Q3FY13

Q2FY13

Growth (%)

Q3FY12

YoY

Q3FY12

YoY

977

729

38%

3%

698

645

498

162

211

-4%

25%

148

110

177

601

598

10%

9%

464

252

500

-7%

EPS (Rs)
Q2FY13

Growth (%)

QoQ

Q3FY13

Q3FY12

YoY

QoQ

40%

8%

10.0

9.2

6.9

44%

8%

-16%

35%

14.8

11.0

17.7

-16%

35%

85%

15.4

8.4

16.6

-7%

85%

Financial Services - Others - Others


CRISIL
ICRA
IT Services
eClerx Services

62345

60910

52454

19%

2%

12861

13287

9489

36%

-3%

8635

8631

5529

56%

0%

12.5

12.5

8.0

56%

0%

Infinite Computer

HCL Tech

3553

3479

2694

32%

2%

608

579

539

13%

5%

342

312

393

-13%

9%

7.9

7.3

8.9

-11%

9%

Hexaware Technologies

5115

5130

4381

17%

0%

829

1153

1056

-22%

-28%

585

840

986

-41%

-30%

1.9

2.8

3.4

-43%

-30%

Infosys
Mahindra Satyam

102004

98580

92980

10%

3%

28787

28720

31330

-8%

0%

21466

23690

23720

-10%

-9%

37.6

41.5

41.5

-10%

-9%

19514

19384

17181

14%

1%

4055

4173

2781

46%

-3%

3001

2779

3084

-3%

8%

2.6

2.4

2.6

-2%

9%
22%

Mindtree

5899

5963

5197

14%

-1%

1204

1319

897

34%

-9%

883

722

606

46%

22%

21.5

17.6

15.0

44%

Mphasis

13446

13062

13672

-2%

3%

2707

2700

2521

7%

0%

1924

2093

1847

4%

-8%

10.0

9.9

8.8

15%

1%

5041

5001

4330

16%

1%

808

848

780

4%

-5%

583

432

643

-9%

35%

10.0

7.5

10.8

-8%

33%

NIIT Tech
Persistent Systems
TCS
Tech Mahindra

3312

3269

2677

24%

1%

877

890

696

26%

-2%

560

446

406

38%

25%

14.0

11.2

10.2

38%

25%

160659

156207

132041

22%

3%

45430

44402

40922

11%

2%

34045

35097

28866

18%

-3%

17.6

18.1

14.9

18%

-3%

17702

16314

14449

23%

9%

3412

3377

2343

46%

1%

3340

2963

2759

21%

13%

16.4

13.6

11.2

47%

21%

109067

106566

99972

9%

2%

18863

18587

17239

9%

1%

16266

16106

14564

12%

1%

6.7

6.6

6.0

11%

1%

DB Corp

4370

3784

3955

10%

15%

1099

861

1017

8%

28%

610

481

553

10%

27%

10%

27%

Dish TV

5562

5333

4905

13%

4%

1420

1557

1202

18%

-9%

-336

-213

-430

59%

Wipro
Print Media

3.3

2.6

3.0

-0.3

-0.2

-0.4

HT Media

5647

5107

5266

7%

11%

831

565

777

7%

47%

529

333

482

10%

59%

2.3

1.4

2.1

10%

Jagran Prakashan

3424

3221

3240

6%

6%

900

782

851

6%

15%

694

694

600

16%

0%

2.2

2.2

1.9

16%

0%

Zee Entertainment

9001

9535

7548

19%

-6%

2150

2176

2160

0%

-1%

1581

1877

1393

13%

-16%

1.7

2.0

1.5

13%

-16%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 16

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Net Sales (Rs mn)
Company Name
Company Name
Pharmaceuticals
Metals & Mining
Aurobindo Pharma
Bhushan Steel
Cadila Healthcare
Godawari Power
Cipla
HEG
Dishman Pharma
Hindalco
Divi's Lab
Hindustan Zinc
Dr. Reddy's Lab
JSW Steel
Glaxosmithkline Pharma
NMDC
Glenmark Pharma
SAIL
Ipca Lab
Sesa Goa
JubilantIndustries
Life Sciences
Sterlite

Growth (%)
Growth (%)

Ebitda (Rs mn)


Ebitda (Rs mn)

Growth (%)
Growth (%)

APAT (Rs mn)


APAT (Rs mn)

Growth (%)
Growth (%)

EPS (Rs)
EPS (Rs)

Growth (%)
Growth (%)

Q3FY13
Q3FY13

Q2FY13
Q2FY13

Q3FY12
Q3FY12

YoY
YoY

QoQ
QoQ

Q3FY13
Q3FY13

Q2FY13
Q2FY13

Q3FY12
Q3FY12

YoY
YoY

QoQ
QoQ

Q3FY13
Q3FY13

Q2FY13
Q2FY13

Q3FY12
Q3FY12

YoY
YoY

QoQ
QoQ

Q3FY13
Q3FY13

Q2FY13
Q2FY13

Q3FY12
Q3FY12

YoY
YoY

QoQ
QoQ

16082
28374
17053
6052
20498
4561
3075
66242
5011
30568
30262
86117
6465
21989
12353
115854
7089
2198
12522
111228

15004
25543
15459
5972
21918
4400
2971
61635
4737
28655
28809
95137
6760
26120
12556
108202
7713
2944
12250
111026

12847
24070
13832
4810
17580
4180
2655
66470
4174
27868
27692
84241
5776
28220
10313
110437
6148
26171
10885
103037

25%
18%
23%
26%
17%
9%
16%
0%
20%
10%
9%
2%
12%
-22%
20%
5%
15%
-92%
15%
8%

7%
11%
10%
1%
-6%
4%
3%
7%
6%
7%
5%
-9%
-4%
-16%
-2%
7%
-8%
-25%
2%
0%

2761
8694
3753
805
5000
809
678
5872
1975
16353
7342
14017
1949
16128
2537
11382
1466
-407
2636
25706

2503
7493
2930
746
6770
681
660
5153
1858
14431
6910
15313
2064
19349
2714
11093
1788
1943
2603
25270

1913
7240
2639
560
3915
851
608
7149
1511
14023
8690
13174
1822
22607
1029
15811
1513
9073
2084
23183

44%
20%
42%
44%
28%
-5%
11%
-18%
31%
17%
-16%
6%
7%
-29%
147%
-28%
-3%

10%
16%
28%
8%
-26%
19%
3%
14%
6%
13%
6%
-8%
-6%
-17%
-6%
3%
-18%

1137
2765
1773
106
2654
595
86
4507
1103
12800
4880
4561
1473
18588
1153
10984
1038
6915
771
9199

24%
-11%
30%
63%
34%
-34%
110%
-10%
30%
28%
-7%
-42%
9%
-23%
23%
-62%
-14%
-24%
46%
56%

9%
22%
48%
-19%
13%
22%
28%
12%
7%
6%
-4%
-1%
-1%
-14%
-2%
-16%
-23%
1%
10%
-6%

4.8
11.6
11.5
5.5
4.4
9.2
2.2
2.1
10.8
3.9
26.8
11.8
19.0
3.6
5.2
1.0
7.2
6.1
7.1
4.3

4.4
9.5
8.7
6.7
3.9
8.1
1.7
1.9
10.1
3.6
28.0
12.0
19.3
4.2
5.4
1.2
9.3
6.0
6.4
4.5

3.9
13.0
8.7
3.3
3.3
14.0
1.1
2.4
8.3
3.0
28.8
20.4
17.4
4.7
4.3
2.7
8.3
8.0
4.8
2.7

24%
-11%
33%
63%
34%
-34%
110%
-10%
30%
28%
-7%
-42%
9%
-23%
23%
-62%
-14%
-24%
46%
56%

9%
22%
33%
-19%
13%
14%
28%
12%
7%
6%
-4%
-1%
-1%
-14%
-2%
-16%
-23%
1%
10%
-6%

23007
341327
2686

18189
331031
2706

33%
-2%
2%

5%
-5%
3%

5392
25405
623

5160
23101
616

3736
17173
519

1%
2%
5%
10%
1%

1294
2015
1556
213
3133
323
141
3589
1339
15398
4750
2675
1634
16786
1452
5013
1162
5227
1025
15239

24126
325933
2762

26%
11%
44%
48%
20%

1410
2459
2297
173
3546
393
181
4034
1430
16333
4539
2643
1611
14360
1419
4218
895
5275
1125
14328
3106
-1388
550

2906
-4066
546

2351
-6027
487

32%

7%

5.2
-6.3
16.3

7%

1%

6.5
-4.2
18.3

33%

13%

6.9
-1.4
18.4

13%

1%

26170
435856
25897
46064
7860
116813

26910
568879
26639
44431
7772
113929

37923
588245
21451
30968
6966
112942

-31%
-26%
21%
49%
13%
3%

-3%
-23%
-3%
4%
1%
3%

3400
-47187
11130
36295
1497
18436

4179
53880
11751
26395
1554
14120

16293
36874
9638
23692
1215
17949

-79%

-19%

15146
31422
6683
22619
755
10914

-20%
-22%
33%
-7%
10%

8.6
69.3
8.7
12.2
11.8
7.8

36.0
43.5
6.5
11.9
8.9
8.6

-20%

6%
37%
23%
-1%

6.9
-72.8
6.8
16.2
11.0
8.5

-81%

-5%
38%
-4%
31%

3608
50348
9032
23222
995
9854

-81%

15%
53%
23%
3%

2899
-52987
7076
30900
930
10822

6%
36%
23%
-1%

-22%
33%
-7%
10%

2711
7880
14342
2592

2642
8359
13474
2772

2226
6499
12090
2755

22%
21%
19%
-6%

3%
-6%
6%
-6%

545
1159
5022
2367

529
1368
5170
2561

368
290
3760
2535

48%
299%
34%
-7%

3%
-15%
-3%
-8%

361
760
3468
1182

365
993
3749
1328

245
248
2520
1262

47%
207%
38%
-6%

-1%
-23%
-8%
-11%

4.0
5.9
31.7
2.1

4.0
7.7
34.3
2.4

2.7
1.9
23.0
2.2

47%
207%
38%
-6%

-1%
-23%
-8%
-11%

386398
19775
948008
13952
8710
3509
25502
0
186210
4312
78599

491298
14331
1060012
13440
8552
3602
25194
0
197882
9058
75486

479174
10594
1152084
9830
6631
3877
23738
0
181238
3967
63303

-19%
87%
-18%
42%
31%
-10%
7%

-21%
38%
-11%
4%
2%
-3%
1%

35725
3021
107247
2130
1504
914
13754
-66
106576
3570
5032

198%

70%
28%
39%
-17%

16%
-6%
-1%
-9%

27252
-633
24884
740
691
168
10140
69
67306
595
2954

136%
27%
201%
-10%
-100%
-18%

80.5
-0.3
10.2
5.9
4.9
1.1
16.9
0.0
7.9
0.3
3.9

20765
903350
5627

17687
851350
5707

25%
4%
5%

5914
69116
2486

5769
77050
1966

3496
72850
2383

69%
-5%
4%

1989
49609
502

1819
53760
544

274
44400
755

-8%
9%
-8%
-8%

68.7
-1.7
39.6
10.9
7.1
3.5
15.9
0.0
6.9
1.6
4.2

136%
27%
201%
-10%
-100%
-18%

-2%
626%
12%
-34%

-136.2
-0.9
-40.9
14.0
6.3
3.3
15.2
0.0
6.5
0.0
3.9

22136
887004
5989

1%
-58%
-5%
3%
-10%
26%

23271
-3730
96114
1360
992
529
9546
-62
58966
3661
3148

29%
-11%
-4%
-4%

-3%
-4%
-2%

-46129
-1863
-99372
1749
881
506
9116
0
55245
-90
2902

29%
-11%
-4%
-4%

-6%
-52%
4%
7%
-2%
6%

29138
1494
115616
3110
2066
1290
12649
-289
102718
8116
5184

47%

3%
9%
24%

-39129
4447
-71343
3620
1933
1275
11450
0
103729
3430
4923

1.2
15.3
1.3

1.1
16.6
1.5

0.2
13.6
2.0

-2%
626%
13%
-34%

-8%
9%
-8%
-8%

37464
12653
2719
3475
10755
4125

31850
12298
2896
3578
16217
4646

30290
12121
2336
3274
8820
3098

24%
4%
16%
6%
22%
33%

18%
3%
-6%
-3%
-34%
-11%

5242
2367
668
347
4627
1080

5215
2298
707
295
10553
999

6028
1904
471
303
3788
592

-13%
24%
42%
15%
22%
82%

1%
3%
-6%
18%
-56%
8%

-1942
394
666
34
2573
252

-2720
348
654
47
7430
213

777
136
378
74
2121
-176

190%
76%
-54%
21%

13%
2%
-27%
-65%
18%

-0.8
0.7
7.5
0.2
0.2
3.6

-1.1
0.6
7.3
0.3
0.6
3.1

0.3
0.3
4.2
0.5
0.2
-2.5

151%
76%
-54%
21%

15%
2%
-27%
-65%
18%

164007

161196

153333

7%

2%

40037

42241

29050

38%

-5%

26127

20513

22336

17%

27%

3.2

2.5

2.7

17%

27%

Power Grid Corporation

30867

30858

24666

25%

0%

26546

26692

21026

26%

-1%

9817

10289

8027

22%

-5%

2.1

2.2

1.7

22%

-5%

Reliance Power

12637

10512

4573

176%

20%

3927

3650

1401

180%

8%

2467

2167

2039

21%

14%

1.5

1.3

1.2

21%

14%

Tata Power

81230

76411

66459

22%

6%

17547

14507

9889

77%

21%

2261

1348

1172

93%

68%

1.0

0.6

0.5

93%

68%

Lupin
Tata Steel
Pfizer
Oil & Gas
Ranbaxy Labs
BPCL
Sun Pharma
Cairn India
Torrent pharma
GAIL
Unichem Labs
Gujarat Gas
Wockhardt
Gujarat State Petronet
Power
HPCL
Adani Power
Indian Oil
CESC
Indraprastha Gas
Gujarat Industries Power
Oil India
Indiabulls Power
ONGC
Jaiprakash
Power Ventures
Petronet
LNG
JSW Energy
Reliance Industries
KSK Energy
Paper
Lanco
Infratech
Ballarpur
Inds
Nava Bharat Ventures
JK Paper
NHPC
Tamilnadu
Newsprint
NTPC

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-6%

-6%

| Emkay Strategy | 8th January, 2013 | 17

Emkay Universe Q3FY13 Result Preview


Net Sales (Rs mn)
Company Name

Growth (%)

Ebitda (Rs mn)

Q3FY13

Q2FY13

Q3FY12

YoY

QoQ

Q3FY13

Q2FY13

46646

20395

20340

129%

129%

15546

7464

2629

2577

1873

40%

2%

1538

1496

Growth (%)
Q3FY12

APAT (Rs mn)

YoY

QoQ

Q3FY13

8224

89%

108%

6694

1134

36%

3%

1275

Q2FY13

Growth (%)

EPS (Rs)

Q3FY12

YoY

QoQ

Q3FY13

1180

2475

170%

467%

3.9

1244

1021

25%

3%

3.9

Q2FY13

Growth (%)
Q3FY12

YoY

QoQ

0.7

1.5

169%

467%

3.8

3.1

25%

3%

Real Estate
DLF
Oberoi Realty

675

665

505

34%

2%

452

438

373

21%

3%

337

329

269

25%

2%

2.3

2.3

1.9

25%

2%

Prestige Estates

Phoenix Mills

4858

2414

1669

191%

101%

1535

725

502

206%

112%

1023

457

282

263%

124%

3.1

1.4

0.9

263%

124%

Sobha Developers

4828

4148

3032

59%

16%

1380

1285

948

46%

7%

548

501

401

37%

9%

5.6

5.1

4.1

37%

9%

Bharti Airtel

202970

202830

185078

10%

0%

62618

63507

59584

5%

-1%

6923

7211

10113

-32%

-4%

1.8

1.9

2.7

-32%

-4%

Idea Cellular

53991

53140

50308

7%

2%

14489

14225

13446

8%

2%

2344

2400

2010

17%

-2%

0.7

0.7

0.6

17%

-2%

-3%

Telecommunications

Others
Aban Offshore

8594

9541

8659

-1%

-10%

4960

5113

5007

-1%

-3%

689

712

731

-6%

-3%

15.8

16.4

16.8

-6%

Arshiya International

3647

3726

2734

33%

-2%

1029

1082

702

47%

-5%

376

354

345

9%

6%

6.4

6.0

5.9

9%

6%

Essel Propack

4756

4766

4148

15%

0%

817

873

691

18%

-6%

167

232

136

23%

-28%

1.1

1.5

0.9

23%

-28%

Grasim Industries

12986

13345

12429

4%

-3%

2483

2898

2854

-13%

-14%

2365

3827

2745

-14%

-38%

25.8

41.7

29.9

-14%

-38%

Havells India

10236

9642

8982

14%

6%

1304

1192

1279

2%

9%

818

870

789

4%

-6%

6.6

7.0

6.3

4%

-6%

Kajaria Ceramics

4209

3889

3507

20%

8%

648

599

561

16%

8%

294

265

211

39%

11%

4.0

3.6

2.9

39%

11%

Piramal Glass

4199

4214

3464

21%

0%

918

610

861

7%

50%

331

43

188

76%

668%

4.1

0.5

2.3

75%

668%

Sterlite Tech

7977

8421

6635

20%

-5%

756

503

522

45%

50%

237

42

95

150%

462%

0.6

0.1

0.2

150%

462%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 18

Top 10 Companies
Net Sales Growth

Ebitda Grow th

Prestige Estates
Reliance Power

67.4%

Sobha Developers

103.5%

Maruti Suzuki India

86.7%

Motherson Sumi

146.7%

Glenmark Pharma

129.3%

Adani Power

180.3%

Reliance Power

176.4%

DLF

205.9%

Prestige Estates

191.1%

DLF
Tamilnadu Newsprint

59.2%

89.0%
82.3%

CESC

41.9%

Tata Power

Jubilant FoodWorks

40.9%

CESC

70.0%

Oberoi Realty

40.4%

JSW Energy

69.2%

Maruti Suzuki India

38.2%

Motherson Sumi

68.7%

Ebitda Margin Growth

PAT Growth

626.2%

JSW Energy

Gujarat Industries Power

201.5%

Ballarpur Inds
Shree Cements
DLF

1,276 bps

Gujarat Industries Power

262.9%

Prestige Estates

77.4%

Glenmark Pharma

1,057 bps

Tamilnadu Newsprint

706 bps

JSW Energy

695 bps

190.0%
178.0%
170.5%

Tata Power

672 bps

Blue Star

666 bps

Sterlite Tech

149.8%

NTPC

Maruti Suzuki India

143.9%

Mahindra Satyam

CESC

136.4%

Nava Bharat Ventures

441 bps

CEBBCO

434 bps

Dishman Pharma

110.5%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

547 bps
459 bps

| Emkay Strategy | 8th January, 2013 | 19

Bottom 10 Companies
Ebitda Growth

Net Sales Growth

Sesa Goa-91.6%

Ranbaxy Labs
-31.0%

Ranbaxy Labs

Voltas

-22.1%

NMDC

-28.7%
-28.0%

-19.0%

SAIL

Lakshmi Machine Works

-18.6%

Lakshmi Machine Works


-9.5%

Thermax

-7.2%

Mphasis

-33.4%

NMDC

Ashok Leyland

Gujarat Industries Power

-35.3%

Ashok Leyland

-20.7%

Coromandel International

-51.7%

Orient Paper

-27.3%

TRF

-79.1%

-25.0%

GSFC

-21.6%

Hexaware Technologies

-21.5%

-1.6%

Hindalco

-17.9%

Ebitda Margin Growth

PAT Growth

-80.9%

Sesa Goa

Ranbaxy Labs

-5,319 bps

-73.6%

Ranbaxy Labs

India Cements
Orient Paper

Jaiprakash Power Ventures

-71.8%

-2,997 bps
-1,044 bps

SAIL

-61.6%

Orient Paper

-811 bps

Jaiprakash Associates

-60.9%

Hexaware Technologies

-790 bps

JK Paper
Mcnally Bharat Engineering
JSW Steel
Hexaware Technologies
Madras Cements

-54.1%
-48.6%
-42.1%
-40.7%
-36.0%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

Dr. Reddy's Lab

-712 bps

DLF

-710 bps

Phoenix Mills

-698 bps

NMDC

-676 bps

eClerx Services

-664 bps

| Emkay Strategy | 8th January, 2013 | 20

Top 5 Sectors
Net Sales Grow th

Real Estate

Ebitda Growth

117.5%

Auto Ancillaries

Real Estate

36.1%

Power

Power

14.9%

Consumers

14.8%

37.5%

Paper

35.6%

Auto Ancillaries

34.4%

19.6%

IT Services

82.9%

Consumers

17.3%

Ebitda Margin Growth

PAT Growth

Paper

Real Estate

1915.3%

122.1%

Power

380 bps

Paper

360 bps

Auto Ancillaries

22.0%

Consumers

Media &
Entertainment

18.5%

Auto Ancillaries

Consumers

18.1%

Engineering &
Capital Goods

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

34 bps

-12 bps

-15 bps

| Emkay Strategy | 8th January, 2013 | 21

Bottom 5 Sectors
Net Sales Growth

Ebitda Growth

Pharmaceuticals

Metals & Mining -1.4%

Engineering & Capital


Goods

Metals & Mining

6.2%

Agri Input & Chemicals

-5.8%

Cement

7.2%

Cement

9.2%

Construction

Pharmaceuticals

Automobiles

Metals & Mining

1.4%

Automobiles

4.7%

Ebitda Margin Growth

PAT Growth

Telecommunications

1.0%

Agri Input &


Chemicals

8.2%

Telecommunications

-4.6%

-23.6%

Real Estate -649 bps

-20.2%

Pharmaceuticals

Cement

-135 bps

IT Services

-131 bps

Media & Entertainment

-125 bps

-16.7%

-4.9%

-3.3%

-406 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 22

Frequency Distribution (No. of Companies)


Net Sales Grow th

PAT Grow th
45

70
60
60

41

40

53

35

50

30

40

25

31
22
18

20

30

13

15

16

20

10

10

5
0

<0%

0%-10%

10%-25%

25%-50%

0%-15%

15%-30%

30%-50%

>50%

>50%

EBITDA Grow th
45

39

40
35

31
27

30

25

25
20
15

11

10
5
0
<0%

0%-15%

15%-30%

30%-50%

>50%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 23

Frequency Distribution (Percentage)


Net Sales Growth

12%

PAT Growth

4%

14%
33%

39%

10%

25%

45%

18%
0%-10%

10%-25%

25%-50%

>50%

<0%

0%-15%

15%-30%

30%-50%

>50%

EBITDA Growth
8%
23%
19%

20%

<0%

0%-15%

30%

15%-30%

30%-50%

>50%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 24

Sectoral Analysis of Q3FY13 Results

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 25

Agri Input and Chemicals


n On an aggregate basis, we expect our universe to report topline growth of 7%YoY driven predominantly by increase

in chemicals revenues by 18%YoY. APAT is expected to increase by 6%YoY.


n Fertiliser revenues are expected to remain flat. Complex fertiliser consumption dropped by 31%YoY during

Oct/Nov12 however Urea sales increased by 16%. Aggregate fertiliser margins for our universe are expected to
decline by 170bpsYoY to 8.7%
n On the chemicals side, we expect chemicals revenues for our universe to increase by 18%YoY however EBIT is

expected to increase only by 10%YoY due to pressure on margins. Aggregate chemicals EBIT margin is expected to
decline by 130bpsYoY to 17.3%. Deepaks chemicals margins are likely to be impacted (down by 700bpsYoY to 17.0%)
due to high ammonia & propylene costs. GSFCs margins are expected to decline (860bpsYoY) due to decline in
caprolactam-benzene spreads. GNFCs & Tata Chemicals chemicals margins are expected to improve 100bpsYoY.
n Agrochemicals

consumption remained weak during H1FY13, however Q3FY13 has witnessed improved

agrochemicals usage across different crops. Rabi season has panned out well for agrochemicals consumption & we
are likely to witness volume growth during this quarter.
n We remain optimistic on the outlook for agri-input companies. Dhanuka Agritech, Coromandel Intl, Tata Chemicals

remain our top picks. Dhanuka with strong revenue visibility & sustainable RoCE/RoE of 30%/ 26% is trading at 30%
discount to peers. Complex fertiliser consumption remains under pressure, however Coromandel is likely to witness
strong earnings growth during FY14 driven by increase in capacity, leadership position, strong focus on non-subsidy
business, improvement in volumes.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 26

Agri Input and Chemicals


Name

Dec12E

% Chg
YoY

Sep12

Dec11

21,266

23,407

17,966

18.4%

2,056

1,951

2,039

0.8%

9.7

8.3

11.4 -168 bps

PAT (Rs mn)

932

896

862

8.2%

EPS (Rs)

2.2

2.2

2.1

8.2%

20,213

25,678

25,497

-20.7%

1,920

2,374

2,335

-17.8%

9.5

9.2

9.2

34 bps

1,044

1,532

1,472

-29.1%

3.7

5.5

5.2

-29.1%

6,207

6,934

6,015

3.2%

1,149

-14.9%

% Chg
QoQ

Comments

Chambal Fertilisers
CMP(Rs)

70

Net Sales (Rs mn)

Mkt Cap (Rs bn)

29

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


98
40%

-9.1% We expect revenues to increase by 18%YoY to Rs 21.2 bn.


We expect manufactured fertilizer revenues to increase by
5.4% 20%YoY to Rs 9.7bn while we expect trading revenues to
increase by 25%YoY to Rs 9.9bn. We expect textiles segment
133 bps to report revenue growth of 10%. We expect company to report
EBITDA of Rs 2.1bn, flatYoY with margins of 9.7%. We expect
4.0% APAT to increase by 8%YoY to Rs 932mn and expect
company to report AEPS of Rs 2.2
4.0%

Coromandel International
CMP(Rs)

261

Net Sales (Rs mn)

Mkt Cap (Rs bn)

74

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

340

PAT (Rs mn)

% Upside

30%

EPS (Rs)

CMP(Rs)

130

Net Sales (Rs mn)

Mkt Cap (Rs bn)

11

EBITDA (Rs mn)

977

803

-21.3% We expect revenues to decline by 21%YoY to Rs 20.2bn. We


expect total fertiliser volumes to decline by 38%YoY to 525,000
-19.1% mt. Complex fertiliser volumes continue to remain under
pressure due to high prices & higher level of inventory in the
26 bps system. We expect company to report EBITDA of Rs. 1.9bn, 18%YoY with margins of 9.5%. We expect company to report
-31.9% PBT of Rs 1.5bn, -31%YoY. We expect company to report
APAT of Rs 1.0bn, -30%YoY with AEPS of Rs 3.7
-31.9%

Deepak Fertilisers

Reco

Buy

EBITDA Margin (%)

15.7

11.6

19.1 -335 bps

Target Price (Rs)

172

PAT (Rs mn)

509

406

637

-20.0%

% Upside

32%

EPS (Rs)

5.8

4.6

7.2

-20.0%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-10.5% We expect net revenues to increase by 3%YoY to Rs 6.2bn.


We expect chemicals revenues to increase by 20%YoY to Rs
21.7% 4.1bn while we expect fertiliser revenues to decline by
17%YoY to Rs 2.3bn. Manufactured fertilizer revenues are
417 bps expected to decline by 21%YoY to Rs 985mn while traded
fertiliser revenues are expected to decline by 14%YoY to Rs
25.3% 1.3bn. Company is likely to report EBITDA of Rs 977mn, 15%YoY with margins of 15.7%. We expect company to report
25.3%
APAT of Rs 509mn, -20%YoY with EPS of Rs 5.8

| Emkay Strategy | 8th January, 2013 | 27

Agri Input and Chemicals


Name

Dec12E

% Chg
YoY

Sep12

Dec11

1,314

2,063

1,104

18.9%

EBITDA (Rs mn)

184

306

127

45.4%

11.5 255 bps

% Chg
QoQ

Comments

Dhanuka Agritech

Reco

Buy

EBITDA Margin (%)

14.0

14.8

Target Price (Rs)

150

PAT (Rs mn)

129

237

78

65.1%

-36.3% We expect revenues to increase by 18%YoY to Rs 1.3bn.


Expect company to report EBITDA of Rs 184mn, 45%YoY.
-39.9% EBITDA margins are likely to improve by 250bpsYoY to 14.0%.
We expect Dhanuka to report PBT of Rs 166mn, 70%YoY with
-83 bps PAT of Rs 129mn, 65%YoY. EPS for the quarter is likely to be
around Rs 2.6
-45.4%

% Upside

15%

EPS (Rs)

2.6

4.7

1.6

65.1%

-45.4%

10,578

11,658

10,429

1.4%

1,457

1,453

1,573

-7.4%

CMP(Rs)
Mkt Cap (Rs bn)

131
7

Net Sales (Rs mn)

GNFC
CMP(Rs)

83

Net Sales (Rs mn)

Mkt Cap (Rs bn)

13

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

13.8

12.5

15.1 -131 bps

Target Price (Rs)

105

PAT (Rs mn)

744

724

862

-13.6%

% Upside

27%

EPS (Rs)

4.8

4.7

5.5

-13.6%

14,452

14,160

13,000

11.2%

2,022

2,028

2,580

-21.6%

14.0

14.3

1,471

1,505

1,724

-14.6%

3.7

3.8

4.3

-14.6%

-9.3% We estimate net revenues to increase by 1.5%YoY to Rs 10.6


bn. We expect fertiliser revenues to decline by 10%YoY to Rs
0.3% 5.8bn while we expect chemical segment revenues to increase
by 18%YoY to Rs 4.6bn. We expect fertiliser segment to report
132 bps EBIT of Rs 173 mn while chemical segment is expected to
report EBIT of Rs 920mn. We expect company to report
2.8% EBITDA of Rs 1.5bn, -7%YoY with margins of 13.8%.
Company is likely to report PAT of Rs 744mn, -14%YoY with
2.8%
EPS of Rs 4.8

GSFC
CMP(Rs)

72

Net Sales (Rs mn)

Mkt Cap (Rs bn)

29

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Hold
70
-3%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

19.8 -585 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

2.1% We expect revenues to increase by 11%YoY to Rs 14.5 bn.


We expect fertiliser revenues to increase by 14%YoY to Rs
-0.3% 10.2bn due to higher trading while we expect chemicals
revenues to increase by 5%YoY to Rs 4.2bn. Caprolactam-33 bps benzene spreads declined further to $990/mt in Q3FY13
compared to $1130/mt in Q2FY13. We expect company to
-2.2% report EBITDA of Rs 2.0bn,-22%YoY with margins of 14.0%.
Company is likely to report APAT of Rs 1.5bn, -14%YoY with
-2.2% margins of 10.2%. EPS for the quarter is likely to be around Rs
3.7

| Emkay Strategy | 8th January, 2013 | 28

Agri Input and Chemicals


Name

Dec12E

Sep12

Dec11

3,792

4,855

3,251

611

967

553

16.1

19.9

17.0

% Chg
YoY

% Chg
QoQ

Comments

Rallis India
CMP(Rs)

151

Net Sales (Rs mn)

Mkt Cap (Rs bn)

29

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

-21.9% We estimate consol revenue growth of 17%YoY to Rs 3.8 bn.


We expect standalone revenues to increase by 16%YoY to Rs
10.5% -36.8% 3.6bn. We expect company to report standalone EBITDA of Rs
630mn, 11%YoY with margins of 17.5%. Company is likely to
-90 bps -381 bps report consol EBITDA of Rs 611mn, 11%YoY with margins of
16.1%. We expect company to report consol APAT of Rs
14.0% -40.2% 353mn, 14%YoY with EPS of Rs 1.8
16.6%

Target Price (Rs)

153

PAT (Rs mn)

353

591

310

% Upside

1%

EPS (Rs)

1.8

3.0

1.6

14.0%

CMP(Rs)

371

Net Sales (Rs mn)

45,109

41,518

38,099

18.4%

Mkt Cap (Rs bn)

95

EBITDA (Rs mn)

6,704

6,165

5,558

20.6%

14.9

14.8

14.6

27 bps

2,968

2,327

2,277

30.3%

11.6

9.1

8.9

30.3%

21,361

18,560

19,288

10.7%

3,738

3,261

3,484

7.3%

17.5

17.6

18.1

-56 bps

1,744

1,248

1,154

51.1%

3.8

2.7

2.5

51.1%

-40.2%

Tata Chemicals

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

400

PAT (Rs mn)

% Upside

8%

EPS (Rs)

CMP(Rs)

139

Net Sales (Rs mn)

Mkt Cap (Rs bn)

64

EBITDA (Rs mn)

8.7% We expect standalone revenues to increase by 15%YoY to Rs


26.9 bn, and APAT of Rs 2.0 bn, 32%YoY. We expect increase
8.7% in revenues for BMGL by 16%YoY to Rs 6.1 bn. IMACID is
likely to report revenues of Rs 1.8bn, 2%YoY while we expect
1 bps revenues for TCNA to increase by 20%YoY to Rs 6.7 bn. We
estimate consolidated revenues to increase by 18%YoY to Rs
27.6% 45.1 bn, Company is likely to report consol EBITDA of Rs
6.7bn, 20%YoY with margins of 14.9%. APAT is likely to be
27.6%
around Rs 3.0bn, 30%YoY with EPS of Rs 11.6

United Phosphorus

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

172

PAT (Rs mn)

% Upside

24%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

15.1% We expect consol revenue growth of 11%YoY to Rs 21.4 bn.


Indian revenues are expected to increase by 8%YoY to Rs
14.6% 4.1bn while North American revenues are expected to remain
flat at Rs 3.6bn. Europe is likely to report revenue growth of
-7 bps 10%YoY while RoW revenues are expected to increase by
15%YoY. Company is likely to report EBITDA of Rs 3.7bn,
39.7% 7%YoY with margins of 17.5%. We expect company to report
APAT of Rs 1.7bn, 51%YoY with EPS of Rs 3.8
39.7%

| Emkay Strategy | 8th January, 2013 | 29

Automobiles
n We expect our OEM automobile universe to report a modest 11%YoY/ 12% QoQ growth in sales to Rs 873 bn owing a

late festive season even as overall volume growth trajectory remains lacklustre
n Adjusted EBITDA at Rs 110.9 bn is expected to grow just 5%YoY weighed down by relatively higher input costs.

Sequentially however, EBITDA is expected to increase 15% from the benefits of softer commodity prices and
operating leverage.
n Adjusted EBIDTA margins are likely to decline 80bpsYoY but increase 30 bps QoQ to 12.7%. Companies which we

expect to report significant QoQ improvement in margins are MSIL (+170 bps), BJAUT (+100 bps) and HMCL (+60
bps). Poor CV volumes are likely to lead to a significant QoQ margin drop for AL (-410 bps).
n Adjusted net profits are likely to decline 5%YoY but improve 12% QoQ to Rs 58 bn.
n To get a better sense of the domestic demand environment, if we consider only standalone business of TTMT in

calculation of aggregates, then overall auto universe net sales growth moderates to Rs 509 bn (9%YoY/8% QoQ). Adj.
EBITDA is expected to increase 13% QoQ (8%YoY) to Rs 51.2 bn. Adj. PAT is expected to increase 4%YoY (-21% QoQ)
to Rs 28.6 bn
n Key candidates for positive surprises in the results this quarter are MM & HMCL in our view, whereas CV plays AL,

EIM and TTMT (STDL) could surprise on the negative side


n We remain cautious on OEM demand recovery and believe macro-recovery plays (AL, EIM, MSIL) are already

discounting a strong recovery in FY14. We prefer bottom-up ideas and maintain Buy on HMCL, EXID, AMRJ, MSS and
Accumulate on MM, TTMT

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 30

Automobiles
Name

Dec12E

Sep12

Dec11

23,337

32,960

28,798

1,400

3,341

6.0

10.1

% Chg
YoY

% Chg
QoQ

Comments

Ashok Leyland
CMP(Rs)

27

Net Sales (Rs mn)

Mkt Cap (Rs bn)

71

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

-29.2% AL performance to remain weak due to a steep decline of


29%YoY/ 31% QoQ in M&HCV volumes. EBITDA margins to
2,104 -33.4% -58.1% decline 410 bps QoQ led by poor operating leverage and lower
production from Pantnagar. Key things to watch out for (1)
7.3 -130 bps -414 bps demand outlook for FY14 (2) working capital debt and (3)
Pantnagar volumes
669
n.a.
n.a.
-19.0%

Target Price (Rs)

28

PAT (Rs mn)

-400

1,426

% Upside

5%

EPS (Rs)

-0.2

0.5

0.3

Net Sales (Rs mn)

54,981

49,724

49,859

10.3%

EBITDA (Rs mn)

10,674

9,152

9,841

8.5%

19.4

18.4

19.7

-32 bps

8,233

7,407

8,364

-1.6%

28.5

25.6

28.9

-1.6%

16,042

14,831

15,766

1.7%

1,329

1,114

1,538

-13.6%

8.3

7.5

9.8 -147 bps

8.2% EIM to report modest growth driven by volume performance.


EBIDTA margins to be lower 150 bpsYoY as pressure on CV
19.3% sales continues though we expect a slight improvement QoQ.
Key things to watch out for (1) CV demand outlook (2)
77 bps discounting levels in trucks

1,018

660

854

19.1%

54.2%

37.7

24.4

31.6

19.1%

54.2%

n.a.

n.a.

Bajaj Auto
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

2,210
639
Reduce
2,100
-5%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

10.6% BJAUT to benefit from 5%YoY/7.5% QoQ growth in volumes


and a better product mix. Margins to improve 100 bps QoQ due
16.6% to higher share of 3W, pricing action and favorable currency.
Key things to watch out for (1) exports/dom. demand outlook
101 bps (2) new launch plan (3) currency hedges and (4) raw material
contracts
11.2%
11.2%

Eicher Motors
CMP(Rs)
Mkt Cap (Rs bn)
Reco

2,841
77
Reduce

Net Sales (Rs mn)


EBITDA (Rs mn)
EBITDA Margin (%)

Target Price (Rs)

2,400

PAT (Rs mn)

% Upside

-16%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 31

Automobiles
Name

Dec12E

% Chg
YoY

% Chg
QoQ

Sep12

Dec11

Comments

61,963

51,875

60,315

2.7%

8,985

7,192

9,430

-4.7%

14.5

13.9

6,007

4,406

6,130

-2.0%

36.3%

30.1

22.1

30.7

-2.0%

36.3%

114,089

98,130

83,868

36.0%

13,070

11,189

10,208

28.0%

11.5

11.4

12.2

-72 bps

8,411

9,018

6,622

27.0%

13.7

14.6

10.8

27.0%

16.3% Expect strong results driven by 14%YoY/11% QoQ increase in


volumes. Adjusted EBITDA margins to improve by 10 bps QoQ
16.8% due to better product mix (higher share of tractors). Expect
production at 100% subsidiary MVML at 50,000 units and
10 bps EBITDA of Rs 1.8 bn. Results not comparableYoY due to
impact of MADPL merger from Q4. Key things to watch out for
-6.7% (1) tractor demand outlook (2) new launch plan and (3) raw
material contracts
-6.7%

108,923

83,054

78,824

8,492

5,085

4,172

7.8

6.1

5.3

5,016

2,274

2,056

17.4

7.9

7.1

Hero MotoCorp
CMP(Rs)

1,907

Net Sales (Rs mn)

Mkt Cap (Rs bn)

381

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

2,350

PAT (Rs mn)

% Upside

23%

EPS (Rs)

CMP(Rs)

953

Net Sales (Rs mn)

Mkt Cap (Rs bn)

585

EBITDA (Rs mn)

15.6 -113 bps

19.4% Expect HMCL earnings to benefit from 18% QoQ (-1%YoY)


growth in vols and favorable JPY/INR currency. Margins to
24.9% expand 60 bps QoQ due to favorable forex and pricing action.
Key things to watch out for (1) demand outlook (2) new launch
64 bps plan and (3) export ramp up

M&M

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

1,100

PAT (Rs mn)

% Upside

15%

EPS (Rs)

1,588

Net Sales (Rs mn)

Maruti Suzuki
CMP(Rs)
Mkt Cap (Rs bn)

459

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

1,700

PAT (Rs mn)

% Upside

7%

EPS (Rs)

31.1% Post a period of production hit due to various issues, expect


normalized earnings driven by volume growth of 26%YoY/31%
103.5%
67.0% QoQ (on a low base). Adj. EBITDA margins to expand 170 bps
QoQ (250 bpsYoY) led by operating leverage and normalized
250 bps 167 bps mix. Key things to watch out for (1) Currency hedges (2) petrol
demand outlook and (3) new launch plan
143.9% 120.5%
38.2%

143.9%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

120.5%

| Emkay Strategy | 8th January, 2013 | 32

Automobiles
Name

Dec12E

% Chg
YoY

% Chg
QoQ

Sep12

Dec11

Comments

475,800

434,029

452,602

5.1%

65,793

58,611

67,431

-2.4%

13.8

13.5

29,180

26,092

35,780

-18%

8.8

7.9

10.8

-18%

18,372

16,906

17,622

4.3%

1,212

1,012

1,223

-0.9%

EBITDA Margin (%)

6.6

6.0

6.9

-34 bps

PAT (Rs mn)

603

452

565

6.7%

8.7% TVSL performance to recover led by vol. growth of 6.7% QoQ


(-2%YoY) and better product mix. EBITDA margins to improve
19.7% 60 bps QoQ to 6.6% due to higher share of 3-W and operating
leverage benefits. Key things to watch out for (1) investment in
61 bps subsidiaries (2) performance of Phoenix and (3) new launch
plan
33.4%

EPS (Rs)

1.3

1.0

1.2

6.7%

33.4%

Tata Motors
CMP(Rs)

317

Net Sales (Rs mn)

Mkt Cap (Rs bn)

931

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

350

PAT (Rs mn)

% Upside

10%

EPS (Rs)

14.9 -107 bps

9.6% Standalone business performance to remain lackluster while


JLR to support growth. Expect JLR EBITDA margins to
12.3% improve 20 bps sequentially at 15% led by operating leverage
benefits. Standalone business margins to decline sharply by
32 bps 130 bpsYoY/100 bps QoQ due to poor volumes. Key things to
watch for (1) JLR RR ramp up and new launch pipeline (2)
12% MHCV/LCV demand outlook/ discounts and (3) impact of
currency swings
12%

TVS Motor
CMP(Rs)

47

Net Sales (Rs mn)

Mkt Cap (Rs bn)

22

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Hold
44
-6%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 33

Auto Ancillaries
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Amara Raja
CMP(Rs)

261

Net Sales (Rs mn)

7,358

7,187

6,131

20.0%

Mkt Cap (Rs bn)

45

EBITDA (Rs mn)

1,103

1,180

1,063

3.7%

Reco

Buy

EBITDA Margin (%)

15.0

16.4

17.3 -235 bps

Target Price (Rs)

320

PAT (Rs mn)

707

795

659

7.3%

% Upside

23%

EPS (Rs)

8.3

9.3

7.7

7.3%

34,689

33,748

32,282

7.5%

3,981

3,669

3,243

22.8%

11.5

10.9

1,628

1,533

1,278

27.4%

3.2

3.0

2.5

27.4%

1,550

1,538

1,328

16.7%

2.0

28.9%

2.4% We expect AMRJ to continue with the healthy revenue growth


momentum as in the previous quarters. However, margins are
-6.5% likely to decline 140 bps QoQ due to ~10%QoQ increase in
global lead prices while pricing action came in only towards the
-143 bps end of the quarter. Key things to watch out for are
-11.0% OEM/replacement mix, capacity ramp-up plans and
replacement demand outlook.
-11.0%

Apollo Tyres
CMP(Rs)

89

Net Sales (Rs mn)

Mkt Cap (Rs bn)

45

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

95

PAT (Rs mn)

% Upside

7%

EPS (Rs)

CMP(Rs)

93

Net Sales (Rs mn)

Mkt Cap (Rs bn)

EBITDA (Rs mn)

287

312

10.0 143 bps

2.8% While we expect tonnage growth in domestic business to


remain subdued, however, profitability should benefit from
8.5% moderation in rubber prices and winter tyre sale in Europe.
Expect tonnage growth of 3%YoY (flat QoQ) in consolidated
60 bps business and conso. margins to improve 60 bps QoQ to
11.5%. Key things to watch out for are tonnage growth,
6.2% OEM/replacement
mix,
subsidiary
performance
and
capacity/QIP plans
6.2%

CEBBCO

Reco

Buy

EBITDA Margin (%)

18.5

20.3

Target Price (Rs)

130

PAT (Rs mn)

145

163

% Upside

39%

EPS (Rs)

2.6

3.0

0.8% Healthy earning momentum to continue driven by continued


preference seen for FBVs from the OEMs. We expect EBITDA
188
52.5%
-8.0% margins to decline 180 bps QoQ due to mix shifting in favour
of OEMs as against replacement in the previous quarter. Key
14.2 434 bps -177 bps things to watch out for are replacement FBV demand outlook,
railway tendering process and capacity expansion plans
113
28.9% -11.0%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-11.0%

| Emkay Strategy | 8th January, 2013 | 34

Auto Ancillaries
Name

Dec12E

% Chg
YoY

% Chg
QoQ

Sep12

Dec11

Comments

15,475

15,214

12,502

23.8%

2,130

1,882

1,762

20.9%

13.8

12.4

14.1

-33 bps

1,411

1,202

1,182

19.4%

1.7

1.4

1.4

19.4%

17.3%

64,280

58,905

38,408

67.4%

4,477

4,100

2,654

68.7%

7.0

7.0

6.9

10 bps

1,306

700

1,030

26.8%

9.1% MSS performance to benefit from better PV sales QoQ for


domestic business and higher utilization in SMP/SMR.
9.2% Reported results to be impacted by forex translation losses due
to adverse forex. We expect Adjusted EBITDA margins to
- remain flat QoQ. Expect SMP margins to remain at ~4%. Key
things to look out for are revenue growth in the domestic
86.5% market and margins for the subsidiaries.

2.2

1.2

1.8

25.3%

86.5%

Exide Industries
CMP(Rs)

146

Net Sales (Rs mn)

Mkt Cap (Rs bn)

124

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

190

PAT (Rs mn)

% Upside

30%

EPS (Rs)

CMP(Rs)

200

Net Sales (Rs mn)

Mkt Cap (Rs bn)

117

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

215

PAT (Rs mn)

% Upside

8%

EPS (Rs)

1.7% We expect EXID to continue its >20%YoY revenue growth


driven by strong replacement demand and slight gain in market
13.2% share. Margins to expand 140 bps QoQ driven by price hike of
~5% taken in Oct. and a better mix. Key things to watch out for
139 bps OEM/replacement mix, market share in 2W/4W, demand
17.3% outlook.

Motherson Sumi

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 35

Banking and Financial Services


n NII growth for our banking universe is expected to come in modest at 8%YoY (10%YoY in Q2FY13) primarily on back of

sluggish 3.3%YoY growth in NII for our PSU space. Margin pressures (on account of full impact of base rate reduction
implemented in Q2 and relatively higher share of bulk deposits), 161bpsYoY contraction in LDR and 13.5%YoY growth in
loan portfolio vs 16%YoY on a systemic level will weigh on NII performance for our the PSU space. NII growth for private
banks is expected to remain healthy at 22%YoY aided by 16bpsYoY improvement in NIM to 3.23%.
n Dismal show on fee income front (+4%YoY for our coverage universe) would be off-set by higher trading gains +33%YoY

(ex-SBI) thereby resulting in 13.5%YoY growth in non-int income. SBI had trading losses to the tune of Rs10.9bn in
Q3FY12. Also, with stable opex, operating profit growth is expected to remain modest at 11%YoY / 5% qoq.
n NPA pressure will persist with PSU space expected to report 18%YoY growth in gross slippages to 2.5% of loans. The

larger challenge however remains towards recovery / up-gradations from the same. We suspect PSU banks to resort to
more of write-off / OTS towards problematic loans. We are factoring 68bps of credit cost for our PSU universe. With well
controlled net slippages, we are factoring 58bps of credit cost for our private sector universe.
n Favorable yield movement (unlike Q3FY12 which saw huge MTM provisioning) will be off-set by increased levels of NPA /

standard asset provisioning due to a) migration of few lumpy accounts into lower buckets b) improving incremental PCR
and c) 75bps of additional provisioning on standard restructuring assets. Resultant, we expect our universe to report
12%YoY growth in net profit on back of 6%YoY growth in net profit for PSU space and 23%YoY growth in private space.
Key things to watch: Restructuring, net slippages and provisions there-off
n Our top picks for the quarterly results HDFC Bank, ICICI Bank and United bank in banking space. Mahindra Finance and

CRISIL are our top picks in NBFC space

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 36

Banking and Financial Services


Name

Dec12E

% Chg
YoY

Sep12

Dec11

13,649

11,743

13,805

-1.1%

9,339

8,023

10,300

-9.3%

3.0

2.7

0.0

302 bps

3,021

2,342

5,604

-46.1%

6.0

4.7

11.8

-48.7%

% Chg
QoQ

Comments

Allahabad Bank
CMP(Rs)

184

NII (Rs mn)

Mkt Cap (Rs bn)

92

Op. Profit (Rs mn)

Reco

Hold

NIM (%)

Target Price (Rs)

145

PAT (Rs mn)

% Upside

-21%

EPS (Rs)

16.2% NII growth is expected to decline by -1%YoY on back of


45bpsYoY contraction in NIMs and 14.8%YoY growth in loan
16.4% portfolio. NIMs at 2.9% (adjusted for int. reversals of Rs1.7bn
on loans in the previous quarter) are expected to remain flat
34 bps qoq. Slippages are expected to remain higher at Rs10bn
(equivalent to average for past 4-quarters) and with higher
29.0% provisioning requirements and muted non-int income, net profit
is expected to decline 46%YoY. Key things to watch out:
29.0%
Slippages, margin outlook and restructuring

Andhra Bank
CMP(Rs)

129

NII (Rs mn)

9,365

8,937

9,839

-4.8%

Mkt Cap (Rs bn)

72

Op. Profit (Rs mn)

6,911

6,381

7,676

-10.0%

2.9

2.8

3.4

-56 bps

2,843

3,256

3,032

-6.2%

5.1

5.8

5.4

-6.2%

Reco

Hold

NIM (%)

Target Price (Rs)

105

PAT (Rs mn)

% Upside

-19%

EPS (Rs)

1,373

NII (Rs mn)

24,456

23,269

21,403

14.3%

Op. Profit (Rs mn)

23,945

21,783

20,592

16.3%

3.2

3.1

3.3

-11 bps

12,726

11,235

11,023

15.5%

30.7

27.1

26.7

14.9%

4.8% Andhra Bank to report -5% / -6%YoY decline in NII / net profit
on back of 56bpsYoY contraction in NIM to 2.9%, 200bps+YoY
8.3% decline in LDR to 78% and higher provisioning requirement
(credit cost factored at 65bps vs 57bps in Q2). Adjusting for
8 bps one-off item in Q2, Q3FY13 NIMs at 2.9% would decline
10bps qoq. Slippages run-rate may ease to Rs5bn and would
-12.7% be off-set by recovery / up-gradation. Key things to watch
Share of bulk deposits, recoveries and restructured portfolio.
-12.7%

Axis Bank
CMP(Rs)
Mkt Cap (Rs bn)
Reco

586
Reduce

NIM (%)

Target Price (Rs)

1,050

PAT (Rs mn)

% Upside

-24%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

5.1% Expect 14%YoY growth in NII driven by 22%YoY growth in


loan portfolio. On a qoq basis, NII growth at 5% will be driven
9.9% by 100bps improvement in LDR and NIM at 3.2%. Trading
gains at Rs2bn (on a favorable base) and 9% qoq growth in fee
4 bps income will be used to off-set against provisioning on NPA +
restructured portfolio, thereby resulting in net profit growth of
13.3% 15%YoY / 13% qoq. Key things to watch: Trend in fee income
and stressed asset addition.
13.3%

| Emkay Strategy | 8th January, 2013 | 37

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Bank of Baroda
CMP(Rs)

878

NII (Rs mn)

29,217

28,623

26,555

10.0%

Mkt Cap (Rs bn)

344

Op. Profit (Rs mn)

23,914

23,826

26,082

-8.3%

Reco

Hold

NIM (%)

2.4

2.5

2.7

-25 bps

Target Price (Rs)

800

PAT (Rs mn)

12,183

13,108

12,993

-6.2%

% Upside

-9%

EPS (Rs)

29.5

31.8

33.1

-10.7%

CMP(Rs)

364

NII (Rs mn)

22,079

21,960

20,674

6.8%

Mkt Cap (Rs bn)

209

Op. Profit (Rs mn)

17,522

18,541

17,318

1.2%

2.2

2.2

2.3

-11 bps

7,223

3,019

8,194

-11.8%

12.6

5.3

15.0

-16.0%

2.1% BOB to witness 10%YoY / 2% qoq growth in NII on back of


16%YoY growth in domestic loans. Overall margins at 2.4%
0.4% are expected to decline 5bps qoq driven by domestic NIMs.
Slippages run-rate at Rs12bn may ease vs Rs13.5bn (avg) for
-5 bps past 3-quarters. Higher trading / forex gains in Q3FY12 are
unlikely to repeat in Q3FY13. The same however will be off-set
-7.1% by no investment depreciation in Q3FY13. Resultant, net profit
at Rs12.2bn may decline by 5%YoY. Key things to watch out:
-7.1%
Slippages and restructured portfolio.

Bank of India

Reco
Target Price (Rs)
% Upside

Reduce
240
-34%

NIM (%)
PAT (Rs mn)
EPS (Rs)

0.5% Bank of India to report modest 6.8%YoY growth in NII on back


of 14.3%YoY growth in loan portfolio and 160bpsYoY
-5.5% improvement in overall LDR to 77%. Margins at 2.2% will
remain flat qoq. We are factoring in slippages of Rs13bn vs
-1 bps Rs13.5bn (avg) for past 4-quarters. Higher NPA + restructuring
will be offset against possible investment gains. Net profit at
139.3% Rs7.2bn would be flat you. Key things to watch NIM,
slippages and movement in restructured.
139.3%

Canara Bank
CMP(Rs)

520

NII (Rs mn)

20,363

19,568

19,186

6.1%

Mkt Cap (Rs bn)

230

Op. Profit (Rs mn)

15,758

12,821

15,767

-0.1%

2.1

2.0

2.1

-3 bps

8,105

6,610

9,976

-18.8%

18.3

14.9

22.5

-18.8%

Reco
Target Price (Rs)
% Upside

Reduce
380
-27%

NIM (%)
PAT (Rs mn)
EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

4.1% Expect mere 6.1%YoY growth in NII led by flat margins at 2.1%
and modest 2%YoY loan growth. Higher trading gains
22.9% (Rs1.5bn from CARE Ratings offer for sale) will be used to offset increased cost thereby resulting in flat operating profitYoY.
6 bps Factoring in slippages at Rs12bn. Unlike previous period which
had higher investment depreciation, Q3FY13 will see increased
22.6% provisioning towards NPA + restructuring, Key things to watch:
PCR, slippages and investment reversals.
22.6%

| Emkay Strategy | 8th January, 2013 | 38

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Corporation Bank
CMP(Rs)

486

NII (Rs mn)

8,254

8,032

8,616

-4.2%

Mkt Cap (Rs bn)

72

Op. Profit (Rs mn)

6,685

6,858

8,257

-19.0%

2.0

2.0

2.3

-37 bps

3,376

4,057

4,020

-16.0%

22.8

27.4

27.1

-16.0%

Reco

Hold

NIM (%)

Target Price (Rs)

440

PAT (Rs mn)

% Upside

-9%

EPS (Rs)

CMP(Rs)

522

NII (Rs mn)

5,283

5,059

5,280

0.1%

Mkt Cap (Rs bn)

89

Op. Profit (Rs mn)

4,567

3,496

4,187

9.1%

3.4

3.3

3.7

-30 bps

2,173

2,151

2,019

7.6%

12.7

12.6

11.8

7.6%

2.8% NII to decline by 4%YoY led by 37bpsYoY decline in NIM to


2.0% and muted 9.4%YoY growth in loans. Additionally with
-2.5% lower non-int income and stable costs, operating profit at
Rs6.7bn would decline by 19%YoY. While the slippages run0 bps rate may ease to Rs3bn, larger question remains on ability
towards recovery. Net profit to decline 16%YoY / 17% qoq. Key
-16.8% things to watch: Share of bulk deposit, slippages and recovery /
up-gradations
-16.8%

Federal Bank
4.4% Expect NII to remain flatYoY at Rs5.3bn due to high base.
However expect advance growth to pick up with NIMs largely
30.6% flat at 3.3%. Provision could be higher on account of NAFED
exposure. However with higher other income (gains from
7 bps CARE Ratings offer for sale) net profit to grow by 10%yoy to
Rs2.2bn. Key thing to watch out will be 1) slippages in the
1.0% large corporate book and recoveries

Reco

Hold

NIM (%)

Target Price (Rs)

500

PAT (Rs mn)

% Upside

-4%

EPS (Rs)

668

NII (Rs mn)

39,048

37,317

31,160

25.3%

30,206

25,713

23,780

27.0%

4.1

4.0

3.8

25 bps

4.6% HDFC bank to report 25.3%YoY / 4.6% qoq growth in NII


driven by 22.8%YoY / 3% qoq growth in advances and flat
17.5% NIMs qoq. Asset quality woes remain limited and adequately
provided for with PCR at 80%+. Key things to watch: CASA
3 bps movement and loan mix.

18,683

15,600

14,297

30.7%

19.8%

7.9

6.6

6.1

29.5%

19.8%

1.0%

HDFC Bank Ltd.


CMP(Rs)
Mkt Cap (Rs bn)

1,582

Op. Profit (Rs mn)

Reco

Hold

NIM (%)

Target Price (Rs)

620

PAT (Rs mn)

% Upside

-7%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 39

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

ICICI Bank Ltd.


CMP(Rs)

1,182

NII (Rs mn)

34,318

33,712

27,120

26.5%

Mkt Cap (Rs bn)

1,359

Op. Profit (Rs mn)

32,798

31,933

26,870

22.1%

Reco

Hold

NIM (%)

2.7

2.8

2.4

30 bps

Target Price (Rs)

1,100

PAT (Rs mn)

21,047

19,561

17,280

21.8%

18.3

17.0

15.0

21.7%

% Upside

-7%

EPS (Rs)

CMP(Rs)

903

NII (Rs mn)

38,091

36,501

35,360

7.7%

Mkt Cap (Rs bn)

306

Op. Profit (Rs mn)

27,592

25,336

26,756

3.1%

3.2

3.1

3.4

-25 bps

10,782

10,663

11,492

-6.2%

31.8

31.4

36.3

-12.4%

1.8% ICICI Bank to witness 27%YoY growth in NII led by 17.0%


growth in advances and flat NIMs qoq at 2.7%. Domestic loan
2.7% growth is expected to remain higher at 21%. Muted growth in
fee income (+4%) will be offset against, higher trading gains
-4 bps resulting in 22%YoY growth in operating profit. We after
factoring slippages at Rs11bn for Q3FY13 vs Rs12.2bn in
7.6% Q2FY13. Key things to watch out: RoE improvement and
international loan portfolio.
7.6%

Punjab National Bank

Reco
Target Price (Rs)
% Upside

Reduce
610
-32%

NIM (%)
PAT (Rs mn)
EPS (Rs)

4.4% NII growth to witness modest at 8%YoY / 4% qoq on back of


17%YoY / 4% qoq growth in loan portfolio and flat NIM qoq at
8.9% 3.2%. Full impact of base rate reduction (implemented in Q2)
will be off-set by reduction in share of wholesale deposits).
5 bps NPA pressure to persist with credit cost in excess of 110bps.
With lower non-int income and higher provisioning
1.1% requirement, net profit at Rs10.7bn will decline 6%YoY. Key
thins to watch out recovery and up gradation, bulk deposit
1.1%
and restructuring pipeline.

South Indian Bank


CMP(Rs)

30

NII (Rs mn)

3,253

2,977

2,734

19.0%

Mkt Cap (Rs bn)

40

Op. Profit (Rs mn)

2,037

1,996

1,790

13.8%

2.9

2.8

3.0

-2 bps

1,245

1,189

1,023

21.7%

0.9

0.9

0.9

5.6%

Reco
Target Price (Rs)
% Upside

Hold
25
-17%

NIM (%)
PAT (Rs mn)
EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

9.3% Expect NII growth of 19%YoY driven by 19% loan growth and
10bps expansion in NIMs to 2.9%. As provision continue to
2.1% remain higher on account of further provisions for NAFED
account, PAT to grow by 21.7% to Rs1.24bn Key thing to
13 bps watch out 1) Growth in gold loan portfolio and outlook on the
same 2) slippages
4.7%
4.7%

| Emkay Strategy | 8th January, 2013 | 40

Banking and Financial Services


Name

Dec12E

% Chg
YoY

Sep12

Dec11

115,795

109,738

114,659

1.0%

82,980

73,536

72,600

14.3%

3.2

3.1

3.6

-45 bps

42,925

36,581

32,631

31.5%

64.0

54.5

51.4

24.5%

% Chg
QoQ

Comments

State Bank of India


CMP(Rs)

2,468

NII (Rs mn)

Mkt Cap (Rs bn)

1,656

Op. Profit (Rs mn)

Reco

Reduce

NIM (%)

Target Price (Rs)

1,750

PAT (Rs mn)

% Upside

-29%

EPS (Rs)

5.5% While SBIs reported net profit is expected to grow by


31.5%YoY, adjusted for trading losses in Q3FY12, net profit is
12.8% expected to decline 8%YoY. Core operating matrix remains
weak and is reflected from 2%YoY decline in core operating
8 bps profit. Additionally, investment gains for Q3FY12 are unlike to
repeat in the current quarter. We have are factored 15%YoY
17.3% growth in loan portfolio, NIM at 3.2%, slippages at Rs75bn and
credit cost at 52bps. Key things to watch: Slippages, margin
17.3%
performance and recoveries.

Union Bank of India


CMP(Rs)

275

NII (Rs mn)

19,007

18,502

17,809

6.7%

Mkt Cap (Rs bn)

151

Op. Profit (Rs mn)

12,716

12,727

12,840

-1.0%

2.8

2.8

3.0

-20 bps

6,269

5,546

1,969

218.4%

9.5

8.4

3.1

205.8%

Reco
Target Price (Rs)
% Upside

Reduce
190
-31%

NIM (%)
PAT (Rs mn)
EPS (Rs)

2.7% UNBK NII to grow by a modest 7%yoy on back of 14%YoY


growth in loan portfolio and flat NIM at 2.8%. With muted non-0.1% interest income, primarily lower trading gains, operating profit
is expected to decline 1%YoY. One-off provisioning as seen in
4 bps Q3FY12 (Others (Rs3.8bn) and investment depreciation
(Rs730mn)), are unlikely in Q3FY13, resulting in 2xYoY rise in
13.0% net profit. Key thing to watch out: net slippages and
restructuring
13.0%

United Bank of India


CMP(Rs)

84

NII (Rs mn)

6,317

6,058

6,676

-5.4%

Mkt Cap (Rs bn)

30

Op. Profit (Rs mn)

4,787

4,773

4,833

-1.0%

2.4

2.3

3.0

-59 bps

1,470

1,446

2,260

-34.9%

4.1

4.0

6.6

-37.9%

Reco
Target Price (Rs)
% Upside

Buy
75
-10%

NIM (%)
PAT (Rs mn)
EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

4.3% Expect 5%YoY decline in NII due to modest 8%YoY growth in


loan portfolio and near 50bpsYoY compression in margins to
0.3% 2.4%. Even after factoring for slippages at Rs3.5bn vs Rs4.5bn
in Q2FY13, mgmts intension of providing 70%+ on
5 bps incremental NPAs provide us comfort. With improved recovery
/ upgradations, net slippages are expected to come in at
1.7% Rs2bn vs Rs3.7bn in Q2FY13 resulting in credit cost at 87bps
(annualized) bps vs 152bps in Q2FY12. We expect profit to
1.7%
growth by 1.7% qoq.

| Emkay Strategy | 8th January, 2013 | 41

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

YES Bank
CMP(Rs)

498

NII (Rs mn)

5,789

5,242

4,276

35.4%

Mkt Cap (Rs bn)

178

Op. Profit (Rs mn)

5,454

4,847

3,988

36.7%

Reco

Hold

NIM (%)

2.7

2.6

2.6

16 bps

Target Price (Rs)

440

PAT (Rs mn)

3,472

3,061

2,541

36.7%

9.8

8.6

7.2

34.7%

% Upside

-12%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

10.4% Expect 35%YoY / 10% qoq growth in NII driven by 23%YoY


growth in loan portfolio and 16bpsYoY improvement in NIM to
12.5% 2.7%. Recent reduction in corporate yields will ease borrowing
cost and with improving retail liability franchise, margins should
11 bps remain comfortable at current levels. Asset quality concerns
remain minimal. Key things to watch out: Media account
13.4% exposure, migration to retail + SME franchise and margin
performance.
13.4%

| Emkay Strategy | 8th January, 2013 | 42

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Dewan Housing Finance


CMP(Rs)

221

NII (Rs mn)

1,574

1,546

1,237

27.3%

Mkt Cap (Rs bn)

26

Op. Profit (Rs mn)

1,367

1,331

1,138

20.1%

2.4

2.5

2.5

-17 bps

Reco

Accumulate NIM (%)

Target Price (Rs)

243

PAT (Rs mn)

913

859

750

21.8%

% Upside

10%

EPS (Rs)

7.8

7.3

7.2

8.9%

823

NII (Rs mn)

13,559

12,941

11,557

17.3%

Op. Profit (Rs mn)

14,549

14,940

12,603

15.4%

3.0

2.9

3.0

-6 bps

10,618

10,811

9,162

15.9%

6.9

7.0

6.2

11.0%

1.9% Expect 27%YoY growth in NII led by 24% / 33% growth in


disbursements / loan portfolio. Recent reduction in base rate,
2.7% easing corporate yields and borrowings under ECB route will
help ease borrowings costs. Asset quality pressures remain
-16 bps lower.
6.3% Key things to
performance
6.3%

watch

out:

Securitization

and

margin

HDFC Ltd
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

1,269
Reduce
700
-15%

NIM (%)
PAT (Rs mn)
EPS (Rs)

4.8% HDFC to witness 17%YoY growth in NII aided by 19.5%YoY


growth in loan portfolio and 6qoq improvement in NIM to 3%.
-2.6% With lower non-int income, primarily being dividend income, net
profit is expected to grow by mere 16%YoY. However, adjusted
6 bps for the same, net profit would grow by 18%YoY.
Key things to watch: Growth in developer portfolio and clarity
-1.8%
over securitization agreement with HDFC Bank.
-1.8%

LIC Housing Finance


CMP(Rs)

292

NII (Rs mn)

3,755

3,535

3,258

15.3%

Mkt Cap (Rs bn)

147

Op. Profit (Rs mn)

3,672

3,394

3,263

12.5%

2.1

2.1

2.3

-15 bps

2,681

2,431

2,463

8.8%

0.0

4.8

Reco

Accumulate NIM (%)

Target Price (Rs)

280

PAT (Rs mn)

% Upside

-4%

EPS (Rs)

5.2 -100.0%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

6.2% LICHF to witness 15%YoY growth in NII aided by 24% growth


in loan portfolio and 10bps qoq improvement in spreads.
8.2% Teaser loan re-pricing to the tune of Rs25-30bn in Q3. Recent
easing in term loan rates / corporate yields should also aid
2 bps margin improvement in Q4FY13 / H1FY14. While growth in
operating profit will remain reasonable at 12.5%YoY,
10.3% provisioning requirement will drag profit growth lower. Key
things: developers loan portfolio and margin performance.
-100.0%

| Emkay Strategy | 8th January, 2013 | 43

Banking and Financial Services


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Mahindra Finance
CMP(Rs)

1,203

5,602

5,259

4,228

32.5%

3,929

3,626

2,797

40.5%

9.0

9.2

9.1

-8 bps

2,080

1,876

1,547

34.4%

10.9%

20.2

18.3

15.1

34.2%

10.9%

Mkt Cap (Rs bn)

137

Op. Profit (Rs mn)

Reco

Hold

NIM (%)

Target Price (Rs)

935

PAT (Rs mn)

% Upside

-22%

6.5% MMFSL likely to report 32% growth in NII led by 32.3% growth
in AUMs, while NIM to contract by 20bpsYoY to 9%%. Net
8.3% profit to grow by 35%yoy to Rs2.1bn. Key things to watch 1)
Growth in CV and car loans 2) NIMs
-22 bps

NII (Rs mn)

EPS (Rs)

Manappuram Finance
CMP(Rs)

44

NII (Rs mn)

3,218

3,206

4,300

-25.2%

Mkt Cap (Rs bn)

37

Op. Profit (Rs mn)

1,665

1,597

2,395

-30.5%

9.6

9.8

1,123

1,077

1,614

-30.4%

1.3

1.3

1.9

-30.4%

Reco
Target Price (Rs)
% Upside

Reduce
30
-31%

NIM (%)
PAT (Rs mn)
EPS (Rs)

13.0 -338 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

0.4% MAFGIL NII to remain flat qoq as NIMs to contract further by


25bps even as AUM to grow by 7%qoq. As the company shift
4.3% to lower interest rate products in line with lower LTV, margin
will remain under pressure. However with lower opex net profit
-25 bps to grow by 4.3%qoq to Rs1.12bn. Key things to watch out. 1)
proportion of the book at higher yields 2) impact on margins as
4.3% the company shifts to lower interest rate pdts
4.3%

| Emkay Strategy | 8th January, 2013 | 44

Banking and Financial Services


Name

Dec12E

% Chg
YoY

Sep12

Dec11

2,176

31.6%

% Chg
QoQ

Comments

CRISIL
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

1,048
74

Net Sales (Rs mn)

2,863

2,707

EBITDA (Rs mn)

1,004

977

35.1

36.1

5.8% CRISILs operating revenues to grow by 31.6%YoY largely led


by consolidation of Coalition (acquisition) numbers and
729
37.7%
2.8% moderate growth in rating business OPMs to expand by
155bpsYoY to 35.1%. Key things to look for commentary on
33.5 155 bps -103 bps bond issuances and traction in research business.

PAT (Rs mn)

698

645

498

40.1%

8.2%

EPS (Rs)

10.0

9.2

6.9

44.5%

8.2%

Net Sales (Rs mn)

676

624

542

24.7%

EBITDA (Rs mn)

204

162

211

-3.7%

Accumulate EBITDA Margin (%)


1,050
0%

ICRA
CMP(Rs)
Mkt Cap (Rs bn)

1,447
14

Reco

Hold

EBITDA Margin (%)

30.1

26.0

39.0 -885 bps

Target Price (Rs)

1,300

PAT (Rs mn)

148

110

177

-16.1%

% Upside

-10%

EPS (Rs)

14.8

11.0

17.7

-16.4%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

8.3% We expect ICRA to report a 24.7% growth in operating


revenues primarily driven by consolidation of BPA Tech even
25.4% as rating revenue expected to grow at just 3%yoy. Operating
margins to decline by 840bpsYoY to 30.1% led by high opex
411 bps structure of BPA Tech. However net profit to decline by
16.4%yoy to Rs148mn due to unfavourable base. Key thing to
35.3% watch out Activity in bond market and BPA tech performance.
35.3%

| Emkay Strategy | 8th January, 2013 | 45

Cement
n Cement volumes growth for the current quarter remains subdued as reflected by 2.1%YoY growth (7.4% qoq) for

companies under our coverage. Cement price movement in 3Q13 was unusual with price declines witnessed in Nov
as well as December led by poor overall demand pick up and poor availability of construction materials (sand &
bricks) in Northern and central region impacting construction activities. This has lead to 3QFY13 avg cement prices
declining by 3.6% sequentially to Rs289/bag with sharp declines of ~4.5% witnessed in western and northern regions
n Companies under our coverage are expected to post realization growth of 5.8%YoY (-2.5% qoq to Rs4472/t) leading to

revenue growth of 8.1%YoY. Cost/t is expected to increase 2.3% qoq. Though the complete impact of 5-7% increase
in fuel costs and levy of service tax on rail freight is likely to be witnessed this quarter, we expect the same to be
partially get negated by 15%YoY decline in international coal prices
n EBITDA/t at Rs814/t is expected to decline 1.9%YoY and 19.2% qoq. Overall EBIDTA is expected to grow 1.2%YoY but

decline 11% qoq led by lower realizations Consequently, we estimate APAT (for cement cos under our coverage) to
grow by 4.1%YoY but decline 15% qoq
n Prefer ACC as current high valuations for companies in the sector have left little room for further outperformance for

stocks like UTCEM and Ambuja. Remain positive on Grasim (led by structural change in VSF business) amongst large
caps while in mid caps we prefer Shree Cements and Madras Cements (strong volume growth and improving cost
structure led by better energy efficiencies)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 46

Cement
Name

Dec12E

% Chg
YoY

Sep12

Dec11

26,344

24,445

25,027

3,859

4,350

3,893

14.6

17.8

15.6

2,212

2,487

2,425

11.8

13.2

12.9

-8.8%

25,122

21,684

23,291

7.9%

5,082

5,650

4,300

18.2%

20.2

26.1

3,089

3,371

2,683

15.1%

2.0

2.2

1.8

15.1%

10,102

11,227

9,415

7.3%

1,642

2,051

1,946

-15.6%

% Chg
QoQ

Comments

ACC
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

1,417
266

Net Sales (Rs mn)


EBITDA (Rs mn)

Accumulate EBITDA Margin (%)


1,510

PAT (Rs mn)

7%

EPS (Rs)

CMP(Rs)

204

Net Sales (Rs mn)

Mkt Cap (Rs bn)

314

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

210

PAT (Rs mn)

% Upside

3%

EPS (Rs)

CMP(Rs)

90

Net Sales (Rs mn)

Mkt Cap (Rs bn)

28

EBITDA (Rs mn)

7.8% Volume growth is expected to remain flattish at 0.5%YoY while


a unusual cement price trend in Nov and Dec is expected to
-0.9% -11.3% result in a 2.8% qoq dip in cement realisation. Overall we
expect 5.3%YoY growth in revenues. Variable costs for ACC
-91 bps -315 bps are expected to remain under control with no increase qoq.
Resultant EBITDA/t at Rs645.
-8.8% -11.1%
5.3%

-11.1%

ACL

18.5 177 bps

15.9% We expect volumes to grow at 0.6%YoY at 5.73mnt while


realizations are also expected to decline by 3.2% qoq thereby
-10.1% resulting in revenue growth of 7.9%YoY for Q4CY12. On the
cost front we expect the same trends in freight costs as ACC
-583 bps (due to full impact of diesel hike) and the fall in international
coal prices resulting in lower P&F costs (-6.4% qoq) negating
-8.4% the impact. Resultant EBITDA/t at Rs887/t is expected to
decline by 25% qoq.
-8.4%

India Cement

Reco

Hold

EBITDA Margin (%)

16.3

18.3

20.7 -441 bps

Target Price (Rs)

103

PAT (Rs mn)

149

391

563

-73.6%

% Upside

14%

EPS (Rs)

0.5

1.3

1.8

-73.6%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-10.0% Net revenues are expected to grow by 7.3%YoY to Rs10.1bn.


Cement revenue at Rs9.9bn are expected to improve by
-19.9% 6.7%YoY but decline 9.6% qoq led by lower realizations
(+1.6%YoY and -2.3% qoq). Volumes are expected to decline
-201 bps 7.5% qoq. On the cost front softening prices of international
coal is expected to partially negate the impact of increase in
-61.9% freight expenses. Consequently EBITDA/t is expected to
decline by 22%YoY and 18% qoq to Rs673/t.
-61.9%

| Emkay Strategy | 8th January, 2013 | 47

Cement
Name

Dec12E

% Chg
YoY

Sep12

Dec11

7,410

15.2%

% Chg
QoQ

Comments

Madras Cement
CMP(Rs)

241

Net Sales (Rs mn)

8,536

9,995

Mkt Cap (Rs bn)

57

EBITDA (Rs mn)

1,964

3,139

23.0

31.4

Reco

Accumulate EBITDA Margin (%)

-14.6% MCLs revenues are expected to grow by 15.2%YoY to


Rs8.54bn with cement revenue growth of 15.3%YoY. Net
2,075
-5.3% -37.4% realizations are expected to improve by just 8%YoY (Rs4523/t)
but decline sequentially by 2.3% led by price volatility
28.0 -498 bps -840 bps witnessed in the sate of Andhra Pradesh. EBITDA/t is expected
to decline 13%yoy to Rs1009/t.
768 -36.0% -63.0%

Target Price (Rs)

245

PAT (Rs mn)

492

1,329

% Upside

2%

EPS (Rs)

2.1

5.6

3.2

-36.0%

CMP(Rs)

80

Net Sales (Rs mn)

5,815

5,984

5,678

2.4%

Mkt Cap (Rs bn)

16

EBITDA (Rs mn)

420

417

871

-51.7%

7.2

7.0

15.3 -811 bps

PAT (Rs mn)

135

192

478

-71.8%

15%

EPS (Rs)

0.7

1.0

2.5

-71.8%

4,555

Net Sales (Rs mn)

13,662

13,238

12,586

3,684

3,930

3,440

27.0

29.7

27.3

1,979

2,281

712

3.2% Shrees revenues are estimated to grow by 8.6%YoY to


Rs13.6bn. Cement revenues at Rs11.4bn are expected to grow
7.1%
-6.3% by 5%YoY led by subdued volume growth of 5%YoY and
flatYoY growth in cement realizations (-2.7% qoq) Revenues
-37 bps -272 bps from Power segment are expected to decline 25%yoy at
Rs2.27bn. Cement EBITDA/t at Rs1049/t is expected to
178.0% -13.2% decline 9%YoY and 11% qoq .

56.8

65.5

20.4

178.0%

-63.0%

Orient Paper

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


92

-2.8% OPILs net revenues are estimated to grow 2.4%YoY to


Rs6.03bn. Cement volumes are expected to decline by 2%YoY
0.9% and 3.5% qoq while realizations are expected to decline
3.6%yoy and 5% qoq to Rs3423/t. Resultant revenues from
27 bps cement are expected to decline 5.5%YoY. Revenues from
paper segment are expected to grow 2% to Rs0.96bn while
-29.6% electrical segment is expected to register growth of 18% in
revenues at Rs1.58bn.
-29.6%

Shree Cement
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

159

EBITDA (Rs mn)

Accumulate EBITDA Margin (%)


4,420
-3%

PAT (Rs mn)


EPS (Rs)

8.6%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-13.2%

| Emkay Strategy | 8th January, 2013 | 48

Cement
Name

Dec12E

% Chg
YoY

Sep12

Dec11

50,136

46,996

45,681

9.8%

9,784

10,073

9,647

1.4%

19.5

21.4

5,191

5,499

5,118

1.4%

19.0

20.1

18.7

1.4%

% Chg
QoQ

Comments

Ultratech
CMP(Rs)

2,041

Net Sales (Rs mn)

Mkt Cap (Rs bn)

559

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

1,950

PAT (Rs mn)

% Upside

-4%

EPS (Rs)

21.1 -160 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

6.7% Revenues are expected to grow 10%YoY to Rs50.13 bn led by


subdued volume growth of 1%YoY and a sequential dip of
-2.9% 2.5% in blended realizations. Freight Costs are expected to
increase by 5% qoq while P&F costs decline of 4.6% is
-192 bps expected to negate its impact. The increase in cost/t for
Ultratech is expected to be lowest compared to ACC and
-5.6% Ambuja (-0.1% qoq). However led by lower realizations
resultant EBITDA/t at Rs953/t is expected to decline 11.2%
-5.6%
qoq (flatYoY).

| Emkay Strategy | 8th January, 2013 | 49

Construction & Infrastructure


n Revenue for Construction & Infra companies within Emkay universe is expected to grow 12%YoY to Rs80 bn. Adani

Ports (Standalone) & Ashoka Buildcon (ABL), are expected to deliver healthy growth 20% & 17%YoY respectively
while IRB & IL&FS are expected to deliver 11% & 14% growth. Execution issues will continue to hamper IVRCL with
its revenue growth pegged at 3%YoY.
n Aggregate EBITDA for coverage universe is expected to grow 7% at Rs 22.6bn with EBITDA margins expected to

decline 120 bps to 28%. However Ex JPA the EBIDTA is expected to grow by a healthy 20%YoY. JPA EBIDTA is
expected to decline 11% led by lower cement & construction profits. Adani port is expected to witness healthy
expansion of 85 bps in margins owing to improved mix. IRB Infra is expected to see its margins dip by 138 bps to
44.45% on account of higher proportion of construction revenues, while Ashoka is expected to see its margins
improve 304 bps to 20% on account of higher BoT revenues.
n Interest expense for the infrastructure universe is expected to increase 12%YoY, however we see interest pressure at

low teens is the lowest in last 8 quarters. While JP Associate (standalone interest cost +4%YoY) & Adani ports
(standalone interest cost +8%) are expected to see only single digit increase in interest cost, IVRCL & Ashoka are
expected to see steep jump with their interest charge increasing by 56% & 43% respectively.
n With depreciation cost increasing by 20%YoY, aggregate APAT for coverage universe is expected to decline 20%YoY

to Rs6.8 bn. However the dip in profitability is led by JPA (61%YoY) & IVRCL (Net loss of Rs71 mn as compared to
profit of Rs68 mn). Excluding these two APAT for the quarter is expected to jump 3%YoY, with Ashoka (+18%YoY)
and Adani ports (13%YoY) registering healthy growth in profits.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 50

Construction & Infrastructure


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Adani Ports & SEZ


12.6% Adani ports (ADSEZ) is expected to report revenues of
Rs7.85bn registering a +20%YoY growth led by 26%YoY
11.7% increase in cargo volume and 5% correction in net average
realization. Net profit at Rs3.5 bn is expected to witness a
-59.2 13%YoY growth.

CMP(Rs)

140

Net Sales (Rs mn)

7,856

6,976

6,554

19.9%

Mkt Cap (Rs bn)

281

EBITDA (Rs mn)

5,415

4,850

4,462

21.4%

Reco

Buy

EBITDA Margin (%)

68.9

69.5

68.1

85.0

Target Price (Rs)

150

PAT (Rs mn)

3,524

3,717

3,106

13.4%

-5.2%

% Upside

7%

EPS (Rs)

1.75

1.8

1.5

13.4%

-5.2%

Ashoka Buildcon
CMP(Rs)

218

Net Sales (Rs mn)

4,115

3,099

3,529

16.6%

32.8%

Mkt Cap (Rs bn)

11

EBITDA (Rs mn)

931

841

692

34.7%

10.8%

Reco

Buy

EBITDA Margin (%)

22.6

27.1

19.6 304 bps -449 bps

Target Price (Rs)

340

PAT (Rs mn)

231

286

195

18.1%

-19.3%

% Upside

56%

EPS (Rs)

4.4

5.4

3.7

18.1%

-19.3%

CMP(Rs)

215

Net Sales (Rs mn)

14,461

13,704

12,684

14.0%

Mkt Cap (Rs bn)

42

EBITDA (Rs mn)

4,145

4,527

28.7

33.0

1,002

1,159

5.2

6.0

4.5

14.2%

Ashoka Buildcon (ABL) is expected to report revenues of


Rs4.1bn registering a +17%YoY growth led by 18%YoY
increase in Construction rev. and 12%yoy growth in BOT
revenues. In Q4FY12, ABL commenced toll collection for Durg
& Jaora Nayegaon project & commenced toll collection at
Dhankuni Kharagpur in Q1FY13, the initial collection is ahead
of management estimates. We expect EBIDTA for the quarter
at Rs0.93bn growing 35%yoy with EBITDA margins of 22.6%.
Net profit at Rs0.23 bn for the quarter is expected to witness a
18% growth.

IL&FS Transportation

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

221

PAT (Rs mn)

% Upside

3%

EPS (Rs)

IL&FS Transportation is expected to report revenues of


5.5% Rs14.5bn registering a +14%YoY growth. Construction its
revenues are likely to witness 11%YoY growth at Rs 10bn.
3,207
29.2%
-8.4% Toll/Annuity income will witness ~45%YoY growth to Rs2.15bn.
EBITDA expected at Rs3.96bn registering a 30%yoy growth.
25.3 338 bps -437 bps Margins are expected to expand 338 bps to 28.7%, driven by
changing mix. Net profit for the quarter is expected at Rs 1 bn
878
14.2% -13.6% a growth of 14%YoY .

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-13.6%

| Emkay Strategy | 8th January, 2013 | 51

Construction & Infrastructure


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

IRB Infrastructure
CMP(Rs)

134

Net Sales (Rs mn)

8,278

8,453

7,455

11.0%

Mkt Cap (Rs bn)

44

EBITDA (Rs mn)

3,680

3,807

3,417

7.7%

Reco

Buy

EBITDA Margin (%)

44.5

45.0

45.8 -138 bps

Target Price (Rs)

230

PAT (Rs mn)

960

1,210

1,244

-22.8%

% Upside

72%

EPS (Rs)

2.9

3.6

3.7

-22.8%

12,310

9,947

11,955

3.0%

IRB is expected to report revenues of Rs8.3bn (+11%YoY) led


-2.1% by 13%YoY growth in Construction rev & 10%YoY growth in
BOT revenues led by 8.9% hike in Surat Dahisar from Sept -1.
-3.4% With larger share of high margin BOT segment expanding,
EBIDTA for the quarter is expected at Rs3.7bn growing
-59 bps 7.7%yoy. Consolidated EBITDA margins of 44.5% registering
an contraction of 138bpsYoY. Net profit at Rs0.96bn is
-20.7% expected to witness a 22.7%YoY decline, mainly led by 52%
growth in depreciation & 10% increase in interest expense.
-20.7%

IVRCL
CMP(Rs)

46

Net Sales (Rs mn)

Mkt Cap (Rs bn)

14

EBITDA (Rs mn)

980

699

878

11.6%

EBITDA Margin (%)

8.0

7.0

7.3

62 bps

PAT (Rs mn)

-71

-396

68

NA

EPS (Rs)

-0.3

-1.5

0.3

NA

33,113

29,825

29,470

12.4%

7,483

7,944

22.6

26.6

1,210

1,280

0.6

0.6

1.5

-60.9%

Reco
Target Price (Rs)
% Upside

Hold
39
-16%

IVRCLs is expected to report revenues of Rs12.3bn registering


23.8% a 3% growthYoY. EBITDA for the quarter at Rs 0.98bn is
expected to register 11.6% growthYoY with EBITDA margins at
40.2% 8%, +62 bpsYoY. Adj. Net profit for the quarter at -Rs 71 mn.
Execution issues continue to persist, however positive
94 bps developments like possible monetization of some BOTs or
Real estate will be the key triggers for the stock.
NA
NA

Jaiprakash Associates
CMP(Rs)

99

Net Sales (Rs mn)

Mkt Cap (Rs bn)

213

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)


% Upside

93
-6%

PAT (Rs mn)


EPS (Rs)

Jaiprakash Associates (JPA) is expected to report revenue of


11.0% Rs33.1bn, +12.4%YoY and +11% qoq. Cement revenues are
expected to grow 12.6%YoY (Volume + 6% & realization
8,446 -11.4%
-5.8% growth 6%), 18% growth in real estate revenue to Rs 3.6bn &
5%YoY growth in construction revenue at Rs 13.04bn. EBITDA
28.7 -606 bps -404 bps to decline 11%yoy to Rs7.5bn with a 606bpsYoY decline in
marginsYoY to 22.6%. Adjusted net profit to decline 60.9%YoY
3,097 -60.9%
-5.5% to Rs 1.21bn.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-5.5%

| Emkay Strategy | 8th January, 2013 | 52

Consumers
n Our Consumers universe is expected to report healthy performance: revenue growth of 15%YoY to Rs 204 bn and

Apat growth of 18%YoY to Rs 21bn. Dont expect improvement in growth momentum, especially after the moderation
reported in past quarters. We expect the price-led and volume-led growth to balance-out against lop-sided in past
quarters. The volume-led (8%) and price-led (7%) growth balances out.
n No change in construct of underlying volume growth. Dont expect improvement in growth momentum, especially

after the moderation reported in past quarters (impacted by CSD Channel, Discretionary Spending). Emkay
expectation for volume growth - Asian Paints (+7%), Berger (+7%), HUL (+7%), Colgate (+9%), Nestle (+3%), GSK
Consumer (+4%), Marico (+9%) and Jubilant FoodWorks (SSG 20%). Whereas, Titan is expected to report +5% in
Jewellery against volume decline in previous quarters.
n Input costs have fallen on selective basis (1) Palm Oil down 16% qoq and 9%YoY (2) Brent Crude down 6% qoq and

(3) Titanium Dioxide down 13% qoq and 8%YoY. However, Ebidta gains would not fructify for Asian Paints (offset by
higher A&P spends, owing to corporate branding) and GCPL (impacted by consolidation effect). Even, HUL has seen
significant reduction in input costs in S&D segment, supporting case for qoq expansion in Ebidta margins.
n Robust earnings performance expected for GSK Consumer (27%YoY), Godrej Consumer (28%YoY), Jubilant

FoodWorks (32%YoY), Marico (37%YoY) and Page Industries (36%YoY). Base effects to catch-up with Hindustan
Unilever restricting earnings growth to 12%YoY. Even, Nestle would report muted earnings growth at 10%YoY.
n Current valuations are at a significant premium to 10-yr avg and 5-yr avg valuation. We do not expect consumer

space to re-rate any further. Our preference for companies is clearly driven by earnings visibility, confidence on
earnings and reasonable valuations. Concurrently, preferred buys are Berger, Colgate, GSK Consumer, Marico and
Titan. Whereas, top avoids are Asian Paints, Hindustan Unilever, GCPL, Jubilant FoodWorks and Page Industries.
Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 53

Consumers
Name

Dec12E

% Chg
YoY

Sep12

Dec11

29,362

26,364

25,605

4,697

3,816

3,974

16.0

14.5

15.5

3,166

2,391

2,594

33.0

24.9

27.0

22.0%

8,945

8,111

7,813

14.5%

957

900

840

14.0%

10.7

11.1

10.8

-5 bps

% Chg
QoQ

Comments

Asian Paints
CMP(Rs)

4,382

Net Sales (Rs mn)

Mkt Cap (Rs bn)

420

EBITDA (Rs mn)

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

3,340

PAT (Rs mn)

% Upside

-24%

EPS (Rs)

11.4% Volume growth expectations at 7%YoY and Price growth


expectations at 8%YoY. Any gains on input costs would be
18.2%
23.1% used for spends on Corporate spending. We expect robust
earnings performance in Q3FY13 (1) Revenue +14.7%YoY to
48 bps 152 bps Rs29.4 bn (2) Ebidta +18.2%YoY to Rs4.7 bn and (3) Apat
+22.0%YoY to Rs3.2 bn. Ebidta margins expands 48 bps to
22.0%
32.4% 16.0%.
14.7%

32.4%

Berger Paints
CMP(Rs)

154

Net Sales (Rs mn)

Mkt Cap (Rs bn)

53

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

10.3% Continue to gain from strong growth in Southern and Eastern


region. Volume growth expectations at 7%YoY and Price
6.4% growth expectations at 8%YoY. This translates into revenue
growth of 14.5%YoY to Rs8.9 bn. Ebidta margins to maintain at
-39 bps 10.7%. Consequently, APAT to grow at 20.4%YoY to Rs591
mn.
10.7%

Target Price (Rs)

152

PAT (Rs mn)

591

534

491

20.4%

% Upside

-1%

EPS (Rs)

1.7

1.5

1.4

20.4%

10.7%

Net Sales (Rs mn)

7,834

7,738

6,696

17.0%

1,650

1,571

1,353

21.9%

21.1

20.3

20.2

85 bps

1,387

1,451

1,156

20.0%

1.2% Expected to maintain its growth momentum. Colgate expected


to report (1) revenue growth of 17.0%YoY to Rs7.8 bn (2)
5.0% Ebidta growth at 21.9%YoY to Rs1.6 bn and (3) Apat growth at
20.0%YoY to Rs1.4 bn. The inherent volume growth
75 bps assumption is 9.0%YoY. Even, price led growth continues to
remain strong.
-4.4%

10.2

10.7

8.5

20.0%

Colgate-Palmolive
CMP(Rs)

1,535

Mkt Cap (Rs bn)

209

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)


% Upside

1,400
-9%

PAT (Rs mn)


EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-4.4%

| Emkay Strategy | 8th January, 2013 | 54

Consumers
Name

Dec12E

% Chg
YoY

Sep12

Dec11

17,456

16,003

13,509

29.2%

3,272

2,489

2,721

20.3%

18.7

15.6

2,131

1,593

1,671

27.5%

6.3

4.7

5.2

21.2%

% Chg
QoQ

Comments

Godrej Consumer Products


CMP(Rs)

717

Net Sales (Rs mn)

Mkt Cap (Rs bn)

244

EBITDA (Rs mn)

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

580

PAT (Rs mn)

% Upside

20.1 -139 bps

-19%

EPS (Rs)

3,844

Net Sales (Rs mn)

7,195

8,577

6,248

EBITDA (Rs mn)

1,042

1,706

844

14.5

19.9

13.5

9.1% Drivers to strong performance (1) consolidation of acquired


business (2) strong growth in domestic business, post re31.4% launch of Cinthol and (3) gain from fall in palm oil prices.
International business gain from translation benefit. Expect (1)
319 bps 29.2%YoY growth in revenue to Rs15.0 bn (2) Ebidta margin at
18.7% (3) ebidta growth of 20.1%YoY to Rs2.6 bn and (4)
33.8% APAT growth of 27.5%YoY to Rs2.1 bn.
33.8%

GSK Consumer

Target Price (Rs)

3,400

PAT (Rs mn)

749

1,286

591

-16.1% Negative impact of CSD channel continues on brand Horlicks.


Consequently, volume growth expectations are muted at
23.5% -38.9% 4.0%YoY. But, 5% price hike in Q3CY12 has resulted in 8-9%
price led growth in the quarter. We have forecasted (1)
98 bps -541 bps Revenue growth of 15.2%YoY to Rs7.2 bn (2) EBIDTA growth
23.5%YoY to Rs1.0 bn and (3) APAT growth of 26.7%YoY to
26.7% -41.7% Rs749 mn.

% Upside

-12%

EPS (Rs)

17.8

30.6

14.1

26.7%

Net Sales (Rs mn)

64,916

63,108

59,376

9.3%

10,621

9,767

9,705

9.4%

16.4

15.5

16.3

2 bps

8,589

8,053

7,662

12.1%

4.0

3.7

3.5

12.1%

CMP(Rs)
Mkt Cap (Rs bn)
Reco

162

Accumulate EBITDA Margin (%)

15.2%

-41.7%

HUL
CMP(Rs)

525

Mkt Cap (Rs bn)

1,136

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

490

PAT (Rs mn)

% Upside

-7%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

2.9% Growth momentum decelerates further in Q3FY13 led by (1)


de-merger of export business (2) high base in S&D segment
8.7% and (3) slower premiumization in PP segment. But, reduction in
input costs triggers 88bps qoq expansions in ebidta margins.
88 bps We have forecasted 12.1%YoY growth in APAT to Rs8.6 bn.
We have assumed volume growth of 7%YoY, continuation of
6.7% Q2FY13.
6.7%

| Emkay Strategy | 8th January, 2013 | 55

Consumers
Name

Dec12E

% Chg
YoY

Sep12

Dec11

3,903

3,421

2,770

40.9%
30.9%

% Chg
QoQ

Comments

Jubilant FoodWorks

Target Price (Rs)

1,000

PAT (Rs mn)

402

323

303

32.3%

14.1% No improvement in SSG expected on qoq basis. We have


forecasted SSG at 20% in Q3FY13, equivalent to Q2FY13. Our
16.9% forecasts are (1) Revenue growth of 40.9%YoY to Rs3.9 bn,
(2) EBIDTA growth of 30.9%YoY to Rs686 mn and (3) APAT
42 bps growth of 32.3%YoY to Rs402 mn. SSG to remain under
pressure. We expect EBITDA margin to contract by 134
24.1% bpsYoY.

% Upside

-24%

EPS (Rs)

6.2

5.0

4.7

31.4%

24.1%

12,684

11,559

10,578

19.9%

1,730

1,477

1,218

42.1%

13.6

12.8

11.5 213 bps

1,151

859

841

36.8%

9.7% Growth momentum continues with each of its major categories


registering robust growth. Also, Personal care brands acquired
17.2% from Reckitt Benckiser will do revenue contribution of Rs
400mn, triggering revenue growth of 19.9%YoY. EBITDA
87 bps margins to expand 213 bpsYoY to 13.6%. APAT growth at
36.8%YoY to Rs1.1 bn.
34.0%

1.8

1.3

1.4

30.5%

34.0%

21,502

21,156

19,547

10.0%

4,390

4,360

3,858

13.8%

20.4

20.6

19.7

68 bps

2,545

2,673

2,308

10.2%

26.4

27.7

23.9

10.2%

CMP(Rs)

1,318

Net Sales (Rs mn)

Mkt Cap (Rs bn)

86

EBITDA (Rs mn)

686

587

524

Reco

Sell

EBITDA Margin (%)

17.6

17.2

18.9 -134 bps

Marico
CMP(Rs)

227

Net Sales (Rs mn)

Mkt Cap (Rs bn)

147

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

208

PAT (Rs mn)

% Upside

-9%

EPS (Rs)

Nestle
CMP(Rs)
Mkt Cap (Rs bn)
Reco
Target Price (Rs)
% Upside

4,874
470

Net Sales (Rs mn)


EBITDA (Rs mn)

Accumulate EBITDA Margin (%)


5,000
3%

PAT (Rs mn)


EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

1.6% Low growth continues expecting 3%YoY volume growth and


10%YoY revenue growth. Challenges persist in Milk,
0.7% Confectionary and Beverages portfolio. But, lower input costs
triggers 68 bpsYoY expansion in EBIDTA margins to 20.4%.
-19 bps We forecast EBIDTA growth at 13.8%YoY to Rs4.4 bn and
APAT growth of 10.2%YoY to Rs2.5 bn.
-4.8%
-4.8%

| Emkay Strategy | 8th January, 2013 | 56

Consumers
Name

Dec12E

% Chg
YoY

Sep12

Dec11

2,119

2,201

1,721

23.1%
42.7%

% Chg
QoQ

Comments

Page Industries
CMP(Rs)

3,415

Net Sales (Rs mn)

Mkt Cap (Rs bn)

38

EBITDA (Rs mn)

421

440

295

Reco

Sell

EBITDA Margin (%)

19.9

20.0

17.2 272 bps

Target Price (Rs)

2,849

PAT (Rs mn)

271

308

199

36.1%

% Upside

-17%

EPS (Rs)

24.3

27.6

17.9

36.1%

28,748

22,760

24,401

17.8%

2,756

2,494

2,129

29.4%

9.6

11.0

8.7

86 bps

1,995

1,801

1,636

21.9%

2.2

2.0

1.8

21.9%

-3.7% Sportswear and womens wear would continue to drive


revenues to Rs 2.1bn, growth of 23%YoY, while mens
-4.4% segment may grow slower as compared to its other 2
segments. Expect EBIDTA to grow at 43%YoY led by benefit
-13 bps from lower raw material prices. EBIDTA margins to grow
270bps to 19.9% despite rise in advertising cost. Despite
-11.9% higher interest cost on account of debt for working capital,
APAT to grow at 36%YoY at Rs 271mn.
-11.9%

Titan Industries
CMP(Rs)

282

Net Sales (Rs mn)

Mkt Cap (Rs bn)

250

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

285

PAT (Rs mn)

% Upside

1%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

26.3% Improving volumes due to festive demand, growth from store


expansion and SSG to drive 18%YoY revenue growth to Rs
10.5% 23.5bn in jewellery segment, while watches segment to grow
10%YoY to Rs 4.2bn purely led by price increases.
-137 bps Subsequently, revenues to grow 18%YoY to Rs 28.7bn. Expect
EBIDTA to grow at 29%YoY to Rs 2.8bn, while EBIDTA
10.7% margins to expand 90bps to 9.6% on account of higher share
of studded jewellery. APAT to grow 22%YoY to Rs 2.0 bn.
10.7%

| Emkay Strategy | 8th January, 2013 | 57

Engineering & Capital Goods (ECG)


Expect muted operational performance in Q3FY13E on back of lower revenue growth. Lower other income and higher
interest costs to result in 2% drop in net profits
n Muted revenue growth at 6.2%YoY to Rs356.1 bn witnessed across companies on back of lower order backlogs and

muted demand. Notable exceptions are L&T (+13%), Elecon Engg (+12%) and Punj Lloyd (+12%)
n Expect stable EBITDA margins at 12.4% (-20 bpsYoY) with EBITDA growth at 4.9%YoY to Rs44.2 bn
n High financial leverage (driven by steady deterioration of working capital) to continue to negatively impact ECG

sector earnings performance. Expect net profit to decline by 2.4%YoY to Rs27.2 bn after factoring lower other income
(-13%YoY) and higher interest charges (+30%YoY). Outperformers include L&T (+5%YoY), Greaves Cotton (+13%) and
Blue Star (L/P). Voltas, Thermax, LMW and McNally Bharat to witness +15%YoY decline in net profit
n Expect order inflows to decline 7% qoq to Rs272 bnYoY to Rs302.9 bn (YTD 66% of FY13E target order inflows)

Key actionables for the quarter


n Greaves Cotton Expect positive earnings surprise led by pick-up in 3-W volume growth after 7-8 months of

decline in volumes
n Blue Star - Expect positive earnings surprise led by improvement in operational performance in EMP&PAC division.

We have factored segment EBIT margins at 5.5% (Vs 7.0% in Q2FY13)


Emkays stock selection is purely driven by visibility, cash flows and ROIC of the business models. Our preferred BUYS
are L&T, Cummins India, Greaves Cotton and Blue Star. Though these companies appear to be richly valued (on relative
basis); they should be viewed in conjunction to strength of the business model

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 58

Engineering & Capital Goods (ECG)


Name

Dec12E

BHEL
240

Net Sales (Rs mn)

Mkt Cap (Rs bn)

587

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

220

PAT (Rs mn)

% Upside

-8%

EPS (Rs)

Larsen & Toubro

Mkt Cap (Rs bn)


Reco

Dec11

107,887

105,616

106,586

1.2%

20,239

18,995

19,960

1.4%

18.8

18.0

18.7

3 bps

13,501

12,744

13,936

-3.1%

5.5

5.2

5.7

-3.1%

157,258

131,952

139,836

12.5%

15,306

14,054

13,641

12.2%

9.7

10.7

9.8

-2 bps

10,571

9,146

10,015

5.6%

17.3

15.0

16.4

5.8%

% Chg
QoQ

Comments

Standalone

CMP(Rs)

CMP(Rs)

% Chg
YoY

Sep12

2.2% Expect decline in earnings to continue in Q3FY13E amidst a


declining order backlog and paucity of incremental orders. (1)
6.6% Muted revenue growth at 1%YoY led by Power (-1% to Rs86.7
bn). Industry growth at 6%YoY to Rs25.2 bn (2) Stable margins
77 bps at 18% (3) APAT expected to decline by 3%YoY to Rs13.5 bn
led by lower other income. Implied earnings decline at
5.9% 20%YoY in Q4FY13E lends minimal downside risk. Key
things to watch out will be outlook on order inflows and
5.9% profitable execution of order backlog

Standalone
1,588
977

Net Sales (Rs mn)


EBITDA (Rs mn)

Accumulate EBITDA Margin (%)

Target Price (Rs)

1,759

PAT (Rs mn)

% Upside

11%

EPS (Rs)

CMP(Rs)

535

Net Sales (Rs mn)

9,892

10,869

9,624

2.8%

Mkt Cap (Rs bn)

148

EBITDA (Rs mn)

1,739

1,999

1,612

7.9%

17.6

18.4

16.7

83 bps

1,361

1,609

1,410

-3.5%

4.9

5.8

5.1

-3.5%

19.2% Expect deceleration in earnings to continue led by lower


revenue growth and other income (1) Revenue growth at
8.9% 12%YoY - led by 14% growth in E&C to Rs141.3 bn. Expect
E&E to grow 3%YoY and M&IP to remain flat (2) Stable
-92 bps margins at 9.7% (3) Lower APAT growth at 6%YoY to Rs10.6
bn due to decline in other income. Strong order inflows at
15.6% Rs150 bn (factoring order cancellations of Rs28 bn.
Management ability to retain guidance on order inflow,
15.6%
revenues and EBITDA margins will be critically evaluated.

Cummins India

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

500

PAT (Rs mn)

% Upside

-7%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-9.0% Expect Cummins to witness muted revenue growth at 3%YoY


to Rs9.9 bn led by decline in exports (-2%), industrial (-8%)
-13.0% and automotive (-40%) markets. Domestic power gensets
expected to grow at 8%.. Expect EBITDA margsin to improve
-81 bps 80 bpsYoY to 17.6% (though down 80 bps qoq). Hence
EBITDA growth at 8%YoY to Rs1.7 bn. But APAT expected to
-15.5% decline by 3%YoY to Rs1.4 bn led by lower other income.
Management comment on sustainable operating margins &
-15.5%
demand outlook (export, domestic)) will be keenly awaited

| Emkay Strategy | 8th January, 2013 | 59

Engineering & Capital Goods (ECG)


Name

Dec12E

Thermax

% Chg
YoY

Sep12

Dec11

11,775

11,924

12,693

-7.2%

1,166

1,218

1,354

-13.9%

632

Net Sales (Rs mn)

Mkt Cap (Rs bn)

75

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

9.9

10.2

10.7

-77 bps

Target Price (Rs)

505

PAT (Rs mn)

808

911

955

-15.3%

EPS (Rs)

6.8

7.6

8.0

-15.3%

12,170

11,645

11,580

5.1%

522

440

807

-35.3%

4.3

3.8

7.0 -268 bps

-20%

Voltas

-1.3% Expect continued weak performance owing to muted order


inflows in H2FY12 and low opening order book cover. 1%YoY
-4.3% decline in revenues led by Energy (-11%YoY to Rs8.8 bn).
Environment to grow by 8%YoY to Rs3.3 bn. Expect EBITDA
-31 bps margins to fall by 80 bpsYoY due to negative impact of
operating leverage and rising costs. Led by decline in revenues
-11.2% and EBITDA margins, APAT to fall by 15%YoY to Rs808 mn.
Pick-up in order inflows remain crucial to retain earnings
-11.2% estimates.

Consolidated

CMP(Rs)

105

Net Sales (Rs mn)

Mkt Cap (Rs bn)

35

EBITDA (Rs mn)

Reco

Comments

Standalone

CMP(Rs)

% Upside

% Chg
QoQ

Accumulate EBITDA Margin (%)

Target Price (Rs)

121

PAT (Rs mn)

396

333

610

-35.1%

% Upside

15%

EPS (Rs)

1.2

1.0

1.8

-35.1%

CMP(Rs)

177

Net Sales (Rs mn)

5,996

5,786

5,840

Mkt Cap (Rs bn)

16

EBITDA (Rs mn)

309

202

-88

4.5% After a dismal Q2FY13, expect sequential improvement in


Q3FY13E performance, though net profit to decline by 35%
18.7% onYoY basis. Expect revenues to increase by 5%YoY & 5%
qoq EMP up 2%YoY, EPS up 8%YoY and UCP up 17%YoY.
51 bps Expect EBITDA margins at 4.3% (-270 bpsYoY, +50 bps qoq)
low EBITDA margins due to execution of low margin Sidra
19.1% medical project. Consequently, expect APAT to fall by
35%YoY, though up 19% qoq. Sidra project status update,
19.1% outlook for order inflows, performance of Rohini Electricals will
be key monitorables

Blue Star

Reco

Buy

EBITDA Margin (%)

5.1

3.5

-1.5

Target Price (Rs)

215

PAT (Rs mn)

124

73

-328

% Upside

22%

EPS (Rs)

1.4

0.8

-3.6

3.6% Expect improved performance during Q3FY13E led by EBITDA


margin improvement (1) Revenue growth at 3%YoY
53.2% EMP&PAC (+5% to Rs3.8 bn on declining order backlog),
Cooling products (-1% to Rs1.6 bn weak industry demand),
666 bps 167 bps PEIS (0% to Rs0.5 bn) (2) EBITDA margins at 5.1% - benefits
of operating leverage and change in revenue mix (3) APAT at
n.a.
70.6% Rs124 mn. Traction in order book and BLSRs ability to sustain
EBITDA margins, reduce debt and improve profitability will be
n.a.
70.6%
monitored

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

2.7%

| Emkay Strategy | 8th January, 2013 | 60

Engineering & Capital Goods (ECG)


Name

Dec12E

% Chg
YoY

Sep12

Dec11

4,381

4,696

5,383

-18.6%

EBITDA (Rs mn)

516

608

687

-25.0%

% Chg
QoQ

Comments

Lakshmi Machine Works


CMP(Rs)
Mkt Cap (Rs bn)

2,260
25

Net Sales (Rs mn)

Reco

Hold

EBITDA Margin (%)

11.8

12.9

12.8 -100 bps

Target Price (Rs)

1,923

PAT (Rs mn)

280

306

397

-29.3%

% Upside

-15%

EPS (Rs)

24.9

27.2

35.2

-29.3%

30,289

27,778

27,012

12.1%

2,810

3,139

2,677

5.0%

9.3

11.3

9.9

-63 bps

PAT (Rs mn)

-484

-179

233

n.a.

EPS (Rs)

-1.5

-0.5

0.7

n.a.

5,079

4,501

4,651

9.2%

Punj Lloyd

Consolidated

CMP(Rs)

62

Net Sales (Rs mn)

Mkt Cap (Rs bn)

21

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

-6.7% Tough macro economic conditions have led to lower order


execution. LMW is expected to witness revenue decline during
-15.2% Q3FY13. We expect revenue decline of 19% yoy to Rs4.4bn.
EBITDA margin for LMW is expected to decline 100bps on yoy
-117 bps basis. Operational performance would be marred by revenue
decline and high fuel cost. PAT is expected to decline by 29%
-8.5% yoy to Rs280mn. Order book at the end of Q2FY13 stood at Rs
37bn. On the backdrop of slow economic growth, we expect
-8.5% order inflows during Q3FY13E would remain subdued.

Accumulate EBITDA Margin (%)


74
19%

9.0% Expect continued improvement in operational performance but


negated by high interest costs (1) Revenue growth at 12%YoY
-10.5% to Rs30.3 bn led by strong order book (2) EBITDA margins at
9.3% (-60 bpsYoY) believe to have moved up in the +9%
-202 bps band (3) But low other income (-99%YoY) and high interest
charges (+52%YoY) offset operational performance.
n.a. Consequently expect net loss at Rs484 mn. Sustained
momentum in orders, managements ability to rein in debt key
n.a.
to earnings and rating upgrades.

Greaves Cotton
CMP(Rs)

82

Net Sales (Rs mn)

Mkt Cap (Rs bn)

20

EBITDA (Rs mn)

656

577

577

13.7%

EBITDA Margin (%)

12.9

12.8

12.4

51 bps

PAT (Rs mn)

385

370

342

12.6%

EPS (Rs)

1.6

1.5

1.4

12.6%

Reco
Target Price (Rs)
% Upside

Buy
90
10%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

12.8% After declining for 4 quarters, expect fall in net profits to halt on
favourable base and improved operational performance (1)
13.8% 9%YoY growth in revenues driven by pick-up in 3-W auto
sales volumes. Infrastructure expected to grow at 11% on low
11 bps base to Rs0.4 bn (2) 50 bpsYoY improvement in EBTDA
margins ( (Infra div. EBIT loss at Rs30 mn) (3) APAT growth at
4.0% 13%YoY to Rs385 mn. We await outlook for Infrastructure
division, ramp-up with Tatas & M&M and sustainable EBITDA
4.0%
margins.

| Emkay Strategy | 8th January, 2013 | 61

Engineering & Capital Goods (ECG)


Name

Dec12E

Dec11

4,927

5,142

4,904

0.5%

EBITDA (Rs mn)

336

390

318

5.5%

McNally Bharat Engineering

Standalone

CMP(Rs)

Net Sales (Rs mn)

Mkt Cap (Rs bn)

100
3

% Chg
YoY

Sep12

Reco

Hold

EBITDA Margin (%)

6.8

7.6

6.5

33 bps

Target Price (Rs)

110

PAT (Rs mn)

64

85

125

-48.6%

% Upside

10%

EPS (Rs)

2.1

2.8

4.0

-48.6%

3,359

3,297

3,000

12.0%
1.1%

% Chg
QoQ

Comments

-4.2% Expect performance to be impacted by muted revenue growth,


low other income and high interest expense. (1) Flat revenue
-13.8% growth at 1%YoY to Rs4.9 bn on high base in Q3FY12 (2)
EBITDA margins to improve 30 bpsYoY to 6.8% - probability
-76 bps for upsides exist considering +7% margins in past 3 quarters.
(3) EBITDA growth at 5%YoY to Rs336 mn. (4) Led by decline
-24.8% in other income and high interest expenses, expect APAT to
fall sharply by 49%YoY to Rs64 mn. Outlook on order inflows,
-24.8% EBITDA Margins & FY13E to be tracked.

Elecon Engineering
CMP(Rs)

49

Net Sales (Rs mn)

Mkt Cap (Rs bn)

EBITDA (Rs mn)

485

605

480

EBITDA Margin (%)

14.4

18.3

16.0 -155 bps

PAT (Rs mn)

152

230

152

0.1%

EPS (Rs)

1.6

2.5

1.6

0.1%

3,107

2,652

4,276

EBITDA (Rs mn)

161

149

5.2

0.2

3.5

-146

-8

0.7

-13.2

-0.8

Reco
Target Price (Rs)
% Upside

Hold
56
15%

TRF
CMP(Rs)
Mkt Cap (Rs bn)

Consolidated
241
3

Net Sales (Rs mn)

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

180

PAT (Rs mn)

% Upside

1.9% Expect decline in EBITDA margins to offset 12%YoY revenue


growth (1) 12%YoY growth in revenues led by MHE division
-19.8% (+18%YoY to Rs1.9 bn). TE division to witness healthy growth
at 3%YoY to Rs1.5 bn. (2) 160 bpsYoY drop in EBITDA
-391 bps margins to 14.4% (3) EBITDA growth muted at 1%YoY to
Rs3.4 bn (4) led by drop in EBITDA margins, expect flat APAT
-33.7% at Rs152 mn. Management view on (1) Fresh order inflows (2)
outlook for Benzler Radicon business.
-33.7%

-25%

EPS (Rs)

17.2% TRF (standalone) revenues to decline by 39%YoY to Rs1.7 bn


on declining order backlog and high base. EBITDA margins at
7.6% 2552.0% 4.9% (-30 bpsYoY). 38%YoY rise in interest cost to Rs92 mn.
Hence net loss at Rs18 mn Vs profit of Rs48 mn in Q3FY12
168 bps 494 bps and loss of Rs209 mn in Q2FY13. Auto business performance
impacted by slow down in demand in domestic trailer market
(1) 4%YoY decline in revenue to Rs1.4 bn (1) EBITDA margin
at 5.6% (3) APAT at Rs25 mn (Vs Rs64 mn in Q2FY13).
Outlook for order inflows, demand and margins keenly awaited.
-27.3%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 62

IT Services
n We expect a 2.6-4.2% QoQ US$ rev growth for our Tier I coverage universe (including ~30-40 bps benefit from cross currency

movements) with Wipro at the lower end (however within it's guided range of 1.2-3.2% QoQ growth) and Infosys at the upper
end ( however note that it's helped by incorporation of Lodestone acquisition for 2 months, we build in ~2% QoQ growth on an
organic basis).TCS is expected to lead the Tier I peers both on sequential andYoY revenue growth trajectory with HCL Tech
coming in close aided by ramp ups on recently concluded large deals. Amongst mid tier companies, we build in a 1-10% QoQ
US$ revenue growth with TechM at the higher end (however helped completely by full quarter impact of the HGS acquisition
and partial benefit from Comviva consolidation).
n We expect margins to decline sequentially for almost all the companies in our coverage universe except for eClerx (where we

expect ~150 bps improvement in EBITDA margins on a QoQ basis) impacted adversely by December seasonality, promotion or
partial wage hike impact for certain players. For Hexaware, margins will decline sharply by ~700 bps to 14.8% impacted
adversely by loss of business at one of the key clients (as indicated by the company in early Dec'12).
n We continue to expect a scale down in Infosys's organic rev growth guidance and expect Infosys's revised US$ revenue

guidance at ~5%YoY US$ revenue growth (including Lodestone for 5 months in FY13, thereby meaning a 3.5-3.6%YoY US$
revenue growth on an organic basis for FY13). A reset in INR assumption to Rs 55/$ (V/s Rs 53/$ earlier) will lead a reset in
FY13 EPS outlook to ~Rs 159.5 V/s ~Rs 160.5 earlier. Investors should focus on (1) commentary for demand from fin services
(CTSH and TCS have talked about a better CY13/FY14 recently) and trends in decision making and (2) pricing and vol growth
outlook ahead. Wipro's March'13 quarter rev guidance would be under intense focus and we expect a 1.5-3.5% QoQ US$ rev
growth from Wipro being sentimentally positive for the sector as a whole.
n Remain selectively positive with HCL Tech (ACCUMULATE, TP Rs 650) the preferred pick in the Tier I space as we continue to

back upside risks to earnings est for HCL Tech. Amongst Tier II names, we prefer (1) MindTree ( BUY, TP Rs 750) as we
continue to back modest earnings upgrades led by operational levers (though sector wide weakness continues to increase
challenges on the front) and (2) TechM/Mah Satyam (ACCUMULATE, TP Rs 1050/125)
Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 63

IT Services
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Infosys Ltd
CMP(Rs)

2,375

Net Sales (Rs mn)

Mkt Cap (Rs bn)

1,364

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


2,575
8%

PAT (Rs mn)


EPS (Rs)

102,004

98,580

92,980

9.7%

3.5%

28,787

28,720

31,330

-8.1%

0.2%

28.2

29.1

33.7 -547 bps

-91 bps

21,466

23,690

23,720

-9.5%

-9.4%

37.6

41.5

41.5

-9.5%

-9.4%

160,659

156,207

132,041

21.7%

45,430

44,402

40,922

11.0%

28.3

28.4

34,045

35,097

28,866

17.9%

17.6

18.1

14.9

18.0%

109,067

106,566

99,972

9.1%

18,863

18,587

17,239

9.4%

17.3

17.4

17.2

5 bps

16,266

16,106

14,564

11.7%

6.7

6.6

6.0

11.4%

Comments
We expect Infosys to report a 4.2%% QoQ US$ rev growth
(~2% organic revenue growth) aided by 2 months consolidation
impact of Lodestone acquisition. Margins are expected to
decline by ~90 bps sequentially to 28.2% impacted adversely
by wage hikes , Lodestone acquisition and elongated
shutdowns at certain clients. Profits est at Rs 21.5 bn (-9.4%
QoQ) on a/c of forex losses (we est Rs 720 mn losses V/s
gains of ~Rs 1570 mn in Sep12 qtr). Key things to watch out
for (1)outlook on client budgets and pickup in discretionary
spending, (2) volume growth given instances of aggressive
pricing from Infosys recently

TCS
CMP(Rs)

1,295

Net Sales (Rs mn)

Mkt Cap (Rs bn)

2,534

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

1,200

PAT (Rs mn)

% Upside

-7%

EPS (Rs)

CMP(Rs)

405

Net Sales (Rs mn)

Mkt Cap (Rs bn)

997

EBITDA (Rs mn)

31.0 -271 bps

2.9% We estimate TCS to report a 3.3% US$ QoQ revenue growth


to US$ 2,948mn. Margins estimated to be nearly flat QoQ at
2.3% 28.3%. Profits estimated at Rs 34bn(-3% QoQ, note that we
build in forex losses of ~Rs 300 mn V/s gains of ~Rs 920 mn in
-15 bps Sep12 qtr). Key things to watch out for (1) outlook on client
spending and project ramp ups in top clients, and (2)
-3.0% comments on demand and pricing trends in financial services
vertical and(3) margins trajectory
-3.0%

Wipro

Reco
Target Price (Rs)
% Upside

Reduce
360
-11%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

2.3% Wipro estimated to report a 2.6% QoQ revenue growth, to US$


1,581 mn within guided range of US$1,560-1,590 mn. IT Svcs
1.5% EBIT margins expected to decline by ~20 bps QoQ to 20.5%.
Profits estimated at Rs 16.3 bn (+1% QoQ). Key things to
-15 bps watch out for (1) guidance for Mar13 qtr( we est a 1.5-3.5%
QoQ growth outlook), (2) outlook on demand from key verticals
1.0% and top clients
1.2%

| Emkay Strategy | 8th January, 2013 | 64

IT Services
Name

Dec12E

% Chg
YoY

Sep12

Dec11

52,454

18.9%

% Chg
QoQ

Comments

HCL Tech
2.4% HCL Tech expected to report a 2.8% QoQ growth in revenues
to US$ 1,144 mn with margins declining by ~120 bps QoQ on
9,489
35.5%
-3.2% account of partial impact from wage hikes and higher S&M
expenses in the current qtr. Profits est at Rs 8.6 bn (flat QoQ)
18.1 254 bps -119 bps on account of lower margins. Key things to watch out for (1)
ramp ups on recently won deals, (2) outlook on
5,529
56.2%
0.0% revenues/margins

CMP(Rs)

627

Net Sales (Rs mn)

62,345

60,910

Mkt Cap (Rs bn)

435

EBITDA (Rs mn)

12,861

13,287

20.6

21.8

8,635

8,631

12.5

12.5

8.0

56.2%

17,702

16,314

14,449

22.5%

3,412

3,377

2,343

45.6%

19.3

20.7

3,340

2,963

2,759

21.1%

16.4

13.6

11.2

46.6%

1,693

1,617

1,320

28.3%
9.5%

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

650

PAT (Rs mn)

% Upside

4%

EPS (Rs)

CMP(Rs)

927

Net Sales (Rs mn)

Mkt Cap (Rs bn)

118

EBITDA (Rs mn)

-0.1%

Tech Mahindra

Reco

Accumulate EBITDA Margin (%)

16.2 306 bps

Target Price (Rs)

1,050

PAT (Rs mn)

% Upside

13%

EPS (Rs)

CMP(Rs)

699

Net Sales (Rs mn)

Mkt Cap (Rs bn)

21

EBITDA (Rs mn)

655

601

598

8.5% Tech M expected to report a 10% QoQ growth in US$


revenues to US$ 329 mn aided by full quarter impact of HGS
1.0% acquisition and partial benefit of Comviva acquisition. Margins
expected to decline by ~140 bps QoQ to 19.3% impacted by
-143 bps lower margin profile of HGS acquisition. Key things to watch
out for(1) outlook for business within top clients BT and AT&T,
12.7% (2) spending outlook in the telecom vertical and (3) margin
trajectory ahead
21.1%

eClerx Services

Reco

Hold

EBITDA Margin (%)

38.6

37.2

45.3 (664)bps

Target Price (Rs)

720

PAT (Rs mn)

464

252

500

-7.1%

% Upside

3%

EPS (Rs)

15.4

8.4

16.6

-6.7%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

4.7% eClerx expected to report a 4% QoQ US$ revenue growth to


US$ 31.3 mn. Margins expected to improve by ~140 bps QoQ
8.8% to 38.6% aided by growth leverage and absence of one off
costs unlike Sep12 qtr. Profits expected at Rs 464 mn(+84%
146 bps QoQ) helped by lower forex losses. Key things to watch out for
(1) outlook on demand from top 5 clients as well as pickup in
84.5% volumes in the core business, (2) Agilysts performance and (3)
pricing outlook
84.5%

| Emkay Strategy | 8th January, 2013 | 65

IT Services
Name

Dec12E

% Chg
YoY

Sep12

Dec11

5,115

5,130

4,381

16.7%

% Chg
QoQ

Comments

Hexaware Technologies
CMP(Rs)

90

Net Sales (Rs mn)

Mkt Cap (Rs bn)

27

EBITDA (Rs mn)

829

1,153

-0.3% Hexaware is estimated to report revenues at US$ 92.2 mn (0.6% QoQ) with margins est. at 14.8%, down by ~690 bps on
1,056 -21.5% -28.1% a/c of loss of business at a top 5 client. Profits est at Rs 585
mn (-30% QoQ) impacted adversely by decline in op profits(24.1 -790 bps -627 bps 33% QoQ). Key things to watch out for (1) new deal wins, (2)
update on scope change of a large project at a top 5 client and
986 -40.7% -30.4% (3) dividend payout

Reco

Hold

EBITDA Margin (%)

16.2

22.5

Target Price (Rs)

100

PAT (Rs mn)

585

840

% Upside

11%

EPS (Rs)

1.9

2.8

3.4

-42.7%

CMP(Rs)

531

Net Sales (Rs mn)

3,312

3,269

2,677

23.7%

Mkt Cap (Rs bn)

21

EBITDA (Rs mn)

877

890

696

25.9%

-30.4%

Persistent Systems

Reco

Hold

EBITDA Margin (%)

26.5

27.2

26.0

47 bps

Target Price (Rs)

425

PAT (Rs mn)

560

446

406

37.8%

EPS (Rs)

14.0

11.2

10.2

37.8%

19,514

19,384

17,181

13.6%

4,055

4,173

2,781

45.8%

20.8

21.5

3,001

2,779

3,084

-2.7%

2.6

2.4

2.6

-1.6%

% Upside

-20%

1.3% Persistent expected to report a 1.2% QoQ US$ revenue growth


to US$ 60.8 mn with margins expected to decline by ~70 bps
-1.5% QoQ to 26.5% . Profits est at Rs 560 mn(+25% QoQ) helped
by forex gains ( V/s losses in Sep12 qtr). Key things to watch
-76 bps out for (1) revenue/margin outlook, and (2) progress on IP
based deals that company has been negotiating
25.5%
25.5%

Mahindra Satyam
CMP(Rs)

106

Net Sales (Rs mn)

Mkt Cap (Rs bn)

125

EBITDA (Rs mn)

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

125

PAT (Rs mn)

% Upside

18%

EPS (Rs)

16.2 459 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

0.7% We expect Mah Satyam to report a 1.1% QoQ growth in US$


revenues at US$ 358 mn. EBITDA margins expected to decline
-2.8% by 70 bps QoQ to 20.8%. Profits ( ex exceptional items)
estimated at Rs 3 bn (+8% QoQ).Key things to watch out for
-75 bps (1) revenue growth, (2) outlook on margin trajectory ahead
and (3) hiring trends
8.0%
8.8%

| Emkay Strategy | 8th January, 2013 | 66

IT Services
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

MindTree
CMP(Rs)

694

Net Sales (Rs mn)

5,899

5,963

5,197

13.5%

Mkt Cap (Rs bn)

29

EBITDA (Rs mn)

1,204

1,319

897

34.2%

Reco

Buy

EBITDA Margin (%)

20.4

22.1

17.3 314 bps

Target Price (Rs)

750

PAT (Rs mn)

883

722

606

45.7%

% Upside

8%

EPS (Rs)

21.5

17.6

15.0

43.8%

CMP(Rs)

257

Net Sales (Rs mn)

5,041

5,001

4,330

16.4%

Mkt Cap (Rs bn)

15

EBITDA (Rs mn)

808

848

780

3.6%

16.0

17.0

18.0 -199 bps

-1.1% We expect a 2.2% QoQ US$ revenue growth led largely by IT


Services segment while PES segment rexpected to report a
-8.8% decline on a/c of December seasonality. Margins are expected
to decline ~170 bps QoQ at 20.4% on a/c of higher US$/INR
-172 bps realised rate. Profits est at Rs883 mn(+22% QoQ) helped by
forex gains ( V/s losses in Sep12 qtr) . Key things to watch out
22.3% for (1) outlook on business within IT Services and PES
segment, (2) revenue growth and margin outlook and (3) hiring
22.3%
trends

NIIT Tech

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

325

PAT (Rs mn)

583

432

643

-9.3%

% Upside

27%

EPS (Rs)

10.0

7.5

10.8

-7.8%

CMP(Rs)

390

Net Sales (Rs mn)

13,446

13,062

13,672

-1.6%

Mkt Cap (Rs bn)

82

EBITDA (Rs mn)

2,707

2,700

2,521

7.4%

20.1

20.7

1,924

2,093

1,847

4.2%

10.0

9.9

8.8

14.6%

0.8% We expect NIIT Tech to report a 4.1% QoQ US$ growth with
INR revenues estimated at Rs 5.1 bn (+0.8% QoQ). Margins
-4.7% expected to decline by ~100 bps QoQ to 16% on a/c of higher
onsite work and higher Hardware revenues Profits est at Rs
-93 bps 583 mn (+35% QoQ) helped by translation gains(V/s losses in
Sep12 qtr). Key things to watch out for (1) comments on
35.0% demand from top clients , (2) offshore shift from Morrison deal
and (3) order wins during the current qtr
32.9%

Mphasis Ltd*

Reco

Reduce

EBITDA Margin (%)

Target Price (Rs)

375

PAT (Rs mn)

% Upside

-4%

EPS (Rs)

18.4 169 bps

2.9% We expect a 2.9% QoQ INR revenue growth with margins


expected to decline by ~60 bps QoQ to 20.1% on a/c of
0.2% shutdowns at HP in the current qtr. Profits est at Rs 1.9 bn(-8%
QoQ) on a/c of lower other income as EBITDA remains flat
-54 bps QoQ.Key things to watch out for (1) outlook on business from
HP and direct business, (2) ramp up on business in HP ( Non
-8.1% ES) segment
1.1%

* For Mphasis, Dec12 refers to Jan13 qtr end and so forth

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 67

Media and Entertainment


n Festive season during Q3FY13 is expected to provide some cheers to ad growth. Ad revenue growth of 7.1%YoY for print

media companies would be primarily volume led as pricing continues to remain muted. Ad growth for broadcasters would be
backed by low base of last year and increased ad spends by FMCG companies.
n Print media companies under coverage are expected to report ad revenue growth of 7.1%YoY and 16% qoq to Rs9.8bn.

Regional ad growth is expected at 9.1%YoY and 12.0% qoq to Rs6.7bn, while English ad revenue (HT Media) to remain
weak at 3%YoY growth. In the broadcasting space, Zee is expected to register ad growth 18%, driven by low base of last
year (-10%YoY growth in Q3FY12).
n Subscription revenue is expected to grow by 10%YoY to Rs1.9bn for print media companies, led by higher circulation

and cover price increase in preceding quarters. Subscription revenue for Zee is expected to grow 22%YoY, driven by
strong growth in domestic subscription (both DTH and analogue), while international subscription would remain stable
on constant currency basis.
n Improvement in subscriber addition led by festive season and digitization to drive 3.5% qoq growth in subscription

revenue for Dish TV.


n EBITDA for print universe is expected to grow 7.0%YoY with stable margins at 21.1% v/s 21.3% in Q3FY12. Raw material has

started to stabilize on the back of 1) stable newsprint prices, 2) cost rationalizing by reduction in pagination and wastages and
3) circulation expansion has happened in the last 3-4 quarters for the print media companies. EBITDA for Zee is expected to be
flatYoY, due to 24%YoY increase in programming cost. Zee has increased investment in content and recently launched couple
of new channels. EBITDA for Dish TV is expected to decline 8.8% qoq as content cost increase would be on the back of MediaPro deal.
n Consolidated APAT for print universe is expected to grow 12.2%YoY to Rs1.8bn, driven by revenue growth coupled with stable

operational performance and higher other income. Zees PAT is expected to grow 13%, due to lower tax rate of 32% as
compared to 38% in Q3FY12.
n Recommend BUY on Zee Entertainment, ACCUMULATE on Dish TV and HOLD on Jagran, DB Corp and HT Media.
Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 68

Media and Entertainment


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

DB Corp.
CMP(Rs)

231

Net Sales (Rs mn)

4,370

3,784

3,955

10.5%

Mkt Cap (Rs bn)

42

EBITDA (Rs mn)

1,099

861

1,017

8.0%

Reco

Hold

EBITDA Margin (%)

25.2

22.7

25.7

-57 bps

Target Price (Rs)

219

PAT (Rs mn)

610

481

553

10.3%

% Upside

-5%

EPS (Rs)

3.3

2.6

3.0

10.3%

CMP(Rs)

104

Net Sales (Rs mn)

5,647

5,107

5,266

7.2%

Mkt Cap (Rs bn)

24

EBITDA (Rs mn)

831

565

777

6.9%

15.5% DB Corp is expected to report 10.5% revenue growth onYoY


basis. Print ad revenue growth is expected at 10% driven on
27.7% the back of festive season. Circulation revenue would grow by
11%YoY. EBITDA margin is expected at 25.2%, due to
241 bps 11.3%YoY increase in operating costs. Cost rationalization and
strong revenue growth to drive EBITDA growth of 8%YoY. PAT
27.0% is expected to improve by 10.3%YoY, strong operational
performance and higher other income.
27.0%

HT Media

Reco

Hold

EBITDA Margin (%)

14.7

11.1

14.7

-4 bps

Target Price (Rs)

107

PAT (Rs mn)

529

333

482

9.9%

% Upside

3%

EPS (Rs)

2.3

1.4

2.1

9.9%

CMP(Rs)

115

Net Sales (Rs mn)

3,424

3,221

3,240

5.7%

Mkt Cap (Rs bn)

36

EBITDA (Rs mn)

900

782

851

5.8%

10.6% HT Media is worst affected due to slowdown in macro


economy. HT Medias English segment is expected to report
47.0% ad revenue growth of 3%YoY, after 3 consecutive quarters of
decline. Hindi ad revenue is expected to register growth of
364 bps 11%YoY. We estimate 5%YoY growth in print ad revenues.
EBITDA is expected to rise by 7%YoY. EBITDA margin is
58.9% expected at 14.7%, flatYoY. PAT is estimated at Rs529mn a
growth of 10%YoY, led by stable operational performance and
58.9%
high other income.

Jagran Prakashan

Reco

Hold

EBITDA Margin (%)

26.3

24.3

26.3

3 bps

Target Price (Rs)

108

PAT (Rs mn)

694

694

600

15.7%

% Upside

-6%

EPS (Rs)

2.2

2.2

1.9

15.7%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

6.3% We estimate standalone ad revenue growth of 7%YoY to Rs


2.4bn. Ad growth for Jagran would be lower than other regional
15.2% players due to high base during same period last year.
Circulation revenue is expected at Rs 667mn, growth of
203 bps 7%YoY. Stable EBITDA during the quarter would be driven by
cost rationalization measures. We estimate EBITDA margin of
0.0% 26.3%, flatYoY. PAT is expected at Rs694mn, growth of
16%YoY.
0.0%

| Emkay Strategy | 8th January, 2013 | 69

Media and Entertainment


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Dish TV
CMP(Rs)

79

Net Sales (Rs mn)

5,562

5,333

4,905

Mkt Cap (Rs bn)

84

EBITDA (Rs mn)

1,420

1,557

1,202

25.5

29.2

24.5

Reco

Accumulate EBITDA Margin (%)

4.3% We expect revenue growth of 13.4%YoY, driven on the back of


15%YoY growth in subscription revenue. We expect gross
18.2%
-8.8% adds of 0.8mn v/s 0.5mn addition in the last quarter.
Seasonally strong quarter and digitization of phase I would
103 bps -366 bps lead to strong subscriber addition. ARPU is expected to remain
flat qoq at Rs159.2. Churn is expected to remain stable at 1%
monthly. EBITDA margin is expected at 25.5% with EBITDA
decline of 8.8% qoq due to signing of content deal with Media
Pro. We expect adjusted net loss of Rs335mn v/s 213mn in
Q2FY13.
13.4%

Target Price (Rs)

79

PAT (Rs mn)

-336

-213

-430

% Upside

1%

EPS (Rs)

-0.3

-0.2

-0.4

CMP(Rs)

223

Net Sales (Rs mn)

9,001

9,535

7,548

19.2%

Mkt Cap (Rs bn)

214

EBITDA (Rs mn)

2,150

2,176

2,160

-0.4%

Reco

Buy

EBITDA Margin (%)

23.9

22.8

Target Price (Rs)

275

PAT (Rs mn)

1,581

1,877

1,393

13.5%

% Upside

23%

EPS (Rs)

1.7

2.0

1.5

13.5%

Zee Entertainment

28.6 -472 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-5.6% We expect revenue growth of 19%YoY, driven on the back of


18%YoY growth in ad revenue and 22%YoY growth in
-1.2% subscription revenue. Low base last fiscal to drive ad growth in
Q3FY13. Domestic subscription revenue would continue to
107 bps remain robust with 28%YoY growth. EBITDA margin at 23.9%
is expected to decline 472bpsYoY but improve 107bps qoq.
-15.8% Increased investment in content to weigh on EBITDA. ExSports EBITDA margin is expected at 24.7%. PAT at Rs1.6bn
-15.8%
is expected to improve 13%, due to lower tax rate.

| Emkay Strategy | 8th January, 2013 | 70

Metals and Mining


n We expect Q3FY13 operating performances of the metals and mining companies to be stable. Ferrous metals continue to be

under pressure due to lower demand and issues with raw material sourcing leading to inventory build up. Non-ferrous metals
saw some improvement on account of LME recovery during the quarter. Regulatory scenario continued to be strict with the
Supreme Court banning mining in Goa and also restrictions put by the Orissa government on mining activities.
n Revenue for our Metals and Mining universe is expected to remain flat onYoY as well as QoQ. The major revenue decline is

expected due to ban of mining operations in Goa drastically impacting Sesa Goas performance. In ferrous space, we expect
the revenues to remain muted due to fall in realizations by Rs 1000-1500 per tonne during the quarter. Non-ferrous space
performance is expected to remain stable due to LME price gains.
n EBITDA for the universe is likely to remain flat QoQ and decline 5%YoY. LME prices recovered marginally during the quarter,

resulting in an expected better performance of Hindustan Zinc and Sterlite Industries. In ferrous space, barring JSW and
NMDC, improvement in sales volumes on a QoQ basis should help EBITDA to show positive growth.
n The overall APAT of our coverage universe on QoQ is likely to gain 1% due to better EBITDA performance. On a QoQ basis,

Bhushan (22%), HEG (22%) and Hindalco (12%) are expected to perform better while ferrous players are likely to be laggards.
On aYoY basis, non-ferrous companies (except Hindalco) are expected to witness positive bottomline growth led by Sterlite
(56%) and HZL (28%).
n With mining ban imposed in Goa and stiff restrictions in Orissa, regulatory issues during the quarter continued to weigh heavy

on ferrous metal players. Non-ferrous space on the other hand recovered modestly during the quarter. We continue to remain
concerned on the steel companies due to weak domestic demand and higher inventory while prefer pure mining companies viz
NMDC and Hindustan Zinc.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 71

Metals and Mining


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Tata Steel
CMP(Rs)

441

Net Sales (Rs mn)

Mkt Cap (Rs bn)

428

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Reduce
349
-21%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

325,933

341,327

331,031

-2%

-5%

25,405

23,101

17,173

48%

10%

7.8

6.8

-1,388

-4,066

-6,027

n.a

n.a

-1.4

-4.2

-6.3

n.a

n.a

5.2 +261 bps +103 bps

Comments
We expect Tata Steels domestic sales volume to be 1.85 mt
for Q3FY13. The EBITDA/tonne for the standalone business is
likely to remain flat at US$263/ tonne, as lower coking coal
costs would be offset by lower realizations. We expect the
standalone PAT to be at Rs 13 bn. Seasonality should restrict
any improvement in the European operations. We expect a
volume of 3.3 mt for Tata Steel Europe during the quarter and
an EBITDA/tonne of -US$5. Ramp up progress of 2.9 mtpa
expanded capacity at Jamshedpur and developments in
European operations would be important things to watch out
for

JSW Steel
CMP(Rs)

855

Net Sales (Rs mn)

86,117

95,137

84,241

2%

Mkt Cap (Rs bn)

191

EBITDA (Rs mn)

14,017

15,313

13,174

6%

16.3

16.1

2,643

2,675

4,561

-42%

11.8

12.0

20.4

-42%

115,854

108,202

110,437

5%

11,382

11,093

15,811

-28%

9.8

10.3

4,218

5,013

10,984

-62%

1.0

1.2

2.7

-62%

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


743
-13%

PAT (Rs mn)


EPS (Rs)

15.6 +64 bps

-9% We expect a sales volume of 2 mt for Q3FY13, down ~8% on


QoQ due to lower production on the back of shutdown in one
-8% of the blast furnaces. The company has been operating at
~75% utilization levels recently, as problems related to
+18 bps sourcing of iron ore continue in Karnataka. The EBITDA/
tonne for the quarter is expected to be flat at US$130 for the
-1% standalone business. We would like to have further update on
iron ore sourcing by the company, JSW Ispats performance,
-1% US coking coal mines, plate and pipe mill and also the merger
progress with JSW Ispat

SAIL
CMP(Rs)

100

Net Sales (Rs mn)

Mkt Cap (Rs bn)

411

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)


% Upside

82
-18%

PAT (Rs mn)


EPS (Rs)

14.3 -449 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

7% During the quarter, while the realizations are expected to drop


by ~4%, we expect sales volumes to remain higher at 2.85 mt.
3% Due to fall in realizations and overall rise in other input costs,
the positive impact of lower coking coal prices is likely to be
-43 bps offset. We expect the EBITDA/ tonne for Q3FY13 to be US$74.
The company currently is carrying an inventory of 1.3 mt and
-16% the focus remains to liquidate the same. The key thing to watch
out for would be update on its expansion projects
-16%

| Emkay Strategy | 8th January, 2013 | 72

Metals and Mining


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

NMDC
CMP(Rs)

163

Net Sales (Rs mn)

21,989

26,120

28,220

-22%

Mkt Cap (Rs bn)

648

EBITDA (Rs mn)

16,128

19,349

22,607

-29%

Reco

Hold

EBITDA Margin (%)

73.3

74.1

Target Price (Rs)

196

PAT (Rs mn)

14,360

16,786

18,588

-23%

% Upside

20%

EPS (Rs)

3.6

4.2

4.7

-23%

CMP(Rs)

203

Net Sales (Rs mn)

2,198

2,944

26,171

-92%

Mkt Cap (Rs bn)

176

EBITDA (Rs mn)

-407

1,943

9,073

n.a

Reco

Hold

EBITDA Margin (%)

-18.5

66.0

Target Price (Rs)

153

PAT (Rs mn)

5,275

5,227

6,915

-24%

6.1

6.0

8.0

-24%

111,228

111,026

103,037

8%

25,706

25,270

23,183

11%

23.1

22.8

14,328

15,239

9,199

56%

4.3

4.5

2.7

56%

80.1 -676 bps

-16% The company has reported a sales volume of 5.3 mt for


Q3FY13, which was lower than the estimates. Due to price cuts
-17% taken during October and November months, we expect the
average blended realizations to drop on QoQ basis to US$77/
-73 bps tonne. We continue to keep close watch on the developments
regarding expansion projects in Bailadila and Kumaraswamy.
-14% Any update on these projects and on future pricing policy of
iron ore in the domestic market would be interesting to look at
-14%

Sesa Goa

% Upside

-25%

EPS (Rs)

34.7 -5319 bps

-25% Due to ban of mining in Goa and Karnataka with no iron ore
transportation of ore allowed in Goa we dont expect any iron
n.a ore sales volume in Q3FY13. The revenue is likely to be driven
by only pig iron and met coke. This would result into a loss at
-8451 bps the EBITDA level. Dividend and attributable profit from Cairn
India is likely to drive the consolidated PAT. We keep close
1% watch on the developments regarding Karnataka and Goa
mining. In 2nd week of January the Supreme Court hearing on
1% Goa mining is due and it can provide some clarity on restarting
of mining in Goa. Update on Liberia would also be important

Sterlite Industries
CMP(Rs)

120

Net Sales (Rs mn)

Mkt Cap (Rs bn)

404

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)


% Upside

92
-23%

PAT (Rs mn)


EPS (Rs)

22.5 +61 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

0% In Q3FY13, the average LME prices for all the base metals
gained on a QoQ basis by ~3-4%.. Copper, aluminium, Zinc
2% and lead prices gained 3%, 4%, 3% and 11% over last quarter
to
average
at
US$7909/tonne,
US$1997/tonne,
+35 bps US$1947/tonne and US$2199/tonne respectively. While INR
continued to be weak during the quarter, the Impact of same
-6% was not significant. Overall we expect satisfactory performance
by Sterlite Industry. Update on VALs alumina refinery and
-6% merger process with Sesa Goa would be interesting to watch
out for

| Emkay Strategy | 8th January, 2013 | 73

Metals and Mining


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Hindustan Zinc
CMP(Rs)

141

Net Sales (Rs mn)

30,568

28,655

27,868

10%

Mkt Cap (Rs bn)

597

EBITDA (Rs mn)

16,353

14,431

14,023

17%

Reco

Buy

EBITDA Margin (%)

53.5

50.4

Target Price (Rs)

146

PAT (Rs mn)

16,333

15,398

12,800

28%

% Upside

3%

EPS (Rs)

3.9

3.6

3.0

28%

66,242

61,635

66,470

0%

5,872

5,153

8.9

8.4

4,034

3,589

2.1

1.9

2.4

-10%

6,052

5,972

4,810

26%

EBITDA (Rs mn)

805

746

3.3

63%

Hindalco

50.3 +318 bps

7% We expect the ongoing mine development projects to start


contributing to the overall performance. On the realizations
13% front, while lead LME average remained very strong (up 11%)
during the quarter at US$2199/tonne, LME zinc for the quarter
+313 bps too gained 3% QoQ to US$1947/tonne. Silver prices also
gained 8% during the quarter to ~US$33/ oz. We expect better
6% margins for the current quarter. Update on the projects and
guidance on the CoP would be important to look at
6%

(Standalone)

CMP(Rs)

134

Net Sales (Rs mn)

Mkt Cap (Rs bn)

257

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

134

PAT (Rs mn)

% Upside

0%

EPS (Rs)

120

Net Sales (Rs mn)

7% During the quarter, we expect primary aluminium volumes to


remain flat as compared to Q2FY13 while, copper volume likely
7,149
-18%
14% to improve slightly. LME aluminium and copper gained 4% and
3% on QoQ basis to US$1997/ tonne and US$7909/ tonne
10.8 -189 bps +50 bps respectively. Weak INR also would be helpful for the company.
Update on Hirakud power plant and upcoming Greenfield
4,507
-10%
12% projects would helpful
12%

GPIL
CMP(Rs)
Mkt Cap (Rs bn)

Reco

Buy

EBITDA Margin (%)

13.3

12.5

Target Price (Rs)

151

PAT (Rs mn)

173

213

% Upside

26%

EPS (Rs)

5.5

6.7

1% We believe the capacity utilization of sponge iron would remain


higher at ~65% during the quarter. While pellet production is
560
44%
8% likely to be 1.57 lakh tonnes, the realizations are expected to
drop on a QoQ basis. Iron ore mining is likely to be at 1.65 lakh
11.6 +166 bps +81 bps tonnes. Key things to watch out for would be mining output and
contribution from pellet business.
106
63%
-19%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-19%

| Emkay Strategy | 8th January, 2013 | 74

Metals and Mining


Name

Dec12E

% Chg
YoY

Sep12

Dec11

28,374

25,543

24,070

18%

8,694

7,493

7,240

20%

30.6

29.3

2,462

2,015

2,765

-11%

11.6

9.5

13.0

-11%

4,561

4,400

4,180

9%

EBITDA (Rs mn)

809

681

-34%

% Chg
QoQ

Comments

Bhushan Steel
CMP(Rs)

493

Net Sales (Rs mn)

Mkt Cap (Rs bn)

105

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Reduce
408
-17%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

30.1 +56 bps

11% We expect Bhushan Steel to report better steel volumes but


with lower realizations in Q3FY13. The sales volume is
16% expected to grow 17%YoY to 6.1 lakh tonnes on account of
capacity additions. The EBITDA/ tonne is expected to grow on
+130 bps QoQ basis to Rs 14213/ tonne for the quarter, primarily due to
better capacity utilization. Key things to watch out for will be the
22% progress in Orissa phase III expansion and any guidance on
iron ore availability in Orissa
22%

HEG

Reco

Hold

EBITDA Margin (%)

17.7

15.5

Target Price (Rs)

235

PAT (Rs mn)

393

323

4% We expect capacity utilization for Q3FY13 to be 82%.


Realizations are likely to remain stable. We expect the EBITDA
851
-5%
19% margin to drop 262 bps onYoY basis, as the company
continued to use high-cost needle coke at new contract price.
20.4 -262 bps +226 bps Guidance on utilization of the expanded capacity and
realization trend going forward would be important things to
595
-34%
22% watch out for.

% Upside

0%

EPS (Rs)

9.2

8.1

14.0

CMP(Rs)
Mkt Cap (Rs bn)

235
9

Net Sales (Rs mn)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

14%

| Emkay Strategy | 8th January, 2013 | 75

Oil & Gas


n For Q3FY13, under-recoveries on sale of HSD, SKO and LPG are expected to remain flat QoQ at Rs. 390bn. As

refineries resumed production post maintenance at the global level, refining margins were weak. We expect OMCs
GRM to be in the range of $2- 4/bbl. We have assumed ~38% sharing by upstream companies for the quarter and
factor no government support to the OMCs.
n We expect ONGC and OIL net realization at $47.3/bbl ($46.8/bbl QoQ) and $55.1/bbl ($52.5/bbl QoQ) respectively.
n For RIL, an appreciating rupee on QoQ basis would have marginal negative impact on overall profitability for the

quarter. We factor in lower GRMs on QoQ at US$9/bbl (US$9.5/bbl QoQ). The decline in RILs GRMs on a QoQ basis is
expected to be slower than that witnessed in the benchmark Singapore refining margins which averaged US$7/bbl as
against US$9.3/bbl QoQ. This is on account of sharp decline in fuel oil spreads to US$(18)/bbl (US$12/bbl QoQ) which
forms higher proportion of Singapore GRM product slate and better LPG/Naphtha spreads which form higher
proportion of RILs product slate. Also increase in spread between light-heavy crude oil by US$1.5/bbl to US$4/bbl
has helped RIL GRMs for the quarter. Sequentially petchem margins have declined marginally during the quarter. We
factor in lower gas production from KG basin at 24mmscmd in Q3FY13 from 28.5mmscmd in Q2FY13. Our net profit
estimate for Q3FY13 stands at Rs49.6bn a decline of 7.7%QoQ and growth of 11.7%YoY.
n Natural Gas universe likely to report revenue and profit growth of 2.6% and 1.4% QoQ, respectively, primarily driven

by higher realization across all the segments. We expect transmission and distribution volume to be lower on
sequential basis on the back of further decline in domestic gas production.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 76

Oil & Gas


Name

Dec12E

% Chg
YoY

Sep12

Dec11

887,004

903,350

851,350

4.2%

69,116

77,050

72,850

-5.1%

7.8

8.5

8.6

-76 bps

49,609

53,760

44,400

11.7%

15.3

16.6

13.6

13.0%

-17.7%

% Chg
QoQ

Comments

Reliance Industries
CMP(Rs)

857

Net Sales (Rs mn)

Mkt Cap (Rs bn)

2,805

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

827

PAT (Rs mn)

% Upside

-3%

EPS (Rs)

CMP(Rs)

281

Net Sales (Rs mn)

948,008 1,060,012 1,152,084

Mkt Cap (Rs bn)

683

EBITDA (Rs mn)

-71,343

115,616

107,247

-7.5

10.9

9.3

-99,372

96,114

24,884

n.a.

-40.9

39.6

10.2

n.a.

-1.8% We expect RILs revenue at Rs 887bn, growth of 4.2%YoY.


EBIDTA at Rs 69.1bn, decline of 5.1%YoY and PAT at Rs
-10.3% 49.6bn, growth of 11.7%YoY. We expect EBIDTA margin at
7.8%, down 74bps on QoQ. We expect Gross Refining Margin
-74 bps (GRM) at $9per bbl for Q3FY13 We have factored in gas
production of 24mmscmd as against 28.5mmscmd in Q2FY13.
-7.7%
-7.7%

IOCL

Reco

Accumulate EBITDA Margin (%)

-1,683
bps

Target Price (Rs)

320

PAT (Rs mn)

% Upside

14%

EPS (Rs)

CMP(Rs)

386

Net Sales (Rs mn)

435,856

568,879

588,245

Mkt Cap (Rs bn)

279

EBITDA (Rs mn)

-47,187

53,880

36,874

-10.8

9.5

6.3

-52,987

50,348

31,422

n.a.

-72.8

69.3

43.5

n.a.

-10.6% We expect IOCs revenue at Rs 948bn, EBIDTA loss of


Rs.71.3bn and net loss of Rs.99.3bn. The total under recovery
for Q3 FY13 is expected at Rs390bn. We expect no
-1,843 government support for OMCs and the same has been
bps considered in our estimates. We also consider upstream
support of 38%. We expect Gross Refining Margin (GRM) at
n.a. $3.2 per bbl for Q3FY13.
n.a.

BPCL

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

397

PAT (Rs mn)

% Upside

3%

EPS (Rs)

-25.9%

-1,709
bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-23.4% We expect BPCLs revenue at Rs435.8bn, EBIDTA loss of


Rs.47.1bn and net loss of Rs.52.9bn. The total under recovery
for Q3 FY13 is expected at Rs390bn. We expect no
-2,030 government support for OMCs and the same has been
bps considered in our estimates. We also consider upstream
support of 38%. We expect Gross Refining Margin (GRM) at
n.a. $4 per bbl for Q3FY13.
n.a.

| Emkay Strategy | 8th January, 2013 | 77

Oil & Gas


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

HPCL
CMP(Rs)

329

Net Sales (Rs mn)

386,398

491,298

479,174

-19.4%

Mkt Cap (Rs bn)

111

EBITDA (Rs mn)

-39,129

29,138

35,725

Reco

Buy

EBITDA Margin (%)

-10.1

5.9

7.5

Target Price (Rs)

360

PAT (Rs mn)

-46,129

23,271

27,252

% Upside

9%

EPS (Rs)

-136.2

68.7

80.5

CMP(Rs)

366

Net Sales (Rs mn)

116,813

113,929

112,942

3.4%

Mkt Cap (Rs bn)

465

EBITDA (Rs mn)

18,436

14,120

17,949

2.7%

Reco

Buy

EBITDA Margin (%)

15.8

12.4

15.9

-11 bps

Target Price (Rs)

406

PAT (Rs mn)

10,822

9,854

10,914

-0.8%

% Upside

11%

EPS (Rs)

8.5

7.8

8.6

-0.8%

-1,758
bps

-21.4% We expect HPCLs revenue at Rs386.3bn, EBIDTA loss of


Rs.39.1bn and net loss of Rs.46.1bn. The total under recovery
for Q3 FY13 is expected at Rs390bn. We expect no
government support for OMCs and the same has been
-1,606
bps considered in our estimates. We also consider upstream
support of 38%. We expect Gross Refining Margin (GRM) at
$2 per bbl for Q3FY13.

GAIL
2.5% We expect transmission and trading volume at 105.5mmscmd
and 81mmscmd for the current quarter. Subsidy burden is the
30.6% key concern for GAILs profitability. Based on the expected
under recovery for Q3FY13, we expect subsidy burden for
339 bps GAIL is at ~Rs.7bn. We expect GAILs revenue at Rs.116.8bn,
growth of 3.4%YoY. EBIDTA at Rs.18.4bn, growth of
9.8% 2.7%YoY and PAT at Rs.10.8bn, flatYoY.
9.8%

Gujarat State Petronet


CMP(Rs)

80

Net Sales (Rs mn)

2,592

2,772

2,755

Mkt Cap (Rs bn)

45

EBITDA (Rs mn)

2,367

2,561

2,535

91.3

92.4

92.0

1,182

1,328

1,262

2.1

2.4

2.2

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

86

PAT (Rs mn)

% Upside

8%

EPS (Rs)

-6.5% We expect GSPLs revenue at Rs.2.6bn, decline of 5.9%YoY.


EBIDTA at Rs.2.3bn, decline of 6.6%YoY and PAT at
-6.6%
-7.6% Rs.1.2bn, decline of 6.3%YoY. Lower profitability sequentially
is expected mainly on account of lower transmission tariff
-69 bps -106 bps assumption i.e. Rs.0.97/scm. We expect transmission volume
at 27.5mmscmd for Q3 FY13.
-6.3% -11.0%
-5.9%

-6.3%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-11.0%

| Emkay Strategy | 8th January, 2013 | 78

Oil & Gas


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Indraprastha Gas
1.9% We expect IGLs revenue at Rs.8.7bn, growth of 31.4%YoY.
EBIDTA at Rs.1.9bn, growth of 28.5%YoY and PAT at
28.5%
-6.5% Rs.0.8bn, growth of 27.5%YoY, Growth onYoY basis is mainly
driven by higher volumes and realization. We expect
-50 bps -197 bps distribution volume at 3.68mmscmd and EBIDTA/scm at
Rs.5.7/scm v/s Rs.6.1/4.8scm in QoQ/YoY.
27.5% -11.2%

CMP(Rs)

255

Net Sales (Rs mn)

8,710

8,552

6,631

Mkt Cap (Rs bn)

36

EBITDA (Rs mn)

1,933

2,066

1,504

Reco

Ur

EBITDA Margin (%)

22.2

24.2

22.7

Target Price (Rs)

PAT (Rs mn)

881

992

691

EPS (Rs)

6.3

7.1

4.9

6,499

21.3%

% Upside

-100%

31.4%

27.5%

-11.2%

Gujarat Gas

Reco

Hold

EBITDA Margin (%)

14.7

16.4

Target Price (Rs)

292

PAT (Rs mn)

760

993

-5.7% We expect GGCLs revenue at Rs.7.8bn, decline of 5.7%


QoQ. EBIDTA at Rs.1.1bn, decline of 15.2% QoQ and PAT at
290 299.3% -15.2% Rs.0.76bn, decline of 23.5% QoQ. Due to increase in LNG
prices and no price hike during the quarter, we would see
4.5 1,024 bps -165 bps margin decline on sequential basis. We expect distribution
volume at 3mmscmd and EBIDTA/scm at Rs.4.2/scm v/s
248 206.7% -23.5% Rs.4.6/09/scm in QoQ/YoY.

% Upside

-4%

EPS (Rs)

5.9

7.7

1.9

206.7%

CMP(Rs)

166

Net Sales (Rs mn)

78,599

75,486

63,303

24.2%

Mkt Cap (Rs bn)

125

EBITDA (Rs mn)

4,923

5,184

5,032

-2.2%

Reco

Buy

EBITDA Margin (%)

6.3

6.9

Target Price (Rs)

194

PAT (Rs mn)

2,902

3,148

2,954

-1.7%

-7.8%

% Upside

17%

EPS (Rs)

3.9

4.2

3.9

-1.7%

-7.8%

CMP(Rs)

305

Net Sales (Rs mn)

7,880

8,359

Mkt Cap (Rs bn)

39

EBITDA (Rs mn)

1,159

1,368

-23.5%

Petronet LNG

7.9 -169 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

4.1% We expect Petronet LNGs revenue at Rs.78.6bn, growth of


24.2%YoY. EBIDTA at Rs.4.9bn, decline of 2.2%YoY and
-5.0% PAT at Rs.2.9bn, marginal decline of 1.7%YoY. We expect
total volume offtake at 135.9tbtu and Marketing margin at
-60 bps Rs.41/mmbtu for the current quarter.

| Emkay Strategy | 8th January, 2013 | 79

Oil & Gas


Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

ONGC
CMP(Rs)
Mkt Cap (Rs bn)
Reco

288
2,464

Net Sales (Rs mn)

186,210

197,882

181,238

EBITDA (Rs mn)

103,729

102,718

106,576

55.7

51.9

58.8

55,245

58,966

67,306

6.5

6.9

7.9

Accumulate EBITDA Margin (%)

-5.9% Net sales are expected to increase by 2.7% onYoY basis to


Rs186.2bn. EBIDTA is expected to decline by 2.7% onYoY
-2.7%
1.0% basis and remain flat on QoQ at Rs103.7bn. PAT is expected
to decline by 17.9%YoY and 6.3% QoQ to Rs55.2.bn QoQ.Net
-310 bps 380 bps realization on sale of crude oil after sharing subsidy burden is
expected at US$47.3/bbl compared to US$44.7/bbl in Q3FY12
-17.9%
-6.3% and US$46.8/bbl in 2QFY13. For the quarter, we expect the
company to share Rs121.1bn as subsidy.
-17.9%
-6.3%
2.7%

Target Price (Rs)

313

PAT (Rs mn)

% Upside

9%

EPS (Rs)

CMP(Rs)

485

Net Sales (Rs mn)

25,502

25,194

23,738

7.4%

Mkt Cap (Rs bn)

291

EBITDA (Rs mn)

11,450

12,649

13,754

-16.8%

44.9

50.2

57.9

-1,304
bps

9,116

9,546

10,140

-10.1%

15.2

15.9

16.9

-10.1%

30,968

48.7%

11.9

36.2%

OIL

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

573

PAT (Rs mn)

% Upside

18%

EPS (Rs)

CMP(Rs)

343

Net Sales (Rs mn)

46,064

44,431

Mkt Cap (Rs bn)

654

EBITDA (Rs mn)

36,295

26,395

Reco

Buy

EBITDA Margin (%)

78.8

59.4

Target Price (Rs)

385

PAT (Rs mn)

30,900

23,222

% Upside

12%

EPS (Rs)

16.2

12.2

1.2% OIL India is expected to suffer on account of lowerYoY


realizations on sale of crude oil. We expect net realizations at
-9.5% US$55.1/bbl.Revenues for the quarter are expected to
increase by 7.4%YoY to Rs 25.5bn. EBIDTA for the quarter is
-531 bps expected to decline by 16.8%YoY to Rs11.4bn.PAT is
expected to decline by 10.1%YoY to Rs 9.1 bn. For the
-4.5% quarter, we expect the company to share Rs. 20.2bn as
subsidy.
-4.5%

Cairn India
3.7% The company will benefit from higher production of crude oil
from MBA field onYoY basis and weaker rupee. We model an
23,692
53.2%
37.5% average of 175,000bpd of production during the quarter as
against 171,000bpd in 2QFY13. We expect sales of Rs46bn,
76.5 229 bps 1,939 bps up 48.7%YoY, EBIDTA at Rs36.2bn up 53.2%YoY and PAT at
Rs30.9bn up 36.6%YoY.
22,619
36.6%
33.1%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

33.1%

| Emkay Strategy | 8th January, 2013 | 80

Paper
n On an aggregate basis, we expect our paper universe to report revenues growth of 10%YoY. However, EBITDA is

likely to increase by 36%YoY due to improvement in margins.


n EBITDA margin is expected to improve by 360bpsYoY to 18.7% with EBITDA/mt likely to increase by 27%yoy to Rs

10200/mt. Improvement in bottomline is driven primarily by TNPL which is expected to report profits of Rs 252mn
compared to losses of Rs 176mn last year. BILTs margins are also expected to improve by 300bpsYoY
n Rayon Grade Pulp (RGP) realizations are expected to decline by 9%YoY to Rs 51,000/mt. We expect pulp margins to

decline by 700bpsYoY to 16.0%.


n We maintain Buy on TNPL & Accumulate on BILT. TNPL is gradually gaining mkt share through increased sales

volumes. Inventories are likely to drop in subsequent quarters & margins would improve driven by higher pricing
power
n Post the expansion of both the pulp lines, BILT will become fully integrated in pulp. We expect margins to improve

gradually with increased availability of in-house pulp.


n JK Paper has been facing severe cost pressure on account of sharp increase in coal cost followed by recent increase

in wood cost. Further, commissioning of new plant is likely to put pressure on profitability during stabilization phase
and benefit may come only in FY15. We maintain Sell with target of Rs 30

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 81

Paper
Name

Dec12E

% Chg
YoY

Sep12

Dec11

12,653

12,298

12,121

4.4%

2,367

2,298

1,904

24.4%

18.7

18.7

15.7 300 bps

PAT (Rs mn)

394

348

136

190.0%

EPS (Rs)

0.6

0.6

0.3

151.2%

3,475

3,578

3,274

6.1%

% Chg
QoQ

Comments

BILT (Conso)
CMP(Rs)

23

Net Sales (Rs mn)

Mkt Cap (Rs bn)

15

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


27
16%

2.9% We expect consol net sales to increase by 4%YoY to Rs


12.7bn. We expect paper segment revenues to increase by
3.0% 6%YoY to Rs 9.9bn. We have modeled for paper volumes of
215,000mt, 3%YoY. RGP realizations are expected to decline
2 bps by 9%YoY to Rs 51,000/mt. We expect consol EBITDA to
increase by 24%YoY to Rs 2.4bn and APAT is likely to
13.3% increase by 190%YoY to Rs 394mn. EPS for the quarter is
likely to be around Rs 0.6
15.3%

JK Paper
CMP(Rs)

40

Net Sales (Rs mn)

Mkt Cap (Rs bn)

EBITDA (Rs mn)

347

295

303

14.7%

10.0

8.2

9.3

74 bps

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

30

PAT (Rs mn)

34

47

74

-54.1%

EPS (Rs)

0.2

0.3

0.5

-54.1%

Net Sales (Rs mn)

4,125

4,646

3,098

33.1%

EBITDA (Rs mn)

1,080

999

592

82.3%

% Upside

-25%

-2.9% We estimate net sales to increase by 6%YoY to Rs 3.5bn. We


expect sales volumes to increase by 2%YoY to 70,500mt. We
17.9% expect company to report EBITDA of Rs 347mn, 15%YoY with
EBITDA margins of 10.0%. Company is likely to report PBT of
176 bps Rs 45mn, -17%YoY and APAT of Rs 34mn, -54%YoY. EPS
for the quarter is likely to be around Rs 0.2
-26.9%
-26.9%

TNPL
CMP(Rs)
Mkt Cap (Rs bn)

112
8

Reco

Buy

EBITDA Margin (%)

26.2

21.5

19.1 706 bps

Target Price (Rs)

148

PAT (Rs mn)

252

213

-176

n.a.

% Upside

32%

EPS (Rs)

3.6

3.1

-2.5

n.a.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-11.2% We expect net sales to increase by 33%YoY to Rs 4.1bn. We


expect paper sales volumes to increase by 23%YoY to
8.1% 85,000mt while paper realizations are expected to increase by
4%YoY. We expect company to report EBITDA of Rs 1.1bn,
468 bps 82%YoY with margins of 26.2%. Company is likely to report
PAT of Rs 252mn with EPS of Rs 3.6
18.4%
18.4%

| Emkay Strategy | 8th January, 2013 | 82

Pharmaceutical
n Pharma universe is expected to report a core revenue growth of 21%YoY (1% QoQ)
n

Dr. Reddys (+33%), Sun Pharma (+21%), Lupin (+33%), Aurobindo (+25%), Cadila (+23%), Glenmark (+23%) and
Wockhardt (+19%) will be the out-performers

One-off such as Actos will contribute USD38mn this quarter for Ranbaxy

n OPM for the Emkay Pharma Universe (excluding one-off Actos) is expected to expand by 181bpsYoY & contract

134bps QoQ to 24.3% in Q3FY13 compared to 22.5% in Q3FY12 and 25.6% in Q2FY13.
n

For the companies EBITDA margins expansion will be happen for Wockhardt (+392bpsYoY & -335bps QoQ),
Dr. Reddys (+346bpsYoY & 28bps QoQ), Lupin (+181bpsYoY & -8bps QoQ), Cadila (+293bpsYoY & 306bps QoQ)
and Aurobindo (+227bpsYoY & +49bps QoQ)

n PAT of Pharma universe, is expected to grow by 21%YoY (-4% QoQ)


n

Growth in APAT will be on account of 78% growth in Dr. Reddy (strong contribution from Tacrolimus, Aorva
and Fonda), 38% growth in Wockhardt (18% gr. In US led by ramp-up in niche launches), 24% growth in
Aurobindo (35% growth in US led by 3 Injectable launches from Moraiya facility) & 32% growth in Lupin (15%
gr. In India & 34% $gr. In US)

n Our Preferred Bet Large Caps: Dr. Reddy, Lupin and Wockhardt

Mid Caps: Glenmark Pharma & Aurobindo


n Positive surprises in results: Lupin, Dr. Reddy and Glenmark
n Negative surprises in results: Ranbaxy, Cadila and IPCA

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 83

Pharmaceutical
Name

Dec12E

% Chg
YoY

Sep12

Dec11

16,082

15,004

12,847

25.2%

2,761

2,503

1,913

44.3%

17.2

16.7

1,410

1,294

1,137

24.0%

4.8

4.4

3.9

24.0%

17,053

15,459

13,832

23.3%

3,753

2,930

2,639

42.2%

22.0

19.0

2,297

1,556

1,773

29.5%

11.3

8.7

8.7

33.2%

20,498

21,918

17,580

16.6%

5,000

6,770

24.4

30.9

3,546

3,133

4.4

3.9

3.3

33.6%

% Chg
QoQ

Comments

Aurobindo
CMP(Rs)

202

Net Sales (Rs mn)

Mkt Cap (Rs bn)

59

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

230

PAT (Rs mn)

% Upside

14%

EPS (Rs)

CMP(Rs)

899

Net Sales (Rs mn)

Mkt Cap (Rs bn)

184

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

14.9 227 bps

7.2% Performance will be led by 28% $ growth in US business to


$84mn, on back of launch of 5 products Modafiniland
10.3% Escitalopram, Finasteride, Pramipexole dihydrochloride,
Minocycline hydrochloride
& ramp-up in Singular(11%) ,
49 bps Plavix ( 6%) and Zyprexa (5%)
8.9% EBITDA margins expansion by 227 bpsYoY will be led by
strong US business which in turn will improve gross margins
8.9%

Cadila

Target Price (Rs)

1,000

PAT (Rs mn)

% Upside

11%

EPS (Rs)

CMP(Rs)

424

Net Sales (Rs mn)

Mkt Cap (Rs bn)

341

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

350

PAT (Rs mn)

19.1 293 bps

10.3% Revenues will be driven by 26% growth in India and 35%


growth in US. In US the growth will be led by launch of 1
28.1% injectable and 3 oral solid in Q313 and ramp up of 3
injectables launched last quarter. Gross margins will remain
306 bps stable at 65.6% and EBITDA margins would improve by
300bps on back of operating leverage
29.5%
Company has only USD 19 million @~Rs.50 of hedges
29.5% remained, which will expire this quarter. Last quarter there was
a loss of Rs. 76 crores on hedges.

Cipla

% Upside

-18%

EPS (Rs)

-6.5% 17% growth in revenue will be on back of 12% growth in


domestic and 22% growth in Export formulations, led by
3,915
27.7% -26.1% Dymesta launch. However Lexapro prices have gone down in
this quarter as exclusivity finishes off last quarter.
22.3 213 bps -649 bps
Gross margins are assumed at 60% compared to 63% last
2,654
33.6%
13.2% quarter and 58% last year same quarter.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

13.2%

| Emkay Strategy | 8th January, 2013 | 84

Pharmaceutical
Name

Dec12E

% Chg
YoY

% Chg
QoQ

Sep12

Dec11

3075

2971

2655

15.8%

678

660

608

11.5%

22.0

22.2

22.9

-86

-19

PAT (Rs mn)

181

141

86

110.5%

28%

-11%

EPS (Rs)

2.2

1.7

1.1

110.5%

28%

1,095

Net Sales (Rs mn)

5,011

4,737

4,174

20.0%

1,975

1,858

1,511

30.7%

39.4

39.2

1,430

1,339

1,103

29.6%

10.8

10.1

8.3

29.6%

30,262

28,809

27,692

9.3%

7,342

6,910

8,690

-15.5%

24.3

24.0

4,539

4,750

4,880

-7.0%

-4.5%

26.8

28.0

28.8

-7.0%

-4.5%

Comments

Dishman
CMP(Rs)

120

Net Sales (Rs mn)

Mkt Cap (Rs bn)

10

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Accumulate EBITDA Margin (%)


107

3.5% Revenue growth will be led by 27% growth in MM business and


9% growth in CRAMs business. In MM business growth will be
2.6% primarily from Vitamin D business.
Operating margins will be stableYoY and QoQ.

Divis
CMP(Rs)
Mkt Cap (Rs bn)

145

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

1,250

PAT (Rs mn)

% Upside

14%

EPS (Rs)

1,888

Net Sales (Rs mn)

36.2 322 bps

5.8% Revenue growth will be led by ramp up in new capacity at


Vizag and favorable currency
6.3% Gross margins are estimated at 66% and EBITDA margins at
39%. Earnings will grow by 30%
20 bps
Going forward, Q4 will remain flatYoY. We expect consensus
6.9% earning estimates to come down by 5-10% for FY13 & FY14.
6.9%

Dr. Reddy
CMP(Rs)
Mkt Cap (Rs bn)

320

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

Target Price (Rs)

1,730

PAT (Rs mn)

31.4 -712 bps

5.0% Base business (w/o Zyprexa last year ) will grow by 31% on
back of US business which will clock $202 million in revenue
6.3% led by Tecrolimmus, Toprol, Singular, Lanso and Fonda
28 bps

Gross margins will be at 56.7% and EBITDA margins at 24%.


Adjusted for one offs, PAT will grow by 89% to Rs. 4.5 bn

% Upside

-8%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 85

Pharmaceutical
Name

Dec12E

% Chg
YoY

Sep12

Dec11

12,353

12,556

10,313

19.8%

2,537

2,714

20.5

21.6

1,419

1,452

1,153

23.0%

5.3

5.4

4.3

23.0%

Net Sales (Rs mn)

6,465

6,760

5,776

11.9%

EBITDA (Rs mn)

1,949

2,064

1,822

7.0%

30.1

30.5

1,611

1,634

1,473

9.4%

19.0

19.3

17.4

9.4%

% Chg
QoQ

Comments

Glenmark Pharma
CMP(Rs)

522

Net Sales (Rs mn)

Mkt Cap (Rs bn)

141

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

500

PAT (Rs mn)

% Upside

-4%

EPS (Rs)

-1.6% Revenues growth will be led by 29% growth in India & 19% $
growth in US business to USD75mn on back of launch of
1,029 146.7%
-6.5% Singulair & ramp-up in OC portfolio. Company has lost the
exclusivity on Cutivate and one more company has launched
10.0 1,057 bps -107 bps Melorene.
-2.3% Gross margins are assumed at 65% flat QoQ and 1.5%
higherYoY.
-2.3%

GlaxoSmithkline
CMP(Rs)
Mkt Cap (Rs bn)
Reco

2,182
185
Reduce

EBITDA Margin (%)

Target Price (Rs)

1,963

PAT (Rs mn)

% Upside

-10%

EPS (Rs)

31.5 -140 bps

-4.4% Revenue growth will be driven by growth in Vaccines and


derma segment. Top 10 brands which contribute 42% will drive
-5.6% the growth and profitability
-39 bps

Gross margins will contract by 140bpsYoY to 57.4% on back


of cost pressures & INR depreciation

-1.4% Govt.s price control policy will have a negative impact on GSK
as most of the brands are in premium category. Future growth
-1.4% depends on new vaccine launches

IPCA
CMP(Rs)

510

Net Sales (Rs mn)

7,089

7,713

6,148

15.3%

Mkt Cap (Rs bn)

64

EBITDA (Rs mn)

1,386

1,788

1,513

-8%

-8.1% Revenue growth will be led by 15% growth in India & 14%
growth in Exports, which in turn will be led by 46% in
-22% Institutional business (Rs.13.5bn).

Reco

Buy

EBITDA Margin (%)

19.5

23.2

24.6 -506 bps -364 bps

Target Price (Rs)

525

PAT (Rs mn)

895

1,162

1,038

-14%

-23%

% Upside

3%

EPS (Rs)

7.2

9.3

8.3

-14%

-23%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

Gross margins assumed at 59% QoQ const. and 2%


declineYoY. EBITDA margins will decline by 3% to 20%

| Emkay Strategy | 8th January, 2013 | 86

Pharmaceutical
Name

Dec12E

% Chg
YoY

% Chg
QoQ

Sep12

Dec11

Comments

12,522

12,250

10,885

15.0%

2,636

2,603

2,084

26.5%

21.0

21.2

1,125

1,025

771

45.9%

9.7%

7.1

6.4

4.8

45.9%

9.7%

24,126

23,007

18,189

32.6%

5,392

5,160

3,736

44.4%

4.9% Revenue growth will be led by 34% $ growth in US business on


back of 35% market share in Geodone, 22% MS in Combivir
4.5% and launch of Tricor, Seasonale and two more products.

22.4

22.4

3,106

2,906

2,351

32.1%

6.9%

6.9

6.5

5.2

33.3%

6.9%

26,170

26,910

37,923

-31.0%

3,400

4,179

16,293

-79.1%

13.0

15.5

2,899

3,608

15,146

-80.9%

6.9

8.6

36.0

-80.9%

Jubilant Life
CMP(Rs)

233

Net Sales (Rs mn)

Mkt Cap (Rs bn)

37

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

340

PAT (Rs mn)

% Upside

46%

EPS (Rs)

CMP(Rs)

599

Net Sales (Rs mn)

Mkt Cap (Rs bn)

268

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

630

PAT (Rs mn)

% Upside

5%

EPS (Rs)

CMP(Rs)

512

Net Sales (Rs mn)

Mkt Cap (Rs bn)

216

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

590

PAT (Rs mn)

% Upside

15%

EPS (Rs)

19.1 190 bps

2.2% Revenue growth will be led by Pharmaceuticals business which


will grow by 16% and Ingredients which will grew by 14%.
1.3% EBITDA margins are assumed at21% constant QoQ
-20 bps

Lupin

20.5 181 bps

-8 bps

Gross margins are assumed at 63% and EBITDA margins are


assumed at 22%

Ranbaxy
-2.8% Base revenue will grow by 10% to USD 475 million excluding
Lipitor effect last year and Actos this year. Base US revenue
-18.6% assumed USD 114 million and Actos USD 38 million

43.0 -2,997 bps -254 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

Gross margins assumed 60% and EBITDA margins assumed


at 13%, whereas base EBITDA margins at 8%

-19.6% Assumed Rs. 1.44bn PAT from Actos and rest Rs. 1.4 bn from
base business
-19.6%

| Emkay Strategy | 8th January, 2013 | 87

Pharmaceutical
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Sun Pharma
-2.8% Revenue growth will be led by 18% growth in US, 16% growth
in domestic and 31% growth in ROW. Taro revenue assumed
-5.3% at USD 155mn and a growth 5%.

CMP(Rs)

744

Net Sales (Rs mn)

25,897

26,639

21,451

20.7%

Mkt Cap (Rs bn)

769

EBITDA (Rs mn)

11,130

11,751

9,638

15.5%

Reco

Buy

EBITDA Margin (%)

43.0

44.1

Target Price (Rs)

800

PAT (Rs mn)

7,076

9,032

6,683

5.9%

-21.7%

% Upside

8%

EPS (Rs)

6.8

8.7

6.5

5.9%

-21.7%

CMP(Rs)

728

Net Sales (Rs mn)

7,860

7,772

6,966

12.8%

Mkt Cap (Rs bn)

62

EBITDA (Rs mn)

1,497

1,554

1,215

23.3%

44.9 -195 bps -114 bps

Gross margins assumed at 82% flat QoQ and EBITDA margins


at 43% down 1% QoQ

Torrent
1.1% Revenues will be driven by 15% growth in India,14% growth in
Brazil and 48% growth in US led by launch of Olanzapine,
-3.6% Quetiapine and Clopidogrel earlier in the year
Gross margins are assumed at 71% and EBITDA margins
at19% flat QoQ

Reco

Buy

EBITDA Margin (%)

19.0

20.0

17.4

161 bps

-94 bps

Target Price (Rs)

785

PAT (Rs mn)

930

995

755

23.2%

-6.5%

% Upside

8%

EPS (Rs)

11.0

11.8

8.9

23.2%

-6.5%

CMP(Rs)

191

Net Sales (Rs mn)

2,711

2,642

2,226

21.8%

Mkt Cap (Rs bn)

23

EBITDA (Rs mn)

545

529

368

47.9%

2.6% Revenue growth will be led by 21% growth in domestic market


and same growth in Exports market.
2.9% Gross margins assumed at 63% and EBITDA margins
assumed at 20% flat QoQ
6 bps

Unichem

Reco

Hold

EBITDA Margin (%)

20.1

20.0

16.5

355 bps

Target Price (Rs)

192

PAT (Rs mn)

361

365

245

47.4%

-1.3%

% Upside

0%

EPS (Rs)

4.0

4.0

2.7

47.4%

-1.3%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 88

Pharmaceutical
Name

Dec12E

% Chg
YoY

Sep12

Dec11

2,762

2,686

2,706

2.0%

EBITDA (Rs mn)

623

616

519

20.1%

% Chg
QoQ

Comments

Pfizer
CMP(Rs)
Mkt Cap (Rs bn)

1,165
35

Net Sales (Rs mn)

2.8% Revenue growth flat on back of subdued growth in companys


top brands Corex, Becosules, Gelusil & Dolonex
1.1% EBITDA margins assumed at 22.6% on back of hive off of low

Reco

Hold

EBITDA Margin (%)

22.6

22.9

19.2

339 bps

-37 bps

Target Price (Rs)

1,116

PAT (Rs mn)

550

546

487

13.1%

0.8%

EPS (Rs)

18.4

18.3

16.3

13.1%

0.8%

14,342

13,474

12,090

18.6%

5,022

5,170

3,760

33.6%

35.0

38.4

31.1

3,468

3,749

2,520

37.6%

-7.5%

31.7

34.3

23.0

37.6%

-7.5%

% Upside

-4%

margins Animal Nutrition business

Wockhardt
CMP(Rs)

1,673

Net Sales (Rs mn)

Mkt Cap (Rs bn)

183

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

2,160

PAT (Rs mn)

% Upside

29%

EPS (Rs)

6.4% Revenue growth will be led by 18% growth in US in dollor


terms to USD 121 mn. India is expected to grow by 7%.
-2.9% Gross margins are assumed at 68% and EBITDA margins at

392 bps -335 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

35%

| Emkay Strategy | 8th January, 2013 | 89

Power
n Quarterly Picks (1) GIPCL (Buy; expect 15-20% earnings upgrade in consensus FY13/14E earnings post 3Q13, Expect 20-

25% upside in built up to and post results), (2) PGCIL (Accumulate, 3Q13 slightly weak numbers already in price. Expect
strong guidance for 4Q13 in the analyst meet and expect the stock to bounce back to Rs120+ levels), (3) Nava Bharat
Ventures (Hold, likely to upgrade. PAT at Rs670mn to give confidence on sustainability of this run rate. Further, commissioning
of 64MW and 150MW in 4Q13 to drive earnings growth (30%+) in FY14E, expect the stock to give 20% returns in next 3-4
months) and (4) NTPC (Stock has corrected significantly but results to be good with 17% APAT growth driven by
commissioning. We expect Rs10/sh bounce back in the stock post OFS)
n Strong results but no upside - We also see strong results for (1) CESC (Buy, results to be good, PAT growth 28% qoq,

given 1% tariff hike recognition in 3Q13 even for 1H13. But it is a known factor and there is unlikely to be any upgrades in
earnings. However, we continue to like the stock from longer term perspective), (2) JSWE (Sell, results to be good given
merchant tariffs remaining high. But valuations do not warrant upside) and (3) NHPC Interest on water cess (~Rs1.3bn)
might be recognized this qtr which will lead to better numbers. But stock has already run-up big time and do not expect much
upside unless clarity on Subansiri lower and Parbati II execution.
n Weak results (1) JPVL (Binas low PLF/PAF and lower generation in hydro plants to impact numbers. To report net loss of

Rs90mn, likely earnings downgrade for FY13. However, FY14 earnings may remain unchanged, Stock to remain under
pressure on fund raising overhang), (2) Adani Power (losses to continue but will be lower QoQ. However, 7th Jan SLC meet
decision on permanent linkage to Tiroda and CERC decision on Mundra UMPP tariff increase to drive near term stock price. In
longer term, we remain negative on the stock) and (3) Lanco (losses to continue but will be lower QoQ. Stock performance to
be driven by near term cash flow management).

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 90

Power
n Other Events Based Picks Indiabulls Power (Buy, largest beneficiary of coal price pooling and commissioning lined up in

4Q13) and KSKE (Buy, coal price pooling, 7th Jan SLC meet decision on permanent linkage to Tiroda to set precedent for
Mahanadi, Gare Pelma Stage II forest clearance and commissioning in 1Q14)
n Merchant tariff Trends - Merchant prices on IEX continues to be in the range of Rs3-3.5/unit in rest of the country except

southern region. Southern region prices continue to be at Rs5.5/unit + levels.


n Overall view on the sector focus to shift to earnings - We believe the major reforms (Coal FSA and SEB restructuring)

are behind us and going forward there will be case specific resolutions (Competitive bidding guidelines, tariff escalation, coal
price pooling, case specific clearances, SLC meet on 7th Jan for permanent linkage to Tiroda etc). We believe now the focus
will shift to case specific earnings, valuations and risk profile. Overall, we reiterate our view that select private utilities will be
multibaggers (KSKE, CESC, Indiabulls Power and Reliance Power) and will outperform regulated utilities (Rs10-15/sh upside
in NTPC/PGCIL) by a big margin.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 91

Power
Name

Dec12E

Sep12

Dec11

Adani Power
CMP(Rs)

65

Net Sales (Rs mn)

Mkt Cap (Rs bn)

156

EBITDA (Rs mn)

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

30

PAT (Rs mn)

% Upside

-53%

EPS (Rs)

19,775

14,331

10,594

4,447

1,494

3,021

22.5

10.4

28.5

-1,863

-3,730

-633

-0.9

-1.7

-0.3

% Chg
YoY

% Chg
QoQ

PLFs improved in 3Q13 (62% vs. 54% in 2Q), more so in


Mundra I&II (87%-93%). Tiroda unit 1 is shutdown since 9th
86.7%
38.0% Nov due to some technical problems. We have assumed
Bunyu coal at 1mn MT (0.80mn MT in 2Q13) and CIL at
47.2% 197.6% 0.40mn MT (0.10mn MT in 2Q13). Expect Net loss at Rs1.9bn
(not building in any deferred tax). Difficult to estimate earnings
-603 bps 1,206 bps in Adani until clarity on Bunyu and CIL coal supplies. However,
@ 63, stock is overvalued and likely to maintain Sell. Key
n.a.
n.a. things to watch- (1) coal supply from Bunyu, (2) linkage coal
supply for Mundra-IV/Tiroda, (3) permanent linkage for Tiroda II
n.a.
n.a. (7th Jan meeting) and 4) result of CERC Mundra UMPP
petition.

JSW Energy
CMP(Rs)

68

Net Sales (Rs mn)

Mkt Cap (Rs bn)

112

EBITDA (Rs mn)

Reco

Sell

EBITDA Margin (%)

Target Price (Rs)

45

PAT (Rs mn)

% Upside

-34%

EPS (Rs)

22,136

20,765

17,687

25.2%

6.6%

5,914

5,769

3,496

69.2%

2.5%

26.7

27.8

1,989

1,819

274

626.2%

9.3%

1.2

1.1

0.2

626.2%

9.3%

19.8 695 bps -107 bps

Lanco Infra
CMP(Rs)

15

Net Sales (Rs mn)

Mkt Cap (Rs bn)

35

EBITDA (Rs mn)

Reco
Target Price (Rs)
% Upside

Hold
14
-4%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

Comments

37,464

31,850

30,290

23.7%

5,242

5,215

6,028

-13.0%

14.0

16.4

-1,942

-2,720

777

n.a.

-0.8

-1.1

0.3

n.a.

19.9 -591 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

JSWE will continue to report good numbers with merchant


tariffs in southern region remaining at high levels. Net
generation to decline by 3% qoq to 5.14BU primarily due to
better PLFs at Barmer. Expect PAT of Rs2.0b, higher than
2Q13 mainly due to no under-recovery at Barmer. Key things to
watch - (1) Buyers credit outstanding and (2) clearance for
expansion of lignite mines and 3) final tariff order. We currently
have a Sell rating on the stock and are likely to maintain Sell.

Gross generation to grow by 29% qoq largely due to higher


17.6% generation in Udupi and Anpara. Net sales expected to grow
by 18% qoq driven by higher revenues in Udupi/Anpara and
0.5% higher execution in Construction/EPC segment. Expect net
loss at Rs1.9b, better qoq mainly due to Udupi performance
-238 bps and lower losses at Anpara. To watch (i) Realizations at
Griffin, (2) gas supply, (3) progress on Udupi/Amarkantak tariff
n.a. issues, 4) equity dilution at SPV/Holdco. We have Hold Rating.
n.a.

| Emkay Strategy | 8th January, 2013 | 92

Power
Name

Dec12E

% Chg
YoY

Sep12

Dec11

12,637

10,512

4,573

176.4%

3,927

3,650

1,401

180.3%

31.1

34.7

30.6

43 bps

2,467

2,167

2,039

21.0%

1.5

1.3

1.2

21.0%

% Chg
QoQ

Comments

Reliance Power
CMP(Rs)

97

Net Sales (Rs mn)

Mkt Cap (Rs bn)

271

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

140

PAT (Rs mn)

% Upside

45%

EPS (Rs)

20.2% Rosas PLF has been very good at 90% and we have assumed
PAF of 93%. However, Butibori is not yet declared
7.6% commissioned and therefore no profit/loss from Butibori. We
have assumed Reliance infra supplies similar to last qtr. Expect
-365 bps PAT of Rs2.47b, up 14% qoq mainly driven by better PLF and
PAF. To watch (1) Fuel supply at Rosa & clarity on fuel supply
13.9% at Butibori, (2) mining cost at Sasan, (3) Update on Tilaiya mine
land acquisition and 4) Sasan COD. We have Buy rating on the
13.9% stock.

Jaiprakash Power
CMP(Rs)

39

Net Sales (Rs mn)

4,312

9,058

3,967

8.7%

-52.4%

Mkt Cap (Rs bn)

102

EBITDA (Rs mn)

3,430

8,116

3,570

-3.9%

-57.7%

Reco

Hold

EBITDA Margin (%)

79.6

89.6

90.0

-1,044
bps

-1,004
bps

PAT (Rs mn)

-90

3,661

595

n.a.

n.a.

EPS (Rs)

0.0

1.6

0.3

n.a.

n.a.

Target Price (Rs)


% Upside

45
16%

JPVL to report net loss (Rs90mn) mainly driven by lower PLF


and availability at Bina (PLF stood at 30%, assumed PAF at
50%). However, PLF has improved to 85%+ towards end of
December, so 4Q13 unlikely to have losses from Bina unless
2nd unit after COD runs at low PAF. Further, Hydro plants
generation was down 28%YoY (also due to restrictions
imposed). Karcham/VishnuPrayag generation was zero on 25th
Dec the last reported date. Overall, there is a risk to FY13
numbers (current FY13E EPS Rs2.7/sh - without any equity
dilution and H1FY13 Rs2.4/sh). To watch (1) Merchant
realizations at Karcham, (2) funding arrangement to redeem
bonds due in 4Q13 and (3) status of coal supply for Bina. Likely
to retain Hold on the stock.

KSK Energy
CMP(Rs)

62

Net Sales (Rs mn)

5,989

5,627

5,707

Mkt Cap (Rs bn)

23

EBITDA (Rs mn)

2,486

1,966

2,383

EBITDA Margin (%)

41.5

34.9

41.8

PAT (Rs mn)

502

544

755

EPS (Rs)

1.3

1.5

2.0

Reco
Target Price (Rs)
% Upside

Buy
76
22%

6.4% Expect numbers to improve QoQ mainly driven by better PLF at


VS lignite (80% vs. 52%) and Wardha (72% vs. 67%). We have
4.3%
26.4% assumed fuel cost of Rs2.65/unit at Wardha, any number
higher than this will lead to negative surprise. Expect PAT of
-25 bps 657 bps Rs502mn Key things to watch - (1) coal supply and landed cost
at Wardha, (2) coal and gas supply for smaller plants and (3)
-33.5%
-7.7% status on Gare Pelma III and Mahanadi plant. We have a buy
rating on the stock.
-33.5%
-7.7%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

4.9%

| Emkay Strategy | 8th January, 2013 | 93

Power
Name

Dec12E

% Chg
YoY

Sep12

Dec11

2,719

2,896

2,336

16.4%
41.9%

% Chg
QoQ

Comments

Nava Bharat
CMP(Rs)

182

Net Sales (Rs mn)

Mkt Cap (Rs bn)

16

EBITDA (Rs mn)

668

707

471

Reco

Hold

EBITDA Margin (%)

24.6

24.4

20.2 441 bps

Target Price (Rs)

204

PAT (Rs mn)

666

654

378

76.3%

% Upside

12%

EPS (Rs)

7.5

7.3

4.2

76.3%

158

Net Sales (Rs mn)

164,007

161,196

153,333

7.0%

40,037

42,241

29,050

37.8%

24.4

26.2

26,127

20,513

22,336

17.0%

3.2

2.5

2.7

17.0%

-6.1% Revenue expected at Rs2.72bn, up by ~16%YoY. Ferro alloys


business to register stable profits on the back of Tata Steel
-5.5% agreement. Expect similar profits even in power business as
tariffs and volumes are similar to 2Q13. Net profit expected at
15 bps Rs0.67bn. Key things to watch (1) merchant realizations, (2)
status of its Orissa 64MW and AP 150MW power plant, (3)
1.9% volumes under TISCO contract. We are likely to upgrade the
stock on the back of 150MW commissioning. Currently have a
1.9%
hold rating on the stock.

NTPC
CMP(Rs)
Mkt Cap (Rs bn)
Reco

1,299
Reduce

EBITDA (Rs mn)


EBITDA Margin (%)

18.9 547 bps

Target Price (Rs)

158

PAT (Rs mn)

% Upside

0%

EPS (Rs)

CMP(Rs)

76

Net Sales (Rs mn)

3,509

3,602

3,877

-9.5%

Mkt Cap (Rs bn)

11

EBITDA (Rs mn)

1,275

1,290

914

39.5%

EBITDA Margin (%)

36.3

35.8

23.6 1,276 bps

PAT (Rs mn)

506

529

168

201.5%

EPS (Rs)

3.3

3.5

1.1

201.5%

Est. PAT of Rs26.1b, growth of 17%YoY, is driven by 1)


1.7% regulated equity increase of 13%YoY and no deferred tax
assumed in 3Q13 vs. Rs1b in 3Q12. Generation to increase by
-5.2% 6%YoY to ~59.8BU mainly driven by capacity addition of
2.8GW post 3Q12. Assumed grossing up of RoE at regular tax
-179 bps rate. To watch - (1) coal supply and PAF of its plants, (2) adj. previous yr sales and other extra ordinaries not pass through,
27.4%
(3) UI income and 4) coal mine allocations through auction and
5) any other trigger created before OFS. We currently have
27.4% reduce rating on the stock but likely to upgrade to hold post
3Q13 as stock has corrected.

GIPCL

Reco
Target Price (Rs)
% Upside

Buy
87
15%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-2.6% GIPCL is one of our top picks for 3Q13 results. PLF for Surat
500MW has been excellent at 90% in 3Q13. Expect Net profit
-1.1% of Rs506mn in 3Q13 will be 3rd straight qtr of this run rate.
Post 3Q13, expect 15-20% upgrades in FY13/14 consensus
54 bps EPS (Rs10.2 and Rs11.8 for FY13 & FY14E). Our earnings
stand at Rs12.6 for FY13 and Rs13.4 for FY14. Based on
-4.3% FY14 numbers, stock has 5.8% dividend yield. We believe
stock will run-up by 20-25% in built-up to and post 3Q13
-4.3%
results. To watch PAF and core ROE. Current Reco - Buy.

| Emkay Strategy | 8th January, 2013 | 94

Power
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

CESC
CMP(Rs)

312

Net Sales (Rs mn)

Mkt Cap (Rs bn)

39

EBITDA (Rs mn)

Reco

Ur

EBITDA Margin (%)

Target Price (Rs)

PAT (Rs mn)

% Upside

-100%

EPS (Rs)

13,952

13,440

9,830

41.9%

3.8%

3,620

3,110

2,130

70.0%

16.4%

25.9

23.1

21.7 428 bps

281 bps

1,749

1,360

740

136.4%

28.6%

14.0

10.9

5.9

136.4%

28.6%

PGCIL
CMP(Rs)

114

Net Sales (Rs mn)

30,867

30,858

24,666

25.1%

0.0%

Mkt Cap (Rs bn)

530

EBITDA (Rs mn)

26,546

26,692

21,026

26.3%

-0.5%

86.0

86.5

85.2

76 bps

-50 bps

9,817

10,289

8,027

22.3%

-4.6%

2.1

2.2

1.7

22.3%

-4.6%

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

121

PAT (Rs mn)

% Upside

6%

EPS (Rs)

NHPC
CMP(Rs)

25

Net Sales (Rs mn)

Mkt Cap (Rs bn)

306

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

26

PAT (Rs mn)

% Upside

4%

EPS (Rs)

10,755

16,217

8,820

21.9%

-33.7%

4,627

10,553

3,788

22.1%

-56.2%

43.0

65.1

42.9

10 bps

-2210
bps

2,326

7,430

2,121

9.7%

-68.7%

0.2

0.6

0.2

9.7%

-68.7%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

Comments
Nos to be good on the back of 1% tariff hike recently. CESC to
recognize past two qtrs proportionate tariff impact in this qtr
resulting in an increase of Rs360mn in PAT. Expect full year
standalone EPS of Rs46.9 (likely to be cut by 2% as tariff hike
was slightly lower). We had put CESC on review post last qtr
with a positive view and are likely to upgrade to BUY post
3Q13. Do not see much action based on Qtrly results unless
there is any significant change in Spencers numbers. Key
things to watch- (1) Execution status of under-construction
plants and (2) profitability in Spencers.
3Q13 PAT Rs9.8b, gr. of 22%YoY but decline of 5% qoq. QoQ
decline is attributed to 1) lower other income and lower short
term open access income. We have built a capitalization of
Rs30bn in 3Q13, implying a capitalization of Rs85bn in 4Q13,
which has downside of Rs10-15bn. However, considering
PGCIL will still deliver 16% EPS growth in FY13 and gr. in
FY14 to be even stronger, expect the stock to bounce back to
Rs120 levels post 3Q13 results. Key things to watch 1) incr. in
12th plan capex and any change in mgmt outlook on equity
dilution and 2) capitalization in 4Q13 and FY14.
Nos could be significantly better if interest on water cess
(~Rs1.3b) is recognized in 3Q13 (regulations were notified on
31st Dec but we have not included this in our nos.). PAT of
Rs2.3bn, up 10%YoY, despite Chutak exp recognized but not
revenues, is driven by Chamera Commissioning. Have built
Chutak expenses of Rs250mn but no revenues. Driven by poor
river flow and reservoir levels, despite COD of 231MW
Chamera-III, gross generation to decline by ~12%YoY to
2.54BU in 3Q13. Key things to watch- (1) RoE grossing up (2)
status of dispute with J&K Govt. and (3) status of under
construction plants mainly Subansiri and Parbati II. DO not
expect further upside in the stock and likely to downgrade the
stock from Buy to hold post 3Q13 results.

| Emkay Strategy | 8th January, 2013 | 95

Power
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Tata Power
CMP(Rs)

109

Net Sales (Rs mn)

81,230

76,411

66,459

22.2%

Mkt Cap (Rs bn)

258

EBITDA (Rs mn)

17,547

14,507

9,889

77.4%

Reco

Hold

EBITDA Margin (%)

21.6

19.0

2,261

1,348

1,172

92.9%

EPS (Rs)

1.0

0.6

0.5

92.9%

Target Price (Rs)


% Upside

95
-12%

PAT (Rs mn)

14.9 672 bps

Net sales to grow by 22%YoY and 6% qoq to Rs81bn led by


6.3% higher generation at Mundra and Maithon. Assumed
Rs2009mn of dividend to be received from subsidiary during
21.0% the quarter at standalone level. Standalone net profit expected
at Rs3.4bn. Consolidated net profit on adjusted basis expected
262 bps to grow by 93%YoY driven by better standalone profits and
Key things to watch- (1) Production and realization Bumi, (2)
67.8% Coal blending at Mundra UMPP and (3) decision on Mundra
UMPP tariff petition before CERC. We have a hold rating on
67.8%
the stock.

Indiabulls Power
CMP(Rs)

15

Net Sales (Rs mn)

n.a

n.a

n.a

n.a

Mkt Cap (Rs bn)

41

EBITDA (Rs mn)

n.a

n.a

n.a

n.a

EBITDA Margin (%)

n.a

n.a

n.a

n.a

PAT (Rs mn)

n.a

n.a

n.a

n.a

EPS (Rs)

n.a

n.a

n.a

n.a

Reco
Target Price (Rs)
% Upside

Buy
21
37%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

n.a Boiler light up test conducted for first unit of Amravati Phase-I
and first unit expected to be commissioned by Feb12. Nashik
n.a first unit commissioning expected in March12. Recently MERC
has given its approval to Nashik PPA. Key trigger for the stock
n.a in near term is coal price pooling as Indiabulls is the largest
beneficiary. We expect coal price pooling decision in Jan itself.
n.a Thereafter, commissioning will be the trigger. Indiabulls Power
remains our top pick.
n.a

| Emkay Strategy | 8th January, 2013 | 96

Real Estate
n The Real Estate Q3FY13 results (Emkay Universe) are expected to be a mix bag. DLFs results would be boosted by

booking of NTC Mill land sale although ex-deal, cashflows would not have any significant change QoQ. Oberoi Realty
(OBRE) results will be flat QoQ with flat sale bookings nos. expected. Phoenix Mills (PML) financials too are expected
to be flat QoQ. Prestige Estates (PEPL) & Sobha Developers (SDL) financials to improve QoQ (ex. land monetisation)
with couple of projects crossing construction threshold, but surplus cash from the qtr would remain subdued leading
to no meaningful change in debt
n Sales bookings across the companies are expected to be subdued. DLFs sales booking will be boosted by its only

launch in the quarter of DLF Sky Court in Gurgaon. PEPL soft launched 3 projects with 3.3msf of SBA in Bangalore
which will help it maintain strong sales trajectory. PML had a large residential launch in Bangalore with sales booking
of 0.7msf. SDL sold 0.9msf in the quarter for Rs 5.3bn, nearing its target of Rs 20bn sales booking in FY13. OBRE had
no launches in Q3FY13 and would maintain sales booking QoQ
Sales Booking (msf)

Q3FY13E

Q2FY13

Q3FY12

DLF

1.4

1.6

3.3

Oberoi Realty

0.13

0.13

0.13

Prestige Estates

1.7

1.6

1.0

Sobha Developers

0.94

0.95

0.82

n We dont see any significant change in the o/s debt of the companies except DLF which will report lower debt owning

to cash from land sale. SDL and PEPL to have similar debt o/s QoQ while PML consolidated debt would increase due
to higher drawing for Shangri La project.
n We expect to increase TP across the companies on lower discount rate due to expected 100 bps cut expected in FY14

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 97

Real Estate
Name

Dec12E

% Chg
YoY

Sep12

Dec11

20,340

129.3

% Chg
QoQ

Comments

DLF
128.7 DLFs Q3FY13 results will have accounting of NTC Mill land
sale for Rs 27.3bn. Company has launched 1 project in the qtr
8,224
156.7
140.5 which may result into subdued sales booking of 1.4msf valued
at Rs 8bn. Net debt QoQ would be down by ~Rs 15bn as
40.4 -710bps -327bps stated on Q2FY13 presentation. New launch status and
cashflows timeline of Aman Resorts sale would be the key
2,583
159.1
383.3 things to be watched on the Q3FY13 results presentation.

CMP(Rs)

235

Net Sales (Rs mn)

46,646

20,395

Mkt Cap (Rs bn)

399

EBITDA (Rs mn)

15,546

7,464

33.3

36.6

6,694

1,385

3.9

0.8

1.5

n.a.

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

250

PAT (Rs mn)

% Upside

6%

EPS (Rs)

Phoenix Mills

(Standalone)

CMP(Rs)

258

Net Sales (Rs mn)

675

665

505

33.6

Mkt Cap (Rs bn)

37

EBITDA (Rs mn)

452

438

373

21.0

66.9

65.8

73.9 -698bps

PAT (Rs mn)

336

329

268

25.2

EPS (Rs)

2.3

2.3

1.9

n.a.

Reco
Target Price (Rs)
% Upside

n.a.

Accumulate EBITDA Margin (%)


221
-14%

1.5 Phoenix Mills to continue with steady numbers on the


standalone basis. On consolidated basis, the operations will
3.2 improve on back of strong reported housing sales in Bangalore
(W) and soft launch of Shangri La hotel in Q3FY13. We would
109bps be upgrading our target price on back of higher than expected
residential sales and realisations in the Bangalore (W) project.
2.1
n.a.

Oberoi Realty
CMP

298

Net Sales (Rs mn)

2,629

2,577

1,873

40.4

Mkt Cap (Rs bn)

98

EBITDA (Rs mn)

1,538

1,496

1,134

33.6

58.5

58.1

1,275

1,244

1,021

24.9

3.9

3.8

3.1

n.a.

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

315

PAT (Rs mn)

% Upside

6%

EPS (Rs)

60.5 -205bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

2.0 Oberoi Realty is expected to report subdued results for


Q3FY13. With no new launches, we expect the sales booking
3.2 to be similar to Q2FY12 at 0.13msf.Profitabiity margins are
also expected to be similar QoQ considering the similar mix of
43bps revenue contribution across the offerings. As usual, clarity on
land purchase, Mulund (W) projects environmental clearance
2.5 and Worli project launch is expected in the results coinf. call.
We may marginally increase our TP on FY14 rollover.
n.a.

| Emkay Strategy | 8th January, 2013 | 98

Real Estate
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Sobha Developers
CMP(Rs)

388

Net Sales (Rs mn)

4,828

4,148

3,032

59.2

Mkt Cap (Rs bn)

38

EBITDA (Rs mn)

1,380

1,285

948

45.5

Reco

Hold

EBITDA Margin (%)

28.6

31.0

31.3 -269bps

Target Price (Rs)

380

PAT (Rs mn)

548

501

401

36.6

% Upside

-2%

EPS (Rs)

5.6

5.1

4.1

n.a.

CMP(Rs)

180

Net Sales (Rs mn)

4,858

2,414

1,669

191.1

Mkt Cap (Rs bn)

59

EBITDA (Rs mn)

1,535

725

493

205.9

31.6

30.0

38.5

153bps

1,023

457

263

262.9

3.1

1.4

0.8

n.a.

16.4 Sobha Developers is expected to report strong nos.YoY and


QoQ as we expect a large project to cross construction
7.4 threshold level during the quarter. Margins are going to dip as
there is no revenue from high margin land monetisation is
-241bps expected in the quarter. SDL sold 0.9msf for Rs 5.3bn maintain
its traction and nearing its target sales booking of Rs 20bn in
9.3 FY13. With most of the sales booking coming from old projects,
as no new launches in Q3FY13, the cash inflows from sales
n.a.
would be higher.

Prestige Estates

Reco

Accumulate EBITDA Margin (%)

Target Price (Rs)

165

PAT (Rs mn)

% Upside

-8%

EPS (Rs)

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

101.2 PEPL to report strong financials amid 4 large projects reaching


threshold level of completion fully or partially. Sales booking is
111.8 expected to be subdued at ~ 1.5msf / Rs 7.4bn with 3 soft
launches in the qtr. EBITDA margins would improve marginally
157bps due to revenue booking from high margin projects like
Kingfisher towers. Gross consolidated debt should remain at
124.0 similar levels QoQ
n.a.

| Emkay Strategy | 8th January, 2013 | 99

Telecom
n Despite seasonally strong quarter, companies are expected to report muted volume (1%) and ARPM growth (0.5-1%).

Traffic growth for the sector to be muted led by continuous decline in subscribers (DoT has implemented stricter KYC
norms and operators are also removing inactive subscribers) and operators have been reducing discounting
minutes.
n

Domestic wireless revenue is expected to grow 2.3% sequentially for our coverage universe. Bharti and Idea is
expected to report growth of 2.6% and 2% qoq, respectively. ARPM growth of 1% for the Bharti and Idea to be
backed by data revenue growth as voice ARPM would remain flat qoq.

Traffic growth for Bharti and Idea is expected to be muted at 1% qoq, due to reduction in discounted minutes in
the system and decline in subscriber base. We estimate traffic growth of 1% qoq for Bharti and 0.5% for Idea.

Net subscriber addition during Q3FY13E is expected to further decline due to 1) implementation of stricter KYC
norms implemented by DoT and 2) removal of inactive subscribers from the system.

n Consolidated EBITDA of coverage universe is estimated to grow 2.5% qoq with EBITDA margin at 30%, flat qoq.

Lower subscriber acquisition cost to get offset by higher marketing spends during the quarter. APAT is expected to
grow 42% qoq for Bharti but decline 2.4% for Idea.
n Regulatory overhang has reduced to some extent with the failure of recently conducted 2G auction but many other

issues like spectrum re-farming and abolishment of roaming are yet to be finalized by the regulator. We believe stock
prices would remain volatile with the news flow on pending legal issues.
n We maintain our cautious view on the sector with HOLD rating on Bharti and REDUCE on Idea.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 100

Telecom
Name

Dec12E

% Chg
YoY

Sep12

Dec11

202,970

196,969

185,078

9.67%

62,618

61,007

59,584

5.09%

% Chg
QoQ

Comments

Bharti Airtel*
CMP(Rs)

327

Net Sales (Rs mn)

Mkt Cap (Rs bn)

1,241

EBITDA (Rs mn)

Reco

Hold

EBITDA Margin (%)

30.85

30.97

Target Price (Rs)

280

PAT (Rs mn)

6,923

4,825

10,113

46%

1.8

1.3

2.7

46%

% Upside

-14%

EPS (Rs)

32.19 -134 bps

Bharti is expected to report 3% qoq revenue growth. Indian


3.0% mobile revenue is expected to report 2.6% qoq decline. ARPU
is expected at Rs184. We estimate consolidated Adj. EBITDA
2.6% to grow 2.6% qoq with EBITDA margins of 30.8%. We expect
Africa revenue at Rs61.1bn (+1% qoq) and EBITDA margin of
-12 bps 27.1%. In USD terms, revenue is expected to grow 3% QoQ.
The watch out factor for Bharti would be overall guidance for
43.5% African operations, 3G off take and prevailing pricing trend in
the domestic market.
43.5%

Idea Cellular
CMP(Rs)

110

Net Sales (Rs mn)

53,991

53,140

50,308

7.3%

Mkt Cap (Rs bn)

363

EBITDA (Rs mn)

14,489

14,225

13,446

7.8%

26.8

26.8

26.7

11 bps

2,344

2,400

2,010

16.6%

0.7

0.7

0.6

16.6%

Reco
Target Price (Rs)
% Upside

Reduce
87
-21%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

1.6% Idea Cellular is expected to register revenue growth of 1.6%


QoQ. ARPU and MoU is expected to be at Rs 155 and 366,
1.9% respectively. Voice ARPM continues to remain flat qoq as
discounted minutes have been reduced in last couple of
7 bps months. However, data revenue to support overall ARPM.
EBITDA margin at 26.8% is expected to remain stable
-2.4% sequentially. Higher marketing spend would offset impact lower
subscriber acquisition cost. PAT is expected at Rs2.3bn as
-2.4%
compared to Rs2.4bn in the last quarter.

*Bhartis numbers for Q2FY13 are adjusted for one-offs pertaining to favorable interconnect judgment

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 101

Others
Name

Dec12E

Sep12

Dec11

% Chg
YoY

% Chg
QoQ

Comments

Aban Offshore
CMP(Rs)

398

Net Sales (Rs mn)

8,594

9,541

8,659

Mkt Cap (Rs bn)

17

EBITDA (Rs mn)

4,960

5,113

5,007

57.7

53.6

57.8

Reco

Accumulate EBITDA Margin (%)

-9.9% We expect Aban Offshores Q3FY13 consolidated revenue to


decline 0.7%YoY to Rs8.6bn. EBIDTA for the quarter at Rs4.96
-0.9%
-3.0% bn, is expected to decline 0.9%. However EBITDA margins are
expected to remain flattishYoY at 57.7%. Net profit at Rs0.7 bn
10 bps 410 bps for the quarter is expected to register decline 5.7%YoY.
-0.7%

Target Price (Rs)

500

PAT (Rs mn)

690

712

731

-5.7%

-3.2%

% Upside

26%

EPS (Rs)

15.8

16.4

16.8

-5.7%

-3.2%

125

Net Sales (Rs mn)

3647

3726

2734

33.4

EBITDA (Rs mn)

1029

1082

702

46.7

Arshiya International
CMP(Rs)
Mkt Cap (Rs bn)

Reco

Buy

EBITDA Margin (%)

28.2

29.0

25.7

255bps

Target Price (Rs)

172

PAT (Rs mn)

376

254

345

9.0

% Upside

38%

EPS (Rs)

6.4

6.0

4.8

n.a.

4,756

4,766

4,148

14.7%

-2.1 Arshiya Intl. is expected to report good quarterYoY owning to


revenue contribution from Khurja FTWZ which was absent in
-4.9 Q3FY12. On QoQ the financials would be subdued with
marginal improvement in profitability due to higher Other
-82bps Income. Rail business would get marginally affected due to
increase in haulage charges in Dec12. Delay in Khurja DP and
6.0 rail siding is the major disappointment for the quarter which
needs to be checked.
n.a.

Essel Propack
CMP(Rs)

42

Net Sales (Rs mn)

Mkt Cap (Rs bn)

EBITDA (Rs mn)

817

873

691

18.4%

EBITDA Margin (%)

17.2

18.3

16.6

54 bps

PAT (Rs mn)

167

232

136

23.1%

EPS (Rs)

1.1

1.5

0.9

23.1%

Reco
Target Price (Rs)
% Upside

Buy
62
48%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-0.2% Higher volumes in AMESA (12%YoY) and Europe (2%YoY)


coupled with rising share of non-oral care in revenues to drive
-6.4% growth. Expect EAP region to continue growing at a slow pace
owing to lower volume off-take. We expect EPL to post
-113 bps revenue growth of 14.7%YoY to Rs 4.8bn. Better product mix
on account of non-oral care and reduce loses in Poland would
-27.8% drive margin expansion of 50bpsYoY to 17.2%. Subsequently,
expect APAT to grow at 23%YoY to Rs 167mn.
-27.8%

| Emkay Strategy | 8th January, 2013 | 102

Others
Name

Dec12E

% Chg
YoY

Sep12

Dec11

12,986

13,345

12,429

4.5%

2,483

2,898

2,854

-13.0%

19.1

21.7

23.0

-380

2,365

3,827

2,745

-13.9%

25.8

41.7

29.9

-13.9%

10,295

9,581

8,962

14.9%

1,304

1,192

1279.2

1.9%

% Chg
QoQ

Comments

Grasim
CMP(Rs)

3,180

Net Sales (Rs mn)

Mkt Cap (Rs bn)

292

EBITDA (Rs mn)

Reco

Buy

EBITDA Margin (%)

Target Price (Rs)

4,000

PAT (Rs mn)

% Upside

26%

EPS (Rs)

CMP

646

Net Sales (Rs mn)

Mkt Cap (Rs bn)

81

EBITDA (Rs mn)

-2.7% Grasims standalone net revenue for the quarter is expected to


grow by 4.5%yoy to Rs12.98bn with VSF segment reporting
-14.3% growth of 1.6%YoY at Rs11bn whereas the chemical business
segment revenues growing 13.2%YoY. VSF realizations are
-260 expected to decline by 3% qoq led by price cuts. Overall
EBIDTA at Rs2.48bn is expected to decline 13%yoy.
-38.2% Consequently, pre-exceptional net profit at Rs2.36bn is
expected to decline 13.9%YoY.
-38.2%

Havells India

Reco

Buy

EBITDA Margin (%)

12.7

12.4

14.2

-150

Target Price (Rs)

740

PAT (Rs mn)

818

869.7

788.8

3.6%

% Upside

15%

EPS (Rs)

6.6

7.0

6.3

3.6%

CMP(Rs)

232

Net Sales (Rs mn)

4,209

3,889

3,507

20.0%

Mkt Cap (Rs bn)

17

EBITDA (Rs mn)

648

599

561

15.6%

7.4% New products in ECD & switchgear and added capacities in


lighting & luminaries along with festive season would drive 15%
9.4% revenue growth to Rs 10.3bn. Expect EBIDTA to grow at
2%YoY to Rs 1.3bn, while EBIDTA margins would fall by
40 150bpsYoY to 12.7% owing to high base effect of
corresponding last quarter. We expect APAT to grow at 4%YoY
-6.0% to Rs 818mn. In Sylvania, Europe operations would stagnate,
while LATAM may grow 8-10% led by price increase and cross
-6.0% selling new products. Guided 6% EBIDTA margins may be
difficult to sustain.

Kajaria Ceramics

Reco

Buy

EBITDA Margin (%)

15.4

15.4

16.0

-58 bps

Target Price (Rs)

260

PAT (Rs mn)

294

265

211

39.4%

8.2% We estimate revenues to increase by 20%YoY to Rs 4.2bn.


Company is likely to report EBITDA of Rs 648mn, 16%YoY
8.3% with EBITDA margins of 15.4%. We expect company to report
PBT of Rs 425mn, 40%YoY. We expect company to report
1 bps PAT of Rs 294mn, 39%YoY with margins of 7.0%. EPS is likely
to be around Rs 4.0
10.6%

% Upside

12%

EPS (Rs)

4.0

3.6

2.9

39.4%

10.6%

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 103

Others
Name

Dec12E

% Chg
YoY

Sep12

Dec11

4,199

4,214

3,464

21.2%
6.7%

% Chg
QoQ

Comments

Piramal Glass
CMP(Rs)

88

Net Sales (Rs mn)

Mkt Cap (Rs bn)

EBITDA (Rs mn)

918

610

861

24.9 -299 bps

Reco

Buy

EBITDA Margin (%)

21.9

14.5

Target Price (Rs)

145

PAT (Rs mn)

331

43

188

76.0%

% Upside

65%

EPS (Rs)

4.1

0.5

2.3

74.9%

-0.4% Continued growth in premium C&P segment along with


improving stabilization in new facility to drive 21%YoY revenue
50.4% growth to Rs 4.2bn. However, higher fixed cost and suboptimal product mix of new facility would impact EBIDTA
738 bps margins. Expect EBIDTA to grow 7%YoY to Rs 918mn. We
expect EBIDTA margins to decline 300bpsYoY to 21.9%.
667.6% However, higher other income would result in APAT growth of
76%YoY to Rs 331mn.
667.6%

Sterlite Tech
CMP(Rs)

37

Net Sales (Rs mn)

7,598

8,421

6,635

14.5%

Mkt Cap (Rs bn)

14

EBITDA (Rs mn)

690.2

503.0

522.3

32.1%

9.1

6.0

188.5

42.0

94.7

99.0%

0.5

0.1

0.2

99.0%

Reco
Target Price (Rs)
% Upside

Hold
34
-7%

EBITDA Margin (%)


PAT (Rs mn)
EPS (Rs)

7.9 121 bps

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

-9.8% Revenue is expected to grow 14.5% yoy, led by 18% yoy


revenue growth in power. Muted revenue growth is expected
37.2% in telecom segment due to lower dispatches during the
quarter. Fibre optic volumes are expected at 2.9mn fkm, down
52 bps 1.4% yoy. EBITDA margin at 9.1% is expected to improve by
121bps yoy, led by 214bps margin expansion in Telecom
347.7% segment. Power segment margins are unlikely to show major
improvement in current quarter. PAT is expected to improve
347.7% by 100% yoy due low base last year. Update on UMTP
projects, consolidated debt and outlook on EBITDA/Tone for
power segment would be key things to out for.

| Emkay Strategy | 8th January, 2013 | 104

Valuations
Company Name
Agri Input & Chemicals
Chambal Fertilisers
Coromandel International
Deepak Fertilisers
Dhanuka Agritech
GNFC
GSFC
Rallis India
Tata Chemicals
United Phosphorus
Automobiles
Ashok Leyland
Bajaj Auto
Eicher Motors
Hero Motocorp
Mah & Mah
Maruti Suzuki India
Tata Motors
TVS Motor
Auto Ancillaries
Amara Raja Batteries
Apollo Tyres
CEBBCO
Exide Industries
Motherson Sumi
Cement
ACC
Ambuja Cements
India Cements
Madras Cements
Orient Paper
Shree Cements
Ultratech Cement

Price
(Rs)
70
261
130
131
83
72
151
371
139

27
2,210
2,841
1,907
953
1,588
317
47

Mkt Cap
(Rs bn)
351
29
74
11
7
13
29
29
95
64

Reco

Target
Price
(Rs)

Sales (Rs mn)


FY13e
FY14e
519,154
550,680
57,390
59,659
93,792
102,422
25,334
23,254
5,936
6,867
37,928
41,105
54,432
55,326
14,660
16,279
148,026
156,795
81,657
88,973

EBITDA (Rs mn)


FY13e
FY14e
76,611
88,450
7,379
8,025
9,145
12,050
4,002
4,598
870
1,058
5,739
8,568
7,883
8,934
2,486
2,800
24,284
25,527
14,823
16,889

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
38,861
46,548
16.9
20.2
9.0
7.5
1.4
1.2
14.9
16.5
16.1
17.0
3,724
4,189
8.9
10.1
7.8
7.0
1.4
1.2
11.1
12.3
19.4
18.9
5,803
7,961
20.7
28.4
12.6
9.2
2.7
2.3
18.1
23.6
22.8
27.1
2,016
2,533
22.9
28.7
5.7
4.5
0.8
0.7
16.5
18.8
15.6
17.4
623
754
12.4
15.1
10.5
8.7
2.5
2.0
28.7
29.9
26.1
25.9
2,643
3,771
17.0
24.3
4.9
3.4
0.5
0.4
10.5
14.6
10.1
13.2
5,460
5,879
13.7
14.8
5.3
4.9
0.7
0.6
17.3
16.8
14.5
13.8
1,428
1,632
7.3
8.4
20.5
18.0
4.7
4.1
28.9
29.8
24.2
24.3
9,746
10,809
38.2
42.4
9.7
8.8
1.3
1.2
13.9
14.2
14.4
14.4
7,418
9,022
16.1
19.5
8.7
7.1
1.4
1.2
15.6
17.2
16.6
17.6

Accumulate
Accumulate
Buy
Buy
Buy
Hold
Accumulate
Buy
Accumulate

98
340
172
150
105
70
153
400
172

3,165
71
Hold
639 Reduce
77 Reduce
381
Buy
585 Accumulate
459
Hold
931 Accumulate
22
Hold

28
2,100
2,400
2,350
1,100
1,700
350
44

3,403,228
128,045
202,333
63,213
228,923
396,471
431,959
1,881,917
70,367

4,010,103
147,750
237,703
78,033
255,469
461,367
521,319
2,229,967
78,495

429,221
11,550
37,368
5,647
33,278
46,381
32,191
258,580
4,227

526,209
13,260
48,728
7,932
37,070
54,007
49,431
310,893
4,888

225,946
3,993
30,377
3,544
21,880
32,186
18,261
113,721
1,985

278,949
5,268
37,710
4,474
22,952
37,943
29,589
138,548
2,465

28.7
1.5
105.0
131.2
109.6
52.3
63.2
34.2
4.2

35.4
2.0
130.3
165.7
114.9
61.6
102.4
41.7
5.2

14.0
17.8
21.1
21.6
17.4
18.2
25.1
9.3
11.2

11.3
13.5
17.0
17.1
16.6
15.5
15.5
7.6
9.1

3.3
2.4
8.5
4.3
7.2
4.1
2.7
2.4
1.7

2.7
2.3
6.6
3.5
6.0
3.4
2.4
1.9
1.5

26.0
12.8
61.6
25.1
47.3
26.2
14.4
25.2
15.6

28.2
13.5
61.5
26.5
49.9
27.0
20.9
26.6
17.7

26.8
13.6
44.7
21.5
45.5
24.3
11.4
30.1
16.1

26.8
17.4
43.8
22.4
39.3
24.1
16.4
28.1
17.9

320
95
130
190
215

496,448
29,449
141,444
7,475
63,536
254,543

572,128
35,287
157,466
9,287
76,064
294,023

49,604
4,701
16,398
1,349
9,218
17,937

61,192
5,650
18,078
1,575
12,143
23,746

23,319
2,998
6,974
748
6,194
6,405

30,152
3,667
8,108
897
8,476
9,004

10.8
17.6
13.8
13.6
7.3
10.9

13.9
21.5
16.1
16.3
10.0
15.3

14.4
14.9
6.4
6.9
20.1
18.3

11.2
12.2
5.5
5.7
14.7
13.0

3.2
4.2
1.3
1.6
3.5
5.2

2.6
3.2
1.1
1.3
3.0
4.2

22.2
41.9
20.7
29.8
26.1
18.2

25.2
40.6
20.5
30.0
29.9
24.0

23.9
31.6
22.1
26.1
18.8
31.0

25.5
30.0
21.0
25.6
22.0
35.4

1,510
210
103
245
92
4,420
1,950

598,250
109,306
100,526
46,365
39,134
28,157
58,981
215,782

684,323
126,293
115,002
50,852
44,359
32,180
66,438
249,199

138,776
22,096
26,240
9,179
10,830
3,932
16,790
49,709

159,741
27,087
30,313
10,272
11,904
4,415
18,430
57,322

75,830
13,638
16,791
2,377
3,992
2,109
8,185
28,737

86,245
17,125
19,375
3,059
4,615
2,374
8,195
31,503

27.3
72.6
10.9
7.7
16.8
10.3
235.0
104.9

31.0
91.1
12.6
10.0
19.4
11.6
235.2
114.9

18.5
19.6
18.8
11.8
14.4
8.0
19.6
19.3

16.2
15.6
16.3
9.2
12.5
7.1
19.6
17.6

3.2
3.4
3.5
0.7
2.4
1.3
4.6
3.6

2.8
3.0
3.1
0.7
2.1
1.1
3.8
3.1

20.9
24.0
27.2
9.4
14.7
19.0
25.3
21.4

21.4
27.4
28.3
10.3
15.7
18.6
21.4
21.0

18.8
18.1
19.7
6.5
18.0
17.5
26.4
20.3

18.6
20.4
20.4
7.9
18.0
16.9
21.3
18.8

261
89
93
146
200

336
45
45
5
124
117

1,424
205
91
242
82
4,606
2,023

1,401
267
316
28
58
17
160
555

Buy
Hold
Buy
Buy
Buy

Accumulate
Hold
Hold
Accumulate
Accumulate
Accumulate
Hold

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 105

Valuations
Company Name
Construction
Adani Ports
Ashoka Buildcon
GMR Infrastructure
IL&FS Transportation
IRB Infrastructure
IVRCL
Jaiprakash Associates

Price
(Rs)
139
216
20
219
133
47
102

Mkt Cap
(Rs bn)
Reco
688
278
Buy
11
Buy
79
Hold
43 Accumulate
44
Buy
14
Hold
219
Hold

Target
Price
(Rs)
150
340
21
221
230
39
93

Sales (Rs mn)


FY13e
FY14e
447,345
547,197
40,268
52,313
19,033
23,076
90,936
146,288
70,093
69,324
36,603
44,150
52,385
59,352
138,027
152,695

EBITDA (Rs mn)


FY13e
FY14e
134,742 176,651
27,205
34,781
4,168
4,693
26,948
51,871
18,754
21,647
15,935
18,520
4,342
5,216
37,389
39,922

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
25,540
34,067
2.9
3.8
26.9
20.2
2.0
1.8
7.3
8.3
7.1
9.1
9,151
14,136
4.5
7.0
30.6
19.8
5.1
4.2
7.9
9.2
17.7
23.2
1,168
1,316
22.2
25.0
9.8
8.7
1.0
0.9
3.7
3.0
10.7
10.8
-2,180
375
-0.6
0.1 -36.2 210.6
0.8
0.9
3.8
6.5
-2.3
0.4
4,903
4,471
25.2
23.0
8.7
9.5
1.4
1.2
12.4
11.9
17.0
13.7
4,556
4,462
13.7
13.4
9.7
9.9
1.4
1.2
11.6
10.3
15.0
13.1
70
487
0.2
1.6 204.3
29.5
0.6
0.6
9.0
9.1
0.3
2.1
7,872
8,821
3.7
4.1
27.4
24.5
1.9
1.7
8.8
9.6
6.6
7.3

Consumers
Asian Paints
Berger Paints
Colgate-Palmolive
Glaxosmithkline Consumer
Godrej Consumer Products
Hindustan Unilever
Jubilant FoodWorks
Marico
Nestle
Page Industries
Titan Industries

4,395
157
1,541
3,845
721
529
1,327
228
4,900
3,400
286

3,234
422
54
210
162
245
1,145
86
147
472
38
254

Sell
Accumulate
Buy
Accumulate
Sell
Hold
Sell
Accumulate
Accumulate
Sell
Buy

3,340
152
1,400
3,400
580
490
1,000
208
5,000
2,849
285

784,563
113,837
33,914
30,947
30,588
65,034
255,546
14,457
47,965
82,998
8,481
100,796

916,856
130,574
38,361
35,841
34,930
78,292
289,108
20,223
55,888
100,072
10,638
122,930

123,057
18,152
3,480
6,413
5,993
11,102
39,482
2,594
6,560
17,564
1,700
10,018

146,650
21,066
4,040
7,589
6,882
13,687
46,462
3,646
7,666
21,250
2,130
12,232

87,985
11,990
2,087
5,486
4,420
7,195
32,258
1,494
4,228
10,435
1,144
7,250

103,214
13,753
2,409
6,400
5,078
9,140
36,104
2,101
5,087
12,694
1,418
9,032

18.2
125.0
6.0
40.3
105.1
21.1
14.9
23.0
6.6
108.2
102.6
8.2

21.4
143.4
7.0
47.1
120.7
26.9
16.7
32.3
7.9
131.7
127.1
10.2

36.8
35.2
26.0
38.2
36.6
34.1
35.5
57.8
34.7
45.3
33.2
35.0

31.3
30.7
22.5
32.7
31.8
26.8
31.7
41.1
28.9
37.2
26.8
28.1

15.4
11.8
5.8
37.6
11.7
7.2
22.8
20.0
7.3
29.4
18.3
13.2

12.5
9.3
4.9
29.9
9.7
6.1
18.4
14.4
6.1
27.4
14.7
10.1

55.1
47.4
26.6
151.3
53.9
22.4
105.5
59.7
27.2
63.1
64.7
62.3

54.2
43.4
26.9
140.5
51.1
25.2
90.8
60.1
26.0
79.6
60.9
58.9

47.8
37.9
24.2
110.5
35.0
23.2
75.6
40.9
26.9
72.5
61.4
43.1

44.1
33.8
23.6
101.8
33.3
24.6
64.2
40.7
23.0
76.2
61.0
40.8

Eng. & Capital Goods


BHEL
Blue Star
Cummins India
Elecon Engineering
Greaves Cotton
Larsen & Toubro
Lakshmi Machine Works
Mcnally Bharat Engineering
Punj Lloyd
Thermax
TRF
Voltas

243
180
534
49
81
1,615
2,270
100
62
623
243
107

1,937
595
16
148
5
20
993
26
3
21
74
3
35

Hold
Buy
Accumulate
Hold
Buy
Accumulate
Hold
Hold
Accumulate
Hold
Sell
Accumulate

220
215
500
56
90
1,759
1,923
110
74
505
180
121

1,595,232
466,404
27,933
43,307
12,982
19,124
728,008
22,855
27,632
121,247
56,455
12,441
56,843

1,681,047
410,811
31,252
50,764
14,174
21,489
828,921
25,836
30,748
129,710
60,618
14,266
62,458

222,255
90,698
1,668
8,021
1,906
2,468
92,644
2,871
2,015
11,494
4,890
599
2,979

222,181 131,628
69,942 62,211
2,505
964
9,436
6,261
2,077
612
2,861
1,462
106,503 52,349
3,395
1,542
2,258
552
12,318
129
5,493
3,282
892
-26
4,499
2,290

126,701
47,388
1,431
7,370
695
1,709
57,972
1,869
591
562
3,770
204
3,140

28.6
25.4
10.7
22.6
6.6
6.0
85.5
136.9
17.8
0.4
27.5
-2.4
6.9

27.5
14.7
19.4
9.6
15.9
16.8
26.6
23.6
7.5
7.4
7.0
13.5
94.7
18.9
165.9
16.6
19.0
5.6
1.7 159.0
31.6
22.6
18.5 -102.0
9.5
15.4

15.3
12.5
11.3
20.1
6.5
11.6
17.1
13.7
5.3
36.5
19.7
13.1
11.2

2.6
2.0
3.0
6.9
0.9
2.8
2.9
2.6
0.8
0.7
4.0
1.7
2.1

2.3
1.8
2.6
6.4
0.8
2.4
2.6
2.2
0.7
0.7
3.5
1.6
1.9

16.5
32.2
17.8
41.6
15.2
28.9
11.1
23.4
15.7
9.7
23.6
7.6
20.3

14.4
20.7
28.1
44.7
15.4
29.9
11.1
25.4
15.4
9.8
23.9
11.0
24.8

18.7
22.5
19.0
29.8
13.1
21.8
16.7
16.4
14.2
0.4
18.8
-1.7
14.7

15.8
14.9
24.7
33.0
13.6
22.3
16.1
17.4
13.4
1.9
18.9
12.6
17.7

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 106

Valuations
Price
(Rs)

Company Name
Fin. Services - Others
CRISIL
ICRA

1,044
1,430

IT Services
eClerx Services
HCL Tech
Hexaware Technologies
Infinite Computer
Infosys
Mahindra Satyam
Mindtree
Mphasis
NIIT Tech
Persistent Systems
TCS
Tech Mahindra
Wipro

702
636
89
131
2,350
108
694
393
257
535
1,295
941
408

Media & Entertainment


DB Corp
Dish TV
HT Media
Jagran Prakashan
Zee Entertainment

237
79
103
111
228

Mkt Cap
(Rs bn)
Reco
88
73 Accumulate
14
Hold
5,778
21
441
26
6
1,349
127
29
83
15
21
2,535
120
1,004

Target
Price
(Rs)
1,050
1,300

Sales (Rs mn)


FY13e
FY14e
12,685
16,000
10,072
12,901
2,613
3,099

EBITDA (Rs mn)


FY13e
FY14e
3,994
5,077
3,247
4,168
748
909

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
2,858
3,472
35.7
43.4
30.7
25.2
11.5
9.2
59.8
59.5
41.2
40.4
2,252
2,788
32.1
39.8
32.5
26.2
16.1
12.0
85.5
78.1
57.4
52.4
606
684
60.6
68.4
23.6
20.9
4.6
4.2
27.8
30.5
20.1
20.9

Hold
Accumulate
Hold
Buy
Accumulate
Accumulate
Buy
Reduce
Accumulate
Hold
Hold
Accumulate
Reduce

720
650
100
140
2,575
125
750
375
325
425
1,200
1,050
360

2,017,296
6,656
248,649
21,301
13,924
404,442
77,563
23,447
53,575
19,800
12,856
630,443
68,638
436,002

2,173,787
7,537
271,179
23,724
15,181
433,841
83,630
25,363
59,761
21,839
13,800
679,113
76,455
462,364

488,592
2,562
50,071
4,188
2,370
118,765
16,495
4,794
10,511
3,320
3,377
181,321
14,081
76,736

516,763
2,803
51,543
4,755
2,600
127,836
16,253
4,555
11,454
3,794
3,185
193,987
14,346
79,652

376,096
1,683
33,232
3,196
1,376
92,176
12,450
3,214
7,922
2,176
1,921
136,481
14,548
65,721

399,936
2,086
34,410
3,686
1,555
99,367
12,955
3,239
8,038
2,382
1,868
146,698
14,557
69,095

48.7
56.0
47.3
10.6
32.0
161.3
10.6
78.4
37.6
36.3
48.0
69.7
111.1
26.8

405
43
Hold
84 Accumulate
24
Hold
35
Hold
219
Buy

219
79
107
108
275

110,389
15,915
22,286
20,689
15,499
36,000

124,845
17,476
25,932
22,349
17,437
41,651

24,729
3,639
6,210
2,929
3,182
8,770

30,756
4,327
7,874
3,235
3,842
11,477

11,261
2,081
-831
1,731
1,672
6,608

16,100
2,602
491
2,089
2,261
8,658

4.1
11.4
-0.8
7.4
5.3
6.9

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

51.8
69.4
49.0
12.3
36.1
173.9
11.0
79.0
38.1
39.7
46.7
75.0
111.1
28.2

15.4
12.5
13.4
8.4
4.1
14.6
10.2
8.8
10.4
7.1
11.1
18.6
8.5
15.2

14.4
10.1
13.0
7.3
3.6
13.5
9.8
8.8
10.3
6.5
11.5
17.3
8.5
14.5

5.9
36.0
14.2
20.9
0.5 -101.0
8.9
13.9
7.1
21.0
9.1
32.9

25.2
16.7
171.0
11.6
15.5
25.1

4.0
4.9
3.4
2.0
0.9
3.7
2.2
2.3
1.9
1.4
2.1
6.4
2.3
3.0

3.4
3.9
2.9
1.7
0.8
3.1
1.8
1.9
1.7
1.2
1.8
5.4
1.8
2.7

35.3
55.1
31.5
32.0
29.4
37.4
27.0
36.5
23.7
29.8
31.9
51.3
20.4
24.1

32.3
54.7
27.9
32.7
28.7
35.3
23.1
30.3
22.2
27.8
24.3
45.8
17.7
22.3

28.4
43.4
27.9
24.9
24.7
26.5
23.9
29.3
19.1
22.0
23.4
38.2
31.0
21.4

25.8
42.7
24.1
25.5
23.6
25.2
20.0
23.5
17.5
20.6
17.2
33.9
24.2
19.7

5.7
4.9
4.4
3.9
-84.2 -165.7
1.5
1.3
4.1
3.6
5.7
5.0

0.4
26.7
4.5
14.0
18.9
26.6

0.5
30.4
15.2
14.9
24.5
30.3

0.4
21.9
86.2
11.3
20.7
18.3

0.5
24.8
-65.3
12.2
24.6
21.2

| Emkay Strategy | 8th January, 2013 | 107

Valuations
Company Name
Metals & Mining
Bhushan Steel
Godawari Power
HEG
Hindalco
Hindustan Zinc
JSW Steel
NMDC
SAIL
Sesa Goa
Sterlite Industries
Tata Steel

Price
(Rs)
478
119
236
133
141
827
165
96
201
120
433

Oil & Gas


BPCL
Cairn India
GAIL
Gujarat Gas
Gujarat State Petronet
HPCL
Indian Oil
Indraprastha Gas
Petronet LNG
Oil India
ONGC
Reliance Industries

383
343
370
306
81
323
286
258
167
484
287
866

Paper
Ballarpur Inds
JK Paper
Tamilnadu Newsprint

23
41
111

Mkt Cap
(Rs bn)
Reco
3,197
102 Reduce
4
Buy
9
Hold
255
Buy
597
Buy
185 Accumulate
652
Hold
396
Hold
175
Hold
402
Hold
421 Reduce
8,031
277
655
469
39
46
109
694
36
125
291
2,455
2,836

Accumulate
Buy
Buy
Hold
Accumulate
Buy
Accumulate
Ur
Buy
Accumulate
Accumulate
Hold

29
15 Accumulate
6
Sell
8
Buy

Target
Price
(Rs)
408
151
235
134
146
743
196
82
153
92
349

397
385
406
292
86
360
320
194
573
313
827

27
30
148

Sales (Rs mn)


FY13e
FY14e
3,875,164 4,304,645
113,178
143,217
24,450
25,032
17,587
20,069
816,925
904,832
116,162
130,923
393,935
413,433
114,095
126,872
468,666
560,145
25,381
75,856
431,600
466,473
1,353,184 1,437,795

EBITDA (Rs mn)


FY13e
FY14e
633,794 766,414
34,918
42,229
3,833
4,375
3,362
4,030
76,847
92,769
61,691
71,148
67,599
74,347
86,168
95,641
62,803
78,385
7,734
28,583
98,279 114,093
130,560 160,814

13,954,508 13,378,576 1,450,393 1,501,824


2,237,311 2,103,540
50,879
56,974
169,231
149,272 130,250 104,310
451,957
489,736
60,447
68,074
35,030
37,046
4,656
4,847
11,150
11,236
10,147
10,191
1,860,707 1,775,542
48,538
51,171
3,950,373 3,764,673 208,498 207,749
32,180
36,379
7,334
8,246
299,614
364,355
19,643
22,226
113,976
116,264
43,220
43,053
1,566,499 1,603,119 557,111 594,157
3,226,480 2,927,416 309,671 330,827
82,067
50,896
13,844
17,327

85,977
50,720
18,157
17,100

16,931
11,143
1,471
4,316

19,571
12,130
2,509
4,931

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
325,273 386,546
16.3
19.3
9.8
8.3
1.1
1.0
11.9
12.7
12.2
13.1
10,021
13,228
44.2
58.4
10.8
8.2
1.3
1.1
8.9
9.8
12.7
14.6
1,324
1,475
41.7
46.4
2.8
2.6
0.5
0.4
14.4
12.9
17.6
16.5
1,861
2,082
46.6
52.1
5.1
4.5
1.0
0.9
12.7
13.9
21.0
20.8
27,230
34,316
14.2
17.9
9.4
7.4
0.7
0.7
6.7
7.4
8.2
9.6
62,017
67,461
14.7
16.0
9.6
8.9
1.9
1.6
24.1
23.0
21.2
19.7
18,294
20,871
82.0
93.5
10.1
8.8
1.0
0.9
11.7
11.6
10.6
11.1
72,373
78,244
18.3
19.7
9.0
8.3
2.2
1.9
39.9
36.5
27.0
24.7
32,606
37,233
7.9
9.0
12.1
10.6
0.9
0.9
8.5
8.9
8.0
8.6
24,258
34,197
27.9
39.3
7.2
5.1
1.0
0.9
3.5
12.1
15.2
18.7
55,887
57,823
16.5
17.1
7.2
7.0
0.8
0.7
14.2
14.0
11.5
10.8
19,401
39,617
20.0
40.8
21.7
10.6
0.9
0.9
8.3
9.8
4.2
8.4
786,880
16,952
109,674
37,076
3,009
4,911
14,146
82,048
3,350
10,743
37,247
262,829
204,894

791,145
21,291
89,191
41,710
3,129
4,848
15,075
82,350
3,648
10,644
37,572
268,854
212,832

38.1
23.4
57.5
29.2
23.5
8.7
41.7
33.8
23.9
14.3
62.0
30.7
63.2

38.3
29.4
46.8
32.9
24.4
8.6
44.5
33.9
26.1
14.2
62.5
31.4
65.0

10.2
16.3
6.0
12.6
13.0
9.3
7.7
8.5
10.8
11.6
7.8
9.3
13.7

10.2
13.0
7.3
11.2
12.5
9.4
7.3
8.4
9.9
11.7
7.7
9.1
13.3

1.6
1.6
1.2
1.9
3.1
1.6
0.8
1.1
2.5
2.8
1.4
1.6
1.9

1.4
1.4
1.1
1.8
2.6
1.4
0.7
1.0
2.1
2.4
1.3
1.5
1.7

16.0
9.2
23.2
18.1
30.3
19.2
7.3
8.7
31.2
22.5
27.5
23.4
12.5

15.3
10.0
16.4
18.5
26.9
17.5
7.5
8.4
27.8
20.3
25.0
22.9
12.0

16.5
9.9
21.7
16.0
26.1
18.4
10.3
13.6
25.3
27.1
19.7
18.2
14.8

14.9
11.5
15.3
16.4
22.4
15.7
10.2
12.5
23.4
22.1
17.7
16.8
13.7

3,031
1,738
342
951

3,896
2,630
-15
1,282

3.5
2.7
2.5
13.7

4.5
4.0
-0.1
18.5

9.4
7.3
8.8
5.8
16.3 -358.7
8.1
6.0

0.6
0.5
0.6
0.7

0.6
0.5
0.7
0.7

7.0
7.2
3.5
9.2

7.9
8.1
4.6
10.5

6.4
6.0
4.0
9.5

7.8
8.6
-0.2
12.0

| Emkay Strategy | 8th January, 2013 | 108

Valuations
Company Name
Pharmaceuticals
Aurobindo Pharma
Cadila Healthcare
Cipla
Dishman Pharma
Divi's Lab
Dr. Reddy's Lab
Glaxosmithkline Pharma
Glenmark Pharma
Ipca Lab
Jubilant Life Sciences
Lupin
Pfizer
Ranbaxy Labs
Sun Pharma
Torrent Pharma
Unichem Labs
Wockhardt
Power
Adani Power
CESC
Gujarat Industries Power
Indiabulls Power
Jaiprakash Power Ventures
JSW Energy
KSK Energy
Lanco Infratech
Nava Bharat Ventures
NHPC
NTPC
Power Grid Corporation
Reliance Power
Tata Power

Price
(Rs)
202
902
419
118
1,105
1,901
2,164
529
510
234
605
1,170
516
743
733
192
1,684

Mkt Cap
(Rs bn)
Reco
3,049
59
Buy
185
Buy
337
Hold
10 Accumulate
147
Buy
323
Hold
183 Reduce
143
Buy
64
Buy
37
Buy
271
Buy
35
Hold
218
Buy
769
Buy
62
Buy
23
Hold
184
Buy

65
316
73
16
39
69
61
15
180
25
159
114
97
110

3,214
154
Sell
40
Ur
11
Buy
41
Buy
101
Hold
113
Sell
23
Buy
35
Hold
16
Hold
309
Buy
1,309 Reduce
529 Accumulate
271
Buy
261
Hold

Target
Price
(Rs)
230
1,000
350
107
1,250
1,730
1,963
500
525
340
630
1,116
590
800
785
192
2,160

30
87
21
45
45
76
14
204
26
158
121
140
95

Sales (Rs mn)


FY13e
FY14e
935,929 1,056,074
54,745
63,102
62,569
72,426
78,791
91,787
12,501
13,818
21,566
27,016
121,255
143,501
27,088
30,878
47,458
54,957
27,794
31,943
49,703
57,676
87,617
100,998
10,528
12,045
131,344
126,480
104,083
116,169
32,013
36,100
10,618
12,189
56,256
64,989
1,566,397
73,727
50,492
14,679
5,518
25,535
90,064
23,134
134,926
13,396
54,788
606,251
128,298
50,464
295,126

2,004,109
150,991
53,510
15,143
51,204
41,939
100,879
39,255
200,448
16,169
64,909
702,000
156,849
65,138
345,674

EBITDA (Rs mn)


FY13e
FY14e
239,794 258,511
9,359
10,759
13,384
16,099
19,422
22,464
2,875
3,184
8,356
10,468
28,170
32,591
9,309
10,726
9,302
10,991
6,117
7,029
10,134
11,968
19,028
21,982
2,014
2,334
34,926
22,388
42,725
46,802
6,230
7,055
1,758
2,164
16,685
19,506

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
158,496 171,920
34.9
37.9
19.2
17.7
4.7
3.8
26.3
24.8
27.1
23.6
4,582
5,508
15.7
18.9
12.8
10.7
2.1
1.8
14.5
17.3
17.8
18.1
8,294
10,142
40.5
49.5
22.3
18.2
5.9
4.6
22.8
24.6
29.0
28.4
12,288
14,104
15.3
17.6
27.4
23.9
3.9
3.4
19.6
19.7
14.6
14.8
904
1,082
11.2
13.4
10.6
8.8
0.9
0.9
10.8
11.6
10.1
10.3
6,135
7,555
46.2
56.9
23.9
19.4
5.5
4.4
32.3
32.2
25.6
25.3
17,567
20,533
103.6 121.1
18.4
15.7
5.0
3.9
27.3
27.9
30.7
28.0
7,050
8,068
83.2
95.3
26.0
22.7
8.3
7.1
52.6
52.5
33.8
33.8
5,445
6,749
20.1
24.9
26.3
21.2
4.9
4.0
18.0
19.4
20.3
20.7
4,071
4,672
32.7
37.5
15.6
13.6
3.9
3.1
26.9
26.3
28.4
25.6
4,189
5,350
26.3
33.6
8.9
7.0
1.4
1.2
11.9
13.9
17.5
18.8
11,588
14,056
26.0
31.5
23.3
19.2
5.4
4.3
29.7
29.6
25.9
25.1
1,953
2,220
65.5
74.4
17.9
15.7
2.4
2.2
22.4
22.7
14.4
14.6
25,742
15,210
61.1
36.1
8.4
14.3
4.1
3.2
39.4
20.2
64.0
24.9
32,559
37,612
31.4
36.3
23.6
20.5
5.2
4.2
30.3
27.5
24.6
22.9
3,826
4,496
45.2
52.5
16.2
14.0
4.5
4.2
30.3
30.7
33.2
31.2
1,141
1,435
12.6
15.9
15.2
12.1
2.3
2.0
18.4
20.1
16.2
17.9
11,161
13,127
102.0 120.0
16.5
14.0
7.1
4.7
32.5
34.8
52.7
40.4

494,040
14,512
12,484
4,995
2,442
21,716
24,909
9,318
30,007
3,266
35,128
149,290
106,650
20,714
58,607

194,227
-10,064
5,889
1,904
359
6,066
7,738
1,796
-3,932
2,710
23,001
97,546
41,003
10,173
10,038

681,400
55,852
13,231
4,984
26,348
31,437
30,129
16,908
58,664
4,074
43,614
166,375
127,450
29,613
72,723

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

255,555
8,225
5,784
2,024
8,385
8,549
10,349
2,136
3,330
3,009
25,952
106,901
49,900
10,759
10,254

4.6
-4.2
46.9
12.6
0.2
2.4
4.7
4.8
-1.6
30.3
1.9
11.8
8.9
3.6
4.2

6.0
3.4
46.0
13.4
3.8
3.0
6.3
5.5
1.4
33.7
2.1
12.7
10.8
3.8
4.3

16.5
-15.3
6.7
5.8
97.5
16.1
14.6
12.7
-8.9
5.9
13.4
13.5
12.9
26.7
26.0

12.6
18.8
6.9
5.4
4.2
12.8
10.9
11.0
10.5
5.4
11.9
12.5
10.6
25.2
25.4

1.5
2.8
0.7
0.7
0.8
1.8
1.7
0.6
0.6
0.6
1.0
1.6
1.9
1.5
2.1

1.4
2.4
0.7
0.7
0.7
1.4
1.5
0.5
0.6
0.6
1.0
1.5
1.7
1.4
2.0

7.8
1.3
9.3
14.0
1.3
7.3
10.3
4.5
4.9
10.2
5.7
8.9
9.2
4.8
9.1

9.2
6.4
8.7
14.1
11.3
8.4
12.2
6.8
9.0
9.2
6.1
8.8
9.8
4.6
10.3

9.5
-16.5
11.5
12.7
0.8
13.0
12.7
4.9
-7.1
11.1
7.9
12.6
15.1
5.6
8.2

11.6
13.7
10.3
12.4
17.2
13.0
14.8
5.3
6.0
11.0
9.0
12.8
16.6
5.6
7.9

| Emkay Strategy | 8th January, 2013 | 109

Valuations
Company Name
Real Estate
DLF
Oberoi Realty
Phoenix Mills
Prestige Estates
Sobha Developers
Telecommunications
Bharti Airtel
Idea Cellular
Reliance Communications
Tulip Telecom
Others
Aban Offshore
Arshiya International
Essel Propack
Grasim Industries
Havells India
Kajaria Ceramics
Piramal Glass
Sterlite Tech

Price
(Rs)
236
304
257
185
391

330
110
82
35

406
125
42
3,179
652
236
88
34

Mkt Cap
(Rs bn)
Reco
637
401 Accumulate
100
Buy
37 Accumulate
61 Accumulate
38
Hold
1,791
1,252
364
170
5

Hold
Reduce
Reduce
Reduce

443
18 Accumulate
8
Buy
7
Buy
292
Buy
81
Buy
17
Buy
7
Buy
13
Hold

Target
Price
(Rs)
250
315
221
165
380

Sales (Rs mn)


FY13e
FY14e
170,558
171,446
110,781
94,579
14,433
18,777
7,387
9,370
18,574
25,313
19,383
23,408

EBITDA (Rs mn)


FY13e
FY14e
73,702
77,388
50,075
43,955
8,488
13,716
3,868
5,557
5,315
7,339
5,956
6,820

PAT (Rs mn)


EPS (Rs)
PE (x)
PB (x)
ROCE (%)
ROE (%)
FY13e
FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
28,977
34,710
11.2
13.4
22.0
18.4
1.7
1.5
10.0
10.5
8.0
8.8
15,048
15,919
8.9
9.4
26.7
25.2
1.5
1.4
8.6
7.7
5.8
5.7
7,051
10,350
21.5
31.5
14.1
9.6
2.3
1.8
22.9
30.0
17.3
21.1
1,907
1,888
13.2
13.0
19.5
19.7
2.0
1.8
8.6
11.2
10.7
9.7
2,407
3,537
7.3
10.8
25.2
17.2
2.6
2.3
10.9
13.8
10.7
14.2
2,564
3,016
26.2
30.8
15.0
12.7
1.7
1.6
15.8
16.5
12.2
13.0

280
87
49
92

1,267,986
805,418
217,456
215,449
29,662

1,357,788
863,839
238,002
222,859
33,088

380,231
248,352
58,319
65,998
7,563

418,288
275,201
66,755
67,731
8,601

50,868
32,151
9,796
6,987
1,934

73,953
47,945
15,065
8,752
2,191

5.5
8.5
3.0
3.4
13.3

7.9
12.6
4.6
4.2
15.1

35.2
38.9
37.1
24.3
2.6

24.2
26.1
24.1
19.4
2.3

1.6
2.2
2.6
0.5
0.3

1.5
2.0
2.3
0.4
0.3

7.0
8.2
9.4
4.0
11.6

8.0
9.5
11.8
4.1
11.9

4.7
5.8
7.2
1.9
12.1

6.5
8.1
10.2
2.3
12.1

500
172
62
4,000
740
260
145
34

477,988
36,316
14,910
18,558
268,269
73,461
15,437
17,270
33,766

546,116
37,553
18,966
20,732
311,919
81,794
17,401
19,793
37,958

105,163
20,681
4,326
3,195
61,247
6,928
2,432
3,520
2,833

122,003
21,622
6,157
3,604
71,553
7,954
2,798
4,215
4,099

39,630
2,910
1,470
680
27,835
3,890
1,095
987
763

47,043
4,985
1,855
906
30,274
4,677
1,373
1,489
1,484

38.6
66.9
23.8
4.3
303.5
31.2
14.9
12.2
1.9

45.4
114.5
25.6
5.8
330.1
37.5
18.7
18.4
3.8

11.2
6.1
5.3
9.7
10.5
20.9
15.9
7.2
17.3

9.4
3.5
4.9
7.3
9.6
17.4
12.7
4.8
8.9

1.6
0.6
0.7
0.7
1.5
6.5
4.7
1.7
1.1

1.4
0.5
0.7
0.7
1.3
5.0
3.6
1.3
1.0

14.8
9.4
10.7
12.4
16.9
31.2
30.6
16.2
10.3

15.5
10.0
13.0
13.9
16.9
32.3
33.3
19.5
13.2

15.3
10.8
15.1
7.5
15.2
35.2
33.7
26.1
6.5

15.8
16.3
15.1
9.3
14.5
32.7
32.4
31.0
11.7

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 110

Valuations

Reco

Target
Price
(Rs)

Price Mkt Cap


Company Name

(Rs)

Banks & Fin. Services

(Rs bn)

(Rs mn)
FY13e
1,680,005

Pre Provision Profit


(Rs mn)

FY14e

FY13e

PAT (Rs mn)

FY14e

FY13e

2,007,134 1,331,078 1,612,956 670,495

EPS (Rs)

PE (x)

PB (x)

ROA (%)

ROE (%)

FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e FY13e FY14e
844,069

49.7

61.9

12.9

10.3

1.9

1.7

1.7

1.8

16.3

17.8

Allahabad Bank

186

93

Hold

145

52,847

63,206

36,883

43,807

15,640

21,926

31.3

43.8

6.0

4.2

1.1

0.9

0.8

1.0

14.1

17.4

Andhra Bank

128

72

Hold

105

37,848

48,366

27,579

35,494

13,268

15,752

23.7

28.1

5.4

4.6

1.0

0.9

1.0

1.0

16.5

16.9

Axis Bank

8,679

Net Interest Income

1,384

591

Reduce

1,050

96,477

117,711

90,476

111,380

49,007

61,261

114.3

141.7

12.1

9.8

2.2

1.9

1.5

1.6

19.2

19.9

Bank of Baroda

888

348

Hold

800

118,889

145,211

97,456

120,882

54,277

67,439

131.6

163.5

6.7

5.4

1.2

1.1

1.1

1.2

18.3

19.4

Bank of India

369

212

Reduce

240

93,083

112,210

74,838

91,848

26,788

34,224

46.6

59.6

7.9

6.2

1.3

1.1

0.6

0.7

12.2

14.2

Canara Bank

529

234

Reduce

380

79,581

90,941

56,193

65,636

27,268

29,864

61.6

67.4

8.6

7.9

1.3

1.2

0.7

0.7

11.5

11.5

Corporation Bank

490

73

Hold

440

33,558

38,052

27,770

31,706

14,175

15,039

95.7

101.5

5.1

4.8

0.9

0.8

0.8

0.8

16.1

15.3

Dewan Housing

222

26 Accumulate

243

6,321

7,892

4,729

5,821

3,391

4,224

29.0

36.1

7.7

6.1

1.4

1.1

1.4

1.4

15.6

17.0

Federal Bank

532

91

Hold

500

21,408

25,980

16,288

20,223

8,830

10,724

51.6

62.7

10.3

8.5

1.6

1.3

1.4

1.4

14.6

15.9

HDFC

830

1,280

Reduce

700

58,068

67,859

63,999

74,838

47,558

55,380

30.9

36.0

26.9

23.1

4.5

4.4

2.6

2.6

20.1

19.1

HDFC Bank

675

1,598

Hold

620

149,017

184,114

111,488

143,645

67,372

88,235

28.5

37.1

23.7

18.2

4.6

3.8

1.8

2.0

20.5

22.4

1,181

1,358

Hold

1,100

135,719

159,466

129,321

152,816

79,820

95,504

69.2

82.8

17.1

14.3

2.1

1.9

1.6

1.7

12.6

13.8

ICICI Bank
LIC Housing Finance

150 Accumulate

280

15,042

20,830

14,758

20,351

10,438

15,826

20.7

31.3

14.4

9.5

2.4

2.0

1.4

1.8

17.2

22.5

1,204

137

Hold

935

22,470

28,815

15,510

19,573

8,842

10,425

78.5

92.5

15.3

13.0

3.1

2.6

4.0

3.6

23.6

21.0

Manappuram Finance

43

36

Reduce

30

14,117

14,117

7,516

7,237

4,880

4,477

5.8

5.3

7.5

8.1

1.3

1.2

3.7

2.8

18.9

15.0

Punjab National Bank

911

309

Reduce

610

150,524

176,001

113,854

136,640

49,782

61,580

146.8

181.6

6.2

5.0

1.4

1.2

1.0

1.1

16.7

17.9

South Indian Bank

29

39

Hold

25

12,831

15,950

8,255

10,496

4,794

6,328

3.6

4.7

8.2

6.2

1.4

1.2

1.1

1.1

18.6

19.5

State Bank of India

2,492

1,672

Reduce

1,750

453,310

534,228

334,893

395,344

140,321

186,824

209.1

278.4

11.9

9.0

2.2

1.8

1.0

1.1

15.6

17.9

Union Bank of India

280

154

Reduce

190

77,459

91,934

55,674

68,928

22,375

29,879

40.6

54.3

6.9

5.2

1.4

1.1

0.8

0.9

14.4

17.0

United Bank Of India

85

31

Buy

75

30,160

34,867

23,230

27,449

8,847

10,841

23.1

25.4

3.7

3.3

0.8

0.7

0.8

0.9

17.1

17.7

493

176

Hold

440

21,276

29,383

20,369

28,839

12,821

18,317

35.7

42.3

13.8

11.7

3.1

2.2

1.6

1.8

24.5

23.7

Mah & Mah Fin. Services

Yes Bank

297

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 111

Thank You

Emkay Global Financial Services Ltd.


7th Floor, The Ruby, Senapati Bapat Marg, Dadar - West, Mumbai - 400028. India Tel: +91 22 66121212 Fax: +91 22 66121299 Web: www.emkayglobal.com
DISCLAIMER: Emkay Global Financial Services Limited and its affiliates are a full-service, brokerage, investment banking, investment management, and financing group. We along
with our affiliates are participants in virtually all securities trading markets in India. Our research professionals provide important input into our investment banking and other business
selection processes. Investors may assume that Emkay Global Financial Services Limited and/or its affiliates may seek investment banking or other business from the company or
companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business.
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the
opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein.
In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other
important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This report is not directed to, or intended for
distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication,
availability or use would be contrary to law or regulation or which would subject Emkay Global Financial Limited or its group companies to any registration or licensing requirement
within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an
official confirmation of any transaction to any U.S. person unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this
document may be distributed in Canada or used by private customers in United Kingdom. All material presented in this report, unless specifically indicated otherwise, is under
copyright to Emkay. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior
express written permission of Emkay. All trademarks, service marks and logos used in this report are trademarks or registered trademarks of Emkay or its Group Companies. The
information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or
copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that you have read Risk Disclosure Document for Capital Market and Derivatives
Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is
believed to be reliable, although its accuracy and completeness cannot be guaranteed.

Q3FY13 Results Preview: Earnings to slump again as margins face renewed hurdles

| Emkay Strategy | 8th January, 2013 | 112

Anda mungkin juga menyukai